
<!DOCTYPE html>
<html lang="en"     class="pb-page"  data-request-id="de6ef628-1966-4faf-8c00-41d7893f55f2"  
><head data-pb-dropzone="head"><meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="pbContext" content=";issue:issue:doi\:10.1002/ijc.v132.4;page:string:Article/Chapter View;article:article:doi\:10.1002/ijc.27730;ctype:string:Journal Content;website:website:pericles;journal:journal:10970215;wgroup:string:Publication Websites;pageGroup:string:Publication Pages;subPage:string:Full Text;requestedJournal:journal:10970215"/>

<script type="text/javascript">var $DoubleClickZone = "ij-cancer_ijc";var $DoubleClickSite =  "wly.onco.radthr_000091";</script><script id="analyticDigitalData">digitalData = {"site":{"ip":"216.165.249.165","environment":"LIVE","website":"onlinelibrary.wiley.com","websiteCode":"pericles","serverDate":"2022-03-06"},"identities":[{"type":"SmartGroupUser","uuid":"b238ab85-6bb4-49e4-84ca-a0d9f3ee5a35"},{"type":"SmartGroupUser","uuid":"eabce89b-65c2-4a09-ab7c-bd2b3fea2f10"},{"type":"RegionUser","uuid":"3c5060a1-6620-438f-862b-902a4d4cd4ac"},{"type":"BasicGroup","uuid":"e623deab-c83b-41e3-84a2-d9f1d46c5f17"},{"type":"SmartGroupUser","uuid":"a86d27d2-6bcd-4b94-bca5-fe16f4882855"},{"type":"ReferrerUser","uuid":"5a2c1d70-1255-4a45-95f3-a3aa3a2771fb"},{"type":"InstitutionUser","uuid":"ea77208c-eba1-49cf-a446-5d73daccdfad","customerRecords":[{"customerDomain":"ALM-CU","customerNumber":"TESTOHIOSTATECOCHRANE"}]},{"type":"SmartGroupUser","uuid":"da88d808-3f7b-4bde-9210-10862b6d121b"},{"type":"SmartGroupUser","uuid":"8c72a733-117a-4bc9-a682-13475f13e6a3"},{"type":"SmartGroupUser","uuid":"756fc162-8722-461f-a077-ebffec4f4fae"},{"type":"SmartGroupUser","uuid":"cf9c85b9-7f3b-4309-aeaa-c41669cabe3b"},{"type":"SmartGroupUser","uuid":"db8b8d10-1aed-4809-b3ee-70938c569014"},{"type":"SmartGroupUser","uuid":"cdce41c2-a8de-4a64-a4d9-a85caaaa2314"},{"type":"ReferrerUser","uuid":"6401b279-b825-4f41-a389-04e29feb967f"},{"type":"SmartGroupUser","uuid":"39f911ce-44b6-4dba-9978-8b2e947a8eb0"},{"type":"RegionUser","uuid":"18971d33-e3f1-4194-be84-47668d10cf64"},{"type":"SmartGroupUser","uuid":"b7acda8c-ce18-451b-a68d-e14b72f9b5b8"},{"type":"SmartGroupUser","uuid":"055a2bdd-861f-4fa7-bd49-9773db7e0e3e"},{"type":"BasicGroup","uuid":"197fe835-5b5f-4f4e-b8e9-a74d68491a84"},{"type":"SmartGroupUser","uuid":"b2dbfe27-ecae-4bb6-bb0d-d75e5caa3762"},{"type":"SmartGroupUser","uuid":"1a6297fb-6679-4882-a4c2-fdd124624edf"},{"type":"SmartGroupUser","uuid":"8032f17e-5050-4fb4-9c40-e1f6875d5c2b"},{"type":"BasicGroup","uuid":"2f6750d5-f13f-4356-939b-048ac1423e64"},{"type":"SmartGroupUser","uuid":"ab743440-628f-4964-9216-9983ad3beadf"},{"type":"SmartGroupUser","uuid":"a4187e00-f28e-4754-9a0f-1eb306fb0679"}],"publication":{"item":{"title":"Inhibition of rhabdomyosarcoma cell and tumor growth by targeting specificity protein (Sp) transcription factors\u003clink href\u003d\u0027#fn1\u0027\u003e\u003c/link\u003e","doi":"10.1002/ijc.27730","access":"free","earliestDate":"2012-07-19","formats":["Abstract","Cited by","First page image","Full text","PDF","References","Supplementary Material"],"topics":[{"taxonomyUri":"global-subject-codes","topicLabel":"MEDICAL SCIENCE","topicUri":"md"},{"taxonomyUri":"global-subject-codes","topicLabel":"LIFE SCIENCES","topicUri":"ls"},{"taxonomyUri":"global-subject-codes","topicLabel":"Pharmacology \u0026 Pharmaceutical Medicine","topicUri":"mdm0"},{"taxonomyUri":"global-subject-codes","topicLabel":"Clinical Pharmacology \u0026 Therapeutics","topicUri":"mdm1"},{"taxonomyUri":"global-subject-codes","topicLabel":"Pathology","topicUri":"mdk0"},{"taxonomyUri":"global-subject-codes","topicLabel":"Oncology \u0026 Radiotherapy","topicUri":"mdh0"},{"taxonomyUri":"global-subject-codes","topicLabel":"Surgical Oncology","topicUri":"mdh2"},{"taxonomyUri":"global-subject-codes","topicLabel":"Medical Oncology","topicUri":"mdh3"},{"taxonomyUri":"global-subject-codes","topicLabel":"Palliative Care","topicUri":"mdh4"},{"taxonomyUri":"global-subject-codes","topicLabel":"Hematology","topicUri":"mdc0"},{"taxonomyUri":"global-subject-codes","topicLabel":"Cell \u0026 Molecular Biology","topicUri":"ls30"}]},"group":{"doi":"10.1002/ijc.v132.4","access":"free","volume":"132","issue":"4","coverDate":"2013-02-15","topics":[{"taxonomyUri":"global-subject-codes","topicLabel":"MEDICAL SCIENCE","topicUri":"md"},{"taxonomyUri":"global-subject-codes","topicLabel":"LIFE SCIENCES","topicUri":"ls"},{"taxonomyUri":"global-subject-codes","topicLabel":"Pharmacology \u0026 Pharmaceutical Medicine","topicUri":"mdm0"},{"taxonomyUri":"global-subject-codes","topicLabel":"Clinical Pharmacology \u0026 Therapeutics","topicUri":"mdm1"},{"taxonomyUri":"global-subject-codes","topicLabel":"Pathology","topicUri":"mdk0"},{"taxonomyUri":"global-subject-codes","topicLabel":"Oncology \u0026 Radiotherapy","topicUri":"mdh0"},{"taxonomyUri":"global-subject-codes","topicLabel":"Surgical Oncology","topicUri":"mdh2"},{"taxonomyUri":"global-subject-codes","topicLabel":"Medical Oncology","topicUri":"mdh3"},{"taxonomyUri":"global-subject-codes","topicLabel":"Palliative Care","topicUri":"mdh4"},{"taxonomyUri":"global-subject-codes","topicLabel":"Hematology","topicUri":"mdc0"},{"taxonomyUri":"global-subject-codes","topicLabel":"Cell \u0026 Molecular Biology","topicUri":"ls30"}]},"series":{"title":"International Journal of Cancer","doi":"10.1002/(ISSN)1097-0215","access":"no","code":"10970215","issn":"0020-7136","eissn":"1097-0215","topics":[{"taxonomyUri":"gpt-sitename","topicLabel":"wly.onco.radthr_000091","topicUri":"wly.onco.radthr_000091"},{"taxonomyUri":"global-subject-codes","topicLabel":"MEDICAL SCIENCE","topicUri":"md"},{"taxonomyUri":"global-subject-codes","topicLabel":"LIFE SCIENCES","topicUri":"ls"},{"taxonomyUri":"global-subject-codes","topicLabel":"Pharmacology \u0026 Pharmaceutical Medicine","topicUri":"mdm0"},{"taxonomyUri":"global-subject-codes","topicLabel":"Clinical Pharmacology \u0026 Therapeutics","topicUri":"mdm1"},{"taxonomyUri":"global-subject-codes","topicLabel":"Pathology","topicUri":"mdk0"},{"taxonomyUri":"global-subject-codes","topicLabel":"Oncology \u0026 Radiotherapy","topicUri":"mdh0"},{"taxonomyUri":"global-subject-codes","topicLabel":"Surgical Oncology","topicUri":"mdh2"},{"taxonomyUri":"global-subject-codes","topicLabel":"Medical Oncology","topicUri":"mdh3"},{"taxonomyUri":"global-subject-codes","topicLabel":"Palliative Care","topicUri":"mdh4"},{"taxonomyUri":"global-subject-codes","topicLabel":"Hematology","topicUri":"mdc0"},{"taxonomyUri":"global-subject-codes","topicLabel":"Cell \u0026 Molecular Biology","topicUri":"ls30"},{"taxonomyUri":"gpt-zonename","topicLabel":"ij-cancer_IJC","topicUri":"ij-cancer_ijc"}]}},"page":{"subPage":"Full Text","page":"Article/Chapter View","pageGroup":"Publication Pages","title":"title","errorCode":200},"tokens":{"tokenUsed":false}}</script>







<meta charset="UTF-8">




<meta name="robots" content="noarchive"/>





    














    






    <meta property="og:title" content="Inhibition of rhabdomyosarcoma cell and tumor growth by targeting specificity protein (Sp) transcription factors"/>


    <meta property="og:type" content="Article"/>


        <meta property="og:url" content="https://onlinelibrary.wiley.com/doi/10.1002/ijc.27730"/>
    

        
        <meta property="og:image" content="https://onlinelibrary.wiley.com/cms/asset/17892127-3ce6-4bcc-9dd3-52f0bb298032/ijc.v132.4.cover.gif"/>
    

    <meta property="og:site_name" content="Wiley Online Library"/>



        

        <meta property="og:description" content="What's new? Rhabdomyosarcoma (RMS) is a soft tissue cancer that primarily affects children and adolescents. RMS cells overproduce specificity protein transcription factors Sp1, Sp3, and Sp4. The NSAI..."/>
    



    <meta name="viewport" content="width=device-width,initial-scale=1"/>






















    <link rel="preload" href="https://cmp.osano.com/AzZdRbSORDOOzF9W/67a788d8-9344-4c9b-a3c2-89b5073ee231/osano.js" as="script">
    <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/67a788d8-9344-4c9b-a3c2-89b5073ee231/osano.js"></script>




    

    <meta name="citation_doi" content="10.1002/ijc.27730"/>

    <meta name="dc.identifier" content="10.1002/ijc.27730"/>




<meta name="citation_journal_title" content="International Journal of Cancer"><meta name="citation_title" content="Inhibition of rhabdomyosarcoma cell and tumor growth by targeting specificity protein (Sp) transcription factors"><meta name="citation_keywords" content="tolfenamic acid"><meta name="citation_keywords" content="Sp proteins"><meta name="citation_keywords" content="downregulation"><meta name="citation_keywords" content="RMS cells"><meta name="citation_volume" content="132"><meta name="citation_issue" content="4"><meta name="citation_firstpage" content="795"><meta name="citation_lastpage" content="806"><meta name="citation_publication_date" content="2013/02/15"><meta name="citation_online_date" content="2012/08/03"><meta name="citation_issn" content="1097-0215"><meta name="citation_language" content="en"><meta name="citation_author" content="Gayathri Chadalapaka"><meta name="citation_author_institution" content="Department of Veterinary Physiology and Pharmacology, Texas A&M University, College Station, TX"><meta name="citation_author" content="Indira Jutooru"><meta name="citation_author_institution" content="Department of Veterinary Physiology and Pharmacology, Texas A&M University, College Station, TX"><meta name="citation_author" content="Sandeep Sreevalsan"><meta name="citation_author_institution" content="Department of Veterinary Physiology and Pharmacology, Texas A&M University, College Station, TX"><meta name="citation_author" content="Satya Pathi"><meta name="citation_author_institution" content="Department of Veterinary Physiology and Pharmacology, Texas A&M University, College Station, TX"><meta name="citation_author" content="Kyounghyun Kim"><meta name="citation_author_institution" content="Institute for Biosciences and Technology, Texas A&M Health Science Center, Houston, TX"><meta name="citation_author" content="Candy Chen"><meta name="citation_author_institution" content="Department of Pediatrics, Duke University Medical Center, Durham, NC"><meta name="citation_author" content="Lisa Crose"><meta name="citation_author_institution" content="Department of Pediatrics, Duke University Medical Center, Durham, NC"><meta name="citation_author" content="Corinne Linardic"><meta name="citation_author_institution" content="Department of Pediatrics, Duke University Medical Center, Durham, NC"><meta name="citation_author_institution" content="Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC"><meta name="citation_author" content="Stephen Safe"><meta name="citation_author_institution" content="Department of Veterinary Physiology and Pharmacology, Texas A&M University, College Station, TX"><meta name="citation_author_institution" content="Institute for Biosciences and Technology, Texas A&M Health Science Center, Houston, TX"><meta name="citation_abstract_html_url" content="https://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.27730"><meta name="citation_fulltext_html_url" content="https://onlinelibrary.wiley.com/doi/full/10.1002/ijc.27730"><meta name="citation_pdf_url" content="https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.27730"><meta name="citation_publisher" content="John Wiley & Sons, Ltd"><meta name="article_references" content="Chadalapaka, G., Jutooru, I., Sreevalsan, S., Pathi, S., Kim, K., Chen, C., Crose, L., Linardic, C. and Safe, S. (2013), Inhibition of rhabdomyosarcoma cell and tumor growth by targeting specificity protein (Sp) transcription factors. Int. J. Cancer, 132: 795-806. https://doi.org/10.1002/ijc.27730"><meta name="Description" content="Abstract Specificity protein (Sp) transcription factors Sp1, Sp3 and Sp4 are highly expressed in rhabdomyosarcoma (RMS) cells. In tissue arrays of RMS tumor cores from 71 patients, 80% of RMS patie...">



<title>Inhibition of rhabdomyosarcoma cell and tumor growth by targeting specificity protein (Sp) transcription factors - Chadalapaka - 2013 - International Journal of Cancer - Wiley Online Library</title>










<link rel="stylesheet" type="text/css" href="/wro/l0m7~product.css">

<link rel="preload" href="/products/acropolis/pericles/releasedAssets/fonts/icomoon/icomoon.woff?3a309d1f3a2b45cf678b" as="font" type="font/woff" crossorigin="anonymous"/><link rel="preload" href="/products/acropolis/pericles/releasedAssets/fonts/open-sans/open-sans-v15-latin-regular.woff2?3a309d1f3a2b45cf678b" as="font" type="font/woff2" crossorigin="anonymous"/><link rel="preload" href="/products/acropolis/pericles/releasedAssets/fonts/source-serif-pro/source-serif-pro-v5-latin-regular.woff2?3a309d1f3a2b45cf678b" as="font" type="font/woff2" crossorigin="anonymous"/><link rel="stylesheet" href="/products/acropolis/pericles/releasedAssets/css/build-3a309d1f3a2b45cf678b.css"/><link rel="stylesheet" href="/products/acropolis/pericles/releasedAssets/css/print-3a309d1f3a2b45cf678b.css" media="print"/>




<script async src="/pb-assets/catchpoint-1549680351760.js"></script>
<meta name="referrer" content="origin-when-cross-origin"/>
<link rel="shortcut icon" href="/favicon.ico">


<link rel="stylesheet" type="text/css" href="/pb-assets/hub-assets/pericles/hub-1645698573730.css">


<link rel="stylesheet" type="text/css" href="/pb-assets/css/iucr-1510734465460.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/css/readcube-1510565373110.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/css/dr-overrides-1611780866727.css">
<!-- link rel="stylesheet" type="text/css" href="/pb-assets/css/temporary-1525702334993.css" -->

<style>
/* PERICLES-7186: distorted cover images */
.journal-info-container .cover-image__image img {
    min-height: unset;
}

/* TEMPORARY CSS HACK TO FIX LIT-220590 */
.icon-icon-Rss::before {
    content: "\e629";
}

/* TEMPORARY CSS TO FIX ALIGNMENT OF TOP AD IN RIGHT RAIL */
.publication-cover-info {
    margin-bottom: 20px;
}

.article-row-right > .pb-ad {
    margin-left: 0;
    margin-bottom: 10px;
}

/* TEMPORARY HACK FOR PERICLES-6763 */
.table-of-content .issue-item h2 {
    font-size: 16px;
}

.table-of-content .issue-item h2 a.issue-item__title {
    display: inline;
}

/* TEMPORARY CSS FOR PERICLES-7445 */

input.saml__consent__yes {
    background: #005274;
    font-size: 12px;
    font-size: .75rem;
    padding: 12px 20px;
    border-radius: 0;
    margin-top: 20px;
    margin-right: 10px;
    width: 100px;
}

input.saml__consent__yes:hover {
    background: #003951;
}

/* PERICLES-2166: Site-wide maintenance message */

.admin-message {
    background-color: #005274;
    color: white;
}

/* TEMPORARY CSS FOR STAY-CONNECTED SOCIAL MEDIA ICONS */
.stay-connected ul  {
    list-style: none;
    margin: 0;
    padding: 0;
}

.stay-connected i {
    margin-right: 10px;
    font-size: 25px;
    line-height: 55px;
}

.stay-connected i.icon-hubs-rg-icon,
.stay-connected i.icon-hubs-soundcloud-icon {
    font-size: 41px;
}

.stay-connected .icon-hubs-pinterest-icon:before {
    color: white;
}

.stay-connected .icon-hubs-pinterest-icon {
    background-color: #BD081C;
    border: solid #BD081C;
    border-width: 8px;
}

/* PERICLES-5833: TEMPORARY CSS TO ADJUST POSITION OF ADS */
.article-mpu-bottom .pb-ad {
    margin: 0 0 0 195px;
}


.article-mpu-top .pb-ad {
    padding-top: 20px;
    margin: 0 0 -35px 0;
}

.banner-wrapper .pb-ad {
    padding: 0;
}

/* TEMPORARY CSS FOR THE SOCIETY MEMBER LOGIN PAGE */
.society-member-login .widget__header,
.society-member-login .show-registration,
.society-member-login .show-request-reset-password {
    display: none;
}

.society-member-login .login-form {
    margin-top: 20px;
}

.society-member-login .widget__body .input-group+.input-group {
    margin-top: 15px;
}


/* TEMPORARY CSS TO HIDE FPI IN TOP CONTENT ACTION WIDGET */
.top-content .firstPageImage {
	display: none;
}


.custom-page-pericles .main-content :target:before {
	content: "";
	display: block;
	height: 140px;
	margin: -140px 0 0;
}

/* PERICLES-4777: TEMPORARY CSS TO HIDE OPTIONS IN THE SIDEBAR ON MRW PAGES */
.journal-resources li#TableofContents,
.journal-resources li#Topics,
.journal-resources li#ArticleTitlesAZ {
	display: none;
}

/* TEMPORARY FIX FOR UNWANTED MARGIN BELOW COVER IMAGES ON BOOK SERIES PAGES */
.remove-margin .cover-image {
	margin: 0;
}

/* TEMPORARY FIX TO MAKE IT POSSIBLE TO EDIT RICH TEXT WIDGETS IN SLIDESHOWS */
.bs .modal-backdrop {
	display: none;
}

/* TEMPORARY FIX FOR MENU POSITION */
.hubpage-menu nav {
	padding-bottom: 0;
	position: relative;
}

/* TEMPORARY FOR MARGIN AROUND ADS */
.advert.advert-leaderboard {
	margin: 15px 0;
}

.banner-wrapper {
	box-shadow: none;
}

/* TEMPORARY TO FIX OVERFLOW FOR P IN JOURNAL-NEWS SLIDESHOWS */
.journal-news .slide-item p {
	overflow: unset;
}

/* EDITOR HIGHLIGHTS CSS */
div.ancillary-content.relateditem div.content {
	height: 10em;
}
div.ancillary-content.listitem div.content {
	height: 4em;
}

/* TEMPORARY Fix heading on Topical Index widget for MRWs */
.topical-index h2 {
    margin: 15px 0;
    font-size: 1.75rem;
    line-height: 28px;
    color: #1c1d1e;
    font-family: Source Serif Pro,serif;
    font-weight: normal;
}

/* PERICLES-7288 */
.issue-supplementary-files, .cover-image__virtual-issue {
    margin-bottom: 15px;
}

/* PERICLES-8875 */
.journal-news .slide-item img {
    float: left;
    margin-right: 10px;
}

/* DO NOT REMOVE */
li[heading="Restore Points"].ng-isolate-scope,
li[heading="Disable Widgets"].ng-isolate-scope {
    display: none!important;
}

.modal-header .widgetOrigin {
    display: none;
}

/* PERICLES-10090 */
.cover-image__image img {
    max-width: 150px;
    max-height: 150px;
}

/* LIT-282003 */
.journal-info-container span.info_value:after {
    content: '\003B';
}

.journal-info-container span.info_value:last-child:after {
    content: '';
}

/* LIT-299510 */
h1.citation__title {
    font-size: 22px;
    font-size: 1.375rem;
}

@media (max-width: 991px) {
    h1.citation__title {
        font-size: 18px;
        font-size: 1.125rem;
    }
    h1.citation__title:after {
        content: "";
    }
}

/* LIT-295816 */
.search__item .item__body .meta__details a.publication_meta_serial:after {
    content: "";
    margin: 0;
}
.search__item .item__body .meta__details a.publication_meta_volume_issue:before {
    content: "|";
    margin-left: 4px;
    margin-right: 4px;
}

/* PPV */
.cart-indicator__wrapper {
    padding: 0;
}

/* TrendMD Test */
#article__content #trendmd-suggestions{
    margin-top: 40px !important;
    border-top: 1px solid #ddd;

}
body #article__content .trendmd-widget-container {
    margin-top: 20px !important;
}

body #article__content .trendmd-widget-header__heading{
    font-size: 20px !important;
    margin-bottom: 30px !important
}
body #article__content .trendmd-widget-list-item__link, body #article__content .trendmd-widget-list-item__meta{
    font-family:'Open Sans', arial, sans-serif !important;
}
body #article__content .trendmd-widget{
	font-size:16px !important;
}
body #article__content .trendmd-widget-list-item{
	margin-bottom:24px !important;
}
body #article__content .trendmd-widget-list-item__link{
	color: #005293 !important;
}
body #article__content .trendmd-widget-list-item__meta{
	color: #5d5d5d !important;
	font-size:14px !important;
	margin-top:3px !important;
}
body #article__content .trendmd-widget_horizontal .trendmd-widget-section{
	width: 47% !important;
}

@media (max-width: 450px) {
	body #article__content .trendmd-widget_horizontal .trendmd-widget-section{
		width: 95% !important;
	}
}

#pane-pcw-related .trendmd-widget-header__heading{
	font-size: 18px !important;
	font-family:'Open Sans', arial, sans-serif !important;
}
#pane-pcw-related .trendmd-widget-container{
	padding:0 20px !important;
}
#pane-pcw-related .trendmd-widget-list-item__link{
	 font-family:'Open Sans', arial, sans-serif !important;
	 font-size:14px !important;
	 color: #005293 !important;
	 display:block;
	 margin-bottom: 5px !important;
}
#pane-pcw-related .trendmd-widget-list-item__meta{
	font-family:'Open Sans', arial, sans-serif !important;
	color:#666 !important;
}
#pane-pcw-related .trendmd-widget-list-item{
	margin-bottom:20px !important;
}


</style>

<!-- The Adobe DTM script. Must come after the digitalData object -->
<script src="//assets.adobedtm.com/6e626c9ec247e474f6b98eb15a79a185cf7e26a5/satelliteLib-c1ac050bbdc647f13a62578e71f0d817f8a6cbb5.js"></script>

<!-- Google Search Console verification -->
<meta name="google-site-verification" content="ffz4i4DxIJCdGpRXe0XN6KG6o4FYI-nnFW9I_dg8piM" />

<!-- KRUX Implementation-->
<script class="kxct" data-id="JMOONjNh" data-timing="async" data-version="1.9" type="text/javascript">

	window.Krux || (( Krux = function () {
		Krux.q.push ( arguments )
	}).q = []);

	( function () {
		var k , m , s , src;
		k = document.createElement ( 'script' );
		k.type 	= 'text/javascript';
		k.async = true;
		src = ( m = location.href.match ( /\bkxsrc=([^&]+)/ )) && decodeURIComponent ( m [ 1 ]);
		k.src = /^https?:\/\/([a-z0-9_\-\.]+\.)?krxd\.net(:\d{1,5})?\//i.test ( src ) ? src : src === 'disable' ? '' : ( location.protocol === 'https:'?'https:':'http:' ) + '//cdn.krxd.net/controltag?confid=JMOONjNh';
		s = document.getElementsByTagName ( 'script' ) [ 0 ];
		s.parentNode.insertBefore ( k , s );
	} ());
</script>

<!-- KRUX Implementation cont'd -->
<script type="text/javascript">
	window.Krux || (( Krux = function () {
		Krux.q.push ( arguments );
	}).q = []);

	( function () {
		function retrieve ( n ) {
			var m , k = 'kx' + n;
			if ( window.localStorage ) {
				return window.localStorage [ k ] || '';
			} else if ( navigator.cookieEnabled ) {
				m = document.cookie.match ( k + '=([^;]*)' );
				return ( m && unescape ( m [ 1 ])) || '';
			} else {
				return '';
			}
		}

		Krux.user = retrieve ( 'user' );
		Krux.segments = retrieve ( 'segs' ) && retrieve ( 'segs' ).split ( ',' ) || [];
	}) ();
</script>

<!-- Grapeshot Implementation -->
<script>
	var gs_channels = 'default';
</script>

<script src="//wiley.grapeshot.co.uk/main/channels.cgi?url=https://onlinelibrary.wiley.com/doi/10.1002/ijc.27730" async></script>

<!-- DoubleClick Implementation -->
<script type="text/javascript">
	var $WileyGooglePublisherID = 2215;

	if (!$DoubleClickSite) {
		switch("pericles") {
	  		case "acsess.onlinelibrary.wiley.com":
				var $DoubleClickSite = "wly.agriculture_000018";
				break;
			case "afspubs":
				var $DoubleClickSite = "wly.aqua.fish_000017";
				break;
			case "aasldpubs":
  				var $DoubleClickSite = "wly.gastro.hep_000059";
  				break;
			case "headachejournal":
  				var $DoubleClickSite = "wly.neurology_000086";
  				break;
  			case "wildlife":
				var $DoubleClickSite = "wly.zoology_000120";
				break;
			default:
				var $DoubleClickSite = "undefined-site";
		};
  	};

	if (!$DoubleClickZone) {
		switch("pericles") {
			case "acsess.onlinelibrary.wiley.com":
				var $DoubleClickZone = "Agriculture_ACSESS_Hub";
				break;
			case "afspubs":
				var $DoubleClickZone = "AFS_HUB";
				break;
			case "aasldpubs":
				var $DoubleClickZone = "AASLD-pubs_HUB";
				break;
			case "headachejournal":
				var $DoubleClickZone = "headache_HUB";
				break;
			case "wildlife":
				var $DoubleClickZone = "tws_HUB";
				break;
			default:
				var $DoubleClickZone = "undefined-zone";
		};
	};

	var $GooglePublisherCategory = "/" + $WileyGooglePublisherID + "/" + $DoubleClickSite + "/" + $DoubleClickZone;
</script>

<script>
	var googletag = googletag || {};

	googletag.cmd = googletag.cmd || [];

	( function () {

		var gads = document.createElement ( 'script' ) ,
		node = document.getElementsByTagName ( 'script' ) [ 0 ] ;

		gads.async = true;
		gads.src = document.location.protocol + '//www.googletagservices.com/tag/js/gpt.js';

		node.parentNode.insertBefore ( gads , node );

	}) ();
</script>

<script>
	googletag.cmd.push ( function () {

		var sizes = {
			leaderboard : googletag.sizeMapping ()
				.addSize ([ 300 , 100 ] , [ 300 , 50 ])
				.addSize ([ 740 , 100 ] , [ 728 , 90 ])
				.addSize ([ 0 , 0 ] , 'fluid')
				.build () ,
			rail : googletag.sizeMapping ()
				.addSize ([ 0 , 0 ] , [ 300 , 250 ])
				.build (),
			interstitial : googletag.sizeMapping ()
							.addSize ([ 0 , 0 ] , [ 640 , 480 ])
							.build ()

		};


		gptPage = window.digitalData && digitalData.page && digitalData.page.page ? digitalData.page.page : "blank";
		gptSubPage = window.digitalData && digitalData.page && digitalData.page.subPage ? digitalData.page.subPage : "blank";


		function gptClean(gptText){
			if(typeof(gptText)=="string"){
				gptText = gptText.replace(/\&/g,'%26');


				return gptText.replace(/\^|\*|#|\$|\"|\'|\=|\,|\!|\+|\~|\;|\(|\)|\<|\>|\[|\]|\?|\%|\:|\@|\;|\&|\||\{|\}|\\|/g,'');

			}
			return "blank";
		}


		googletag.pubads ()
			.setTargeting ( 'property' 	, 'value-of-property' 	) 	// Change and duplicate this line for as many additional keywords to send
			.setTargeting ( 'doi' , gptClean('10.1002/ijc.27730')) // Publication DOI
			.setTargeting ( 'gs_cat' 	, gs_channels 		) 	// Grapeshot
			.setTargeting ( 'ksg' 		, Krux.segments 	) 	// Krux
			.setTargeting ( 'kuid' 		, Krux.user 		) 	// Krux
			.setTargeting ( 'pbPage', gptClean(gptPage) )
			.setTargeting ( 'pbSubPage', gptClean(gptSubPage) )
			.setTargeting ( 'urlpath', gptClean(document.location.pathname));

		googletag.defineSlot ( $GooglePublisherCategory, 'fluid', 'advert-leaderboard' )
			.defineSizeMapping ( sizes.leaderboard )
			.addService ( googletag.pubads ())
			.setCollapseEmptyDiv ( true );

		googletag.defineSlot ( $GooglePublisherCategory, 'fluid', 'advert-rail-1' )
			.defineSizeMapping ( sizes.rail )
			.setTargeting ( 'Position', 'advert-rail-1')
			.addService ( googletag.pubads ())
			.setCollapseEmptyDiv ( true );

		googletag.defineSlot ( $GooglePublisherCategory, 'fluid', 'advert-rail-2' )
			.defineSizeMapping ( sizes.rail )
			.setTargeting ( 'Position', 'advert-rail-2')
			.addService ( googletag.pubads ())
			.setCollapseEmptyDiv ( true );

		googletag.defineSlot ( $GooglePublisherCategory, 'fluid', 'advert-video' )
			.defineSizeMapping ( sizes.interstitial )
			.setTargeting ( 'Position', 'advert-video')
			.addService ( googletag.pubads ())
			.setCollapseEmptyDiv ( true );


		googletag.pubads ().enableSingleRequest ();
		googletag.enableServices ();
	});
	//]]>
</script>

<script src="//validate.onecount.net/js/all.min.js#cff4b10c3a3d5cc9bbb7e2b9292cc66eae1deafa"></script>
<script>
	try {
		GCN.onecount.setTargeting();
	} catch (e) {
	}
</script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"65604cf31ed0e4d9","token":"f3dd54df2ac243bab2129483f57546d1","version":"2021.5.1","si":10}'></script>
<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"65cb04cf2c4898e7","token":"f3dd54df2ac243bab2129483f57546d1","version":"2021.5.2","si":10}'></script>
<script async src='/cdn-cgi/bm/cv/669835187/api.js'></script><script type="text/javascript">(function(){window['__CF$cv$params']={r:'65d1a8e0c92cd32a',m:'67aa9be47daef6356de6609e1160d5d3eaa5ffa2-1623318251-1800-AaebyrEA/0jUMhvUAOk0j/wUR0nsoq6UdvlB2Moolrehflza6iixm14P9MalQ+R8Vryip4agQZ71w0jrBJXqJEfdW+xLLufgGKZPRxJhvd4I3qMsuBop2ACJDvs+WtlCjNmSktt5c/WE8XBjCql0oD4=',s:[0x5aebccbc48,0x5cc5562061],}})();</script><script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"65d1a8e0c92cd32a","token":"f3dd54df2ac243bab2129483f57546d1","version":"2021.5.2","si":10}'></script>






    <!-- Get whether TNSI is in live or test mode -->
    
    <!-- Get the configured TNSI Javascript version number -->
    
    <!-- Get the configured TNSI MerchantID -->
    
    <!-- Add "TEST" to beginning of merchant ID when running in test mode -->
    

    










    
    

    
    
    
    
    <!-- loading Javascript for using the persistence Service -->
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        function getParameter(parameterName) {
            let result = null,
                tmp = [];
            location.search
                .substr(1)
                .split("&")
                .forEach(function (item) {
                    tmp = item.split("=");
                    if (tmp[0] === parameterName) result = tmp[1];
                });
            return result;
        }

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            queryParamsDelimiter: encodeURIComponent('?'),

            getWAYFLessUrl: function (entityId) {
                let redirectURL = getParameter('redirectUri');
                if(redirectURL == null){
                    redirectURL = encodeURIComponent(this.returnURL);
                }
                if(redirectURL.indexOf('saml_referrer') < 0){
                    redirectURL += encodeURIComponent(((redirectURL.indexOf(this.queryParamsDelimiter) !== -1) ? '&' : '?') + 'saml_referrer');
                }
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + redirectURL;
            },
            retrieveEntity: function () {
                var self = this;
                var ps = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve, reject) {
                    ps.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var ps = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    ps.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId, entityTitle) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId, entityTitle: entityTitle, eventGroupKey: '2706aa16-22e4-402b-9c14-69c634441286'}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (let i in allSsoInstitutions) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID, ssoInstitution.entity.title)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>



    <script type="text/javascript">
        (function() {
            function riskifiedBeaconLoad() {
                var store_domain = 'https://onlinelibrary.wiley.com';
                var session_id = 'aaaX9G5-ds_aIaX1geD9x';
                var url = ('https:' == document.location.protocol ? 'https://' : 'http://')
                    + "beacon.riskified.com?shop=" + store_domain + "&sid=" + session_id;
                var s = document.createElement('script');
                s.type = 'text/javascript';
                s.async = true;
                s.src = url;
                var x = document.getElementsByTagName('script')[0];
                x.parentNode.insertBefore(s, x);
            }
            if (window.attachEvent)
                window.attachEvent('onload', riskifiedBeaconLoad)
            else
                window.addEventListener('load', riskifiedBeaconLoad, false);
        })();
    </script>


<script>
    var digitalData = window.digitalData ? window.digitalData : {};
    digitalData.page.title = "Inhibition of rhabdomyosarcoma cell and tumor growth by targeting specificity protein (Sp) transcription factors - Chadalapaka - 2013 - International Journal of Cancer - Wiley Online Library";
</script><script async src='/cdn-cgi/bm/cv/669835187/api.js'></script></head>
<body class="pb-ui">

<div class="skip-links">
    <ul class="rlist">
        
                <li><a href="#article__content" tabindex="1">Skip to Article Content</a></li>
                <li><a href="#pane-pcw-detailscon" tabindex="1">Skip to Article Information</a></li>
            
    </ul>
</div>







    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="pageHeader" data-widget-id="62175478-b98a-43d5-90f2-1f2045ac1a7e" class="pageHeader">
        



        
        <header class="page-header">
    <div data-pb-dropzone="main">
    









        <div data-widget-def="ux3-layout-widget" data-widget-id="bb5b5e2c-d3d6-4015-b586-eeade38f59d4" class="admin-message">
        



        
        <div class="container"><div class="row"><div>



        
        



        <div class="pb-ad">
            <div style="background=blue;">
    <div class="container">
        <p style="text-align: center;"><b>Working off-campus?</b> Learn about our <a href="/action/clickThrough?id=101169&url=https%3A%2F%2Fonlinelibrary.wiley.com%2Fresearchers%2Fread%2Faccess-options&loc=%2Fdoi%2F10.1002%2Fijc.27730&pubId=57787093&placeholderId=1029&productId=1011" target="_blank" tabindex="2"><font color="white"><u>remote access options</u></font></a></p>
    </div>
</div>
        </div>
    

</div></div></div>

        </div>
    




        
        <div class="container"><div class="row"><div class="contents col-sm-12 col-md-12">



        
        <div class="pull-left">









        <div data-widget-def="ux3-general-image" data-widget-id="ff262197-0fb8-4973-aaa2-2fceba4b5a61" class="logo-container hidden-xs hidden-sm hidden-md">
        



        
        <a href="/" title="Wiley Online Library"><img id="mainLogo" alt="Wiley Online Library" src="/pb-assets/hub-assets/pericles/logo-header-1526603583437.png"/></a>

        </div>
    










        <div data-widget-def="ux3-general-image" data-widget-id="9a75b789-224c-4745-833a-930cf6c36f35" class="logo-container-mobile hidden-lg hidden-md hidden-sm">
        



        
        <a href="/" title="Wiley Online Library"><img id="mobileLogo" alt="Wiley Online Library" src="/pb-assets/hub-assets/pericles/mobilehublogo-1518781861020.png"/></a>

        </div>
    
</div><div class="pull-right">









        <div data-widget-def="UX3QuickSearchWidget" data-widget-id="48175bb0-0f70-46e6-bb89-7e2781fdb8e4" class="header-quicksearch">
        



        
        <div class="quick-search-wrapper"><a href="#" title="search" aria-label="Search" class="quick-search__item"><i aria-hidden="true" class="icon-search"></i><span class="quick-search__item__arrow"></span></a><div data-linkto-page="true" class="quick-search quickSearchFormContainer"><div class="main-search-field-wrapper"><div class="tab clearfix"><input type="search" placeholder="Search" value="" tabindex="13" class="fakeQSInput quickSearchFilter"/><label for="search-within" class="sr-only">Search within</label><select name="search-within" id="search-within" tabindex="10" class="search-within"><option value="#pane-67065c09-4a88-49cd-934c-ac707951d35c0" data-url="thisCategory" data-value="10970215">This Journal</option><option value="#pane-67065c09-4a88-49cd-934c-ac707951d35c1" data-url="https://onlinelibrary.wiley.com">Anywhere</option></select><ul role="tablist" class="rlist tab__content"><li id="pane-67065c09-4a88-49cd-934c-ac707951d35c0" aria-labelledby="pane-67065c09-4a88-49cd-934c-ac707951d35c0-con" role="tab" class="tab__pane quick-search-pane__anywhere active"><form action="/action/doSearch" name="thisJournalQuickSearch" method="get" title="Quick Search"><div class="input-group option-0"><label for="searchField0" class="hiddenLabel">Search term</label><input type="search" name="AllField" id="searchField0" placeholder="Search" onfocus="this.value = this.value;" data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" tabindex="9" class="autocomplete actualQSInput quickSearchFilter"/><input type="hidden" name="SeriesKey" value="10970215"/><div class="search-options-wrapper quickSearchFilter"><a href="https://onlinelibrary.wiley.com/search/advanced?publication=10970215" title="" tabindex="12" class="advanced">  Advanced Search</a><a href="https://onlinelibrary.wiley.com/search/advanced?publication=10970215#citation" title="" tabindex="12" class="citation">  Citation Search</a></div></div><button type="submit" title="Search" tabindex="11" aria-label="Submit Search" class="btn quick-search__button icon-search"></button></form></li><li id="pane-67065c09-4a88-49cd-934c-ac707951d35c1" aria-labelledby="pane-67065c09-4a88-49cd-934c-ac707951d35c1-con" role="tab" class="tab__pane quick-search-pane__anywhere"><form action="https://onlinelibrary.wiley.com/action/doSearch" name="defaultQuickSearch" method="get" title="Quick Search"><div class="input-group option-1"><label for="searchField1" class="hiddenLabel">Search term</label><input type="search" name="AllField" id="searchField1" placeholder="Search" onfocus="this.value = this.value;" data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" tabindex="9" class="autocomplete actualQSInput quickSearchFilter"/><div class="search-options-wrapper quickSearchFilter"><a href="https://onlinelibrary.wiley.com/search/advanced" title="" tabindex="12" class="advanced">  Advanced Search</a><a href="https://onlinelibrary.wiley.com/search/advanced#citation" title="" tabindex="12" class="citation">  Citation Search</a></div></div><button type="submit" title="Search" tabindex="11" aria-label="Submit Search" class="btn quick-search__button icon-search"></button></form></li></ul></div></div></div></div>

        </div>
    










        <div data-widget-def="ux3-layout-widget" data-widget-id="5ef13ed1-f4ac-4b62-a426-07ec9576a586" class="cart-indicator__wrapper">
        



        
        <div class="pull-left">









        <div data-widget-def="eCommerceCartIndicatorWidget" data-widget-id="4a9f7c04-a273-4a25-91fb-8e7bd9970288" class="cart-indicator__wrapper">
        



        
        















<div class="eCommerceCartIndicatorWidget">
    
            
        
</div>

        </div>
    
</div><div class="pull-right">









        <div data-widget-def="literatumNavigationLoginBar" data-widget-id="d384ca92-7137-45d6-b3c2-78c9c0a98c2b" class="login-bar-container">
        



        
        




    








        




    









    <div class="loginBar login-open">
        <a href="/action/showLogin?uri=%2Fdoi%2F10.1002%2Fijc.27730&amp;aria-label=Log+in+or+Register" class="show-login" role="button" uri="/doi/10.1002/ijc.27730" aria-label="Log in or Register">
            <span class="icon-profile_empty"></span>
            <span class="sign-in-label">Login / Register</span>
        </a>
            
    </div>


    


        </div>
    
</div>

        </div>
    
</div>
</div></div></div>
    </div>
</header>


        </div>
    










        <div data-widget-def="pageBody" data-widget-id="72100436-7a82-49fc-933b-c6c9d8c42914" class="pageBody article-page-tablet body-text">
        



        
        <main id="main-content" tabindex="-1">
    <!--begin pagefulltext-->
    <div class="page-body pagefulltext">
        <div data-pb-dropzone="main">
        



        
        <div>









        <div data-widget-def="literatumAd" data-widget-id="0220a30b-90c0-4b51-8637-141edf12f86a" class="banner-wrapper">
        



        
        



        <div class="pb-ad">
            <aside role="complementary">
		<div id="advert-leaderboard" class="advert advert-leaderboard">
			<script>
				googletag.cmd.push 		( function () {
					googletag.display 	( 'advert-leaderboard' );
				});
			</script>

			<!-- No JavaScript support is a call to an image -->
			<noscript>
				<a href="/action/clickThrough?id=1013&url=https%3A%2F%2Fpubads.g.doubleclick.net%2Fgampad%2Fjump%3Fiu%3D%24googlePublisherCategory%26amp%3Bsz%3D728x90%26amp%3Btile%3D1%26amp%3Bc%3D%24random&loc=%2Fdoi%2F10.1002%2Fijc.27730&pubId=57787093&placeholderId=1015&productId=101018" target="_blank">
					<img src="https://pubads.g.doubleclick.net/gampad/ad?iu=$googlePublisherCategory&amp;sz=728x90&amp;tile=1&amp;c=$random">
				</a>
			</noscript>
		</div>
	</aside>
        </div>
    


        </div>
    




        
        
</div>










        <section data-widget-def="ux3-layout-widget" data-widget-id="0f7bccba-8328-4dbd-a1fa-e84c526dd9ab">
        



        
        <div class="container"><div class="row"><div class=" col-md-12">



        
        <div>



        
        <article data-figures="/action/ajaxShowFigures?widgetId=5cf4c79f-0ae9-4dc5-96ce-77f62de7ada9&amp;ajax=true&amp;doi=10.1002%2Fijc.27730&amp;pbContext=%3Bissue%3Aissue%3Adoi%5C%3A10.1002%2Fijc.v132.4%3Bpage%3Astring%3AArticle%2FChapter+View%3Barticle%3Aarticle%3Adoi%5C%3A10.1002%2Fijc.27730%3Bctype%3Astring%3AJournal+Content%3Bwebsite%3Awebsite%3Apericles%3Bjournal%3Ajournal%3A10970215%3Bwgroup%3Astring%3APublication+Websites%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3BrequestedJournal%3Ajournal%3A10970215&amp;accordionHeadingWrapper=h2" data-references="/action/ajaxShowEnhancedAbstract?widgetId=5cf4c79f-0ae9-4dc5-96ce-77f62de7ada9&amp;ajax=true&amp;doi=10.1002%2Fijc.27730&amp;pbContext=%3Bissue%3Aissue%3Adoi%5C%3A10.1002%2Fijc.v132.4%3Bpage%3Astring%3AArticle%2FChapter+View%3Barticle%3Aarticle%3Adoi%5C%3A10.1002%2Fijc.27730%3Bctype%3Astring%3AJournal+Content%3Bwebsite%3Awebsite%3Apericles%3Bjournal%3Ajournal%3A10970215%3Bwgroup%3Astring%3APublication+Websites%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3BrequestedJournal%3Ajournal%3A10970215&amp;accordionHeadingWrapper=h2" data-related="/action/ajaxShowRecommended?widgetId=5cf4c79f-0ae9-4dc5-96ce-77f62de7ada9&amp;ajax=true&amp;doi=10.1002%2Fijc.27730&amp;pbContext=%3Bissue%3Aissue%3Adoi%5C%3A10.1002%2Fijc.v132.4%3Bpage%3Astring%3AArticle%2FChapter+View%3Barticle%3Aarticle%3Adoi%5C%3A10.1002%2Fijc.27730%3Bctype%3Astring%3AJournal+Content%3Bwebsite%3Awebsite%3Apericles%3Bjournal%3Ajournal%3A10970215%3Bwgroup%3Astring%3APublication+Websites%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3BrequestedJournal%3Ajournal%3A10970215&amp;accordionHeadingWrapper=h2&amp;showSubjects=true&amp;taxonomiesCodes=enter+your+taxonomy+codes+here&amp;displayCitedByLink=true&amp;displayAlmetricDropzone=true&amp;taxonomyUri=publication-features&amp;topicUri=hide-issue-metadata" data-details="/action/ajaxShowPubInfo?widgetId=5cf4c79f-0ae9-4dc5-96ce-77f62de7ada9&amp;ajax=true&amp;doi=10.1002%2Fijc.27730&amp;pbContext=%3Bissue%3Aissue%3Adoi%5C%3A10.1002%2Fijc.v132.4%3Bpage%3Astring%3AArticle%2FChapter+View%3Barticle%3Aarticle%3Adoi%5C%3A10.1002%2Fijc.27730%3Bctype%3Astring%3AJournal+Content%3Bwebsite%3Awebsite%3Apericles%3Bjournal%3Ajournal%3A10970215%3Bwgroup%3Astring%3APublication+Websites%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3BrequestedJournal%3Ajournal%3A10970215&amp;accordionHeadingWrapper=h2&amp;showSubjects=true&amp;taxonomiesCodes=enter+your+taxonomy+codes+here&amp;displayCitedByLink=true&amp;displayAlmetricDropzone=true&amp;taxonomyUri=publication-features&amp;topicUri=hide-issue-metadata" data-mathjax="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/MathJax.js?config=TeX-AMS-MML_HTMLorMML"><div class="row article-row"><div id="article__content" tabindex="-1" class="col-sm-12 col-md-8 col-lg-8 article__content article-row-left"><div data-pb-dropzone="mrwBannerDropZone" class="mrw-banner-dropzone">



        
        
</div><div class="article-citation"><div class="citation">
   <div class="pb-dropzone" data-pb-dropzone="publicaitonContent-series-title"><div id="journal-banner-text" class="journal-banner-text"><a href="/journal/10970215" title="International Journal of Cancer homepage">International Journal of Cancer</a></div><a href="/toc/10970215/2013/132/4" class="volume-issue">Volume 132, Issue 4</a><span class="citation__page-range"> p. 795-806</span><a href="/journal/10970215" title="International Journal of Cancer homepage" class="citation--logo"><img id="journal-banner-image" test="test-value" alt="International Journal of Cancer" src="/pb-assets/journal-banners/10970215-1635434903757.jpg" class="journal-banner-image"></a><script>var image = new Image();

image.onerror = function() {
  // if the image does not exist
  //document.getElementById("journal-banner-text").style.marginBottom = "15px";
  document.getElementById("journal-banner-text").style.fontSize = "22px";
  document.getElementById("journal-banner-image").style.display = "none";
}

image.src = "/pb-assets/journal-banners/10970215-1635434903757.jpg";</script></div>
   <div class="doi-access-container clearfix"><span class="primary-heading"><span class="primary-heading">Cancer Cell Biology</span></span><div class="doi-access-wrapper"><div class="free-access access-type"><i aria-hidden="true" class="icon-icon-lock_open"></i><div class="doi-access">Free Access</div></div></div></div>
   <h1 class="citation__title">Inhibition of rhabdomyosarcoma cell and tumor growth by targeting specificity protein (Sp) transcription factors<a id="link_fn1" class="scrollableLink" aria-label="Scrollable Link" href="#fn1"><sup>†</sup></a></h1>
   <div class="accordion corrections-container">
      <h2 class="corrections-title"><a id="single-accordion-controller-idd14201058" href="#" title="Single Accordion Controller" class="accordion__control corrections-label w-slide__btn" data-slide-target="#d14201058" aria-expanded="false" role="button"><i aria-hidden="true" class="info-icon icon-notice"></i><span class="corrections-label__text">Correction(s) for this article</span><i aria-hidden="true" class="icon-arrow icon-keyboard_arrow_down"></i></a></h2>
      <div style="display: none;" id="d14201058" class="accordion__content corrections-body hidden-xs hidden-sm" role="region" aria-labelledby="single-accordion-controller-idd14201058">
         <ul class="rlist separator corrections-container__list">
            <li><a href="/doi/10.1002/ijc.29551">
   <h6>Erratum: Inhibition of rhabdomyosarcoma cell and tumor growth by targeting specificity protein (sp) transcription factors</h6></a><div class="parent-item">
   <ul class="rlist--inline separator">
      <li><span class="comma">Volume 137</span><span class="comma">Issue 6</span><span>International Journal of Cancer</span></li>
      <li><span>pages: E9-E9</span></li>
      <li>First Published online: July 7, 2015</li>
   </ul>
</div></li>
         </ul>
      </div>
   </div>
   <div class="loa comma visible-xs mobile-authors loa-authors-trunc">
      <div class="comma__list"><span class="accordion-tabbed__tab-mobile  accordion__closed"><a href="/action/doSearch?ContribAuthorRaw=Chadalapaka%2C+Gayathri" class="author-name accordion-tabbed__control" data-id="am1" data-db-target-for="am1" aria-controls="am1" aria-haspopup="true" id="am1_Ctrl" role="button"><span>Gayathri Chadalapaka</span><i aria-hidden="true" class="icon-section_arrow_d"></i></a><span class="comma-separator">, </span><div class="author-info accordion-tabbed__content" data-db-target-of="am1" aria-labelledby="am1_Ctrl" role="region" id="am1">
               <p class="author-name">Gayathri Chadalapaka</p>
               <p>Department of Veterinary Physiology and Pharmacology, Texas A&M University, College Station, TX</p>
               <p>G.C. and I.J. contributed equally to this work.</p><a class="moreInfoLink" href="/action/doSearch?ContribAuthorRaw=Chadalapaka%2C+Gayathri">Search for more papers by this author</a></div></span><span class="accordion-tabbed__tab-mobile  accordion__closed"><a href="/action/doSearch?ContribAuthorRaw=Jutooru%2C+Indira" class="author-name accordion-tabbed__control" data-id="am2" data-db-target-for="am2" aria-controls="am2" aria-haspopup="true" id="am2_Ctrl" role="button"><span>Indira Jutooru</span><i aria-hidden="true" class="icon-section_arrow_d"></i></a><span class="comma-separator">, </span><div class="author-info accordion-tabbed__content" data-db-target-of="am2" aria-labelledby="am2_Ctrl" role="region" id="am2">
               <p class="author-name">Indira Jutooru</p>
               <p>Department of Veterinary Physiology and Pharmacology, Texas A&M University, College Station, TX</p>
               <p>G.C. and I.J. contributed equally to this work.</p><a class="moreInfoLink" href="/action/doSearch?ContribAuthorRaw=Jutooru%2C+Indira">Search for more papers by this author</a></div></span><span class="accordion-tabbed__tab-mobile  accordion__closed"><a href="/action/doSearch?ContribAuthorRaw=Sreevalsan%2C+Sandeep" class="author-name accordion-tabbed__control" data-id="am3" data-db-target-for="am3" aria-controls="am3" aria-haspopup="true" id="am3_Ctrl" role="button"><span>Sandeep Sreevalsan</span><i aria-hidden="true" class="icon-section_arrow_d"></i></a><span class="comma-separator">, </span><div class="author-info accordion-tabbed__content" data-db-target-of="am3" aria-labelledby="am3_Ctrl" role="region" id="am3">
               <p class="author-name">Sandeep Sreevalsan</p>
               <p>Department of Veterinary Physiology and Pharmacology, Texas A&M University, College Station, TX</p><a class="moreInfoLink" href="/action/doSearch?ContribAuthorRaw=Sreevalsan%2C+Sandeep">Search for more papers by this author</a></div></span><span class="accordion-tabbed__tab-mobile  accordion__closed"><a href="/action/doSearch?ContribAuthorRaw=Pathi%2C+Satya" class="author-name accordion-tabbed__control" data-id="am4" data-db-target-for="am4" aria-controls="am4" aria-haspopup="true" id="am4_Ctrl" role="button"><span>Satya Pathi</span><i aria-hidden="true" class="icon-section_arrow_d"></i></a><span class="comma-separator">, </span><div class="author-info accordion-tabbed__content" data-db-target-of="am4" aria-labelledby="am4_Ctrl" role="region" id="am4">
               <p class="author-name">Satya Pathi</p>
               <p>Department of Veterinary Physiology and Pharmacology, Texas A&M University, College Station, TX</p><a class="moreInfoLink" href="/action/doSearch?ContribAuthorRaw=Pathi%2C+Satya">Search for more papers by this author</a></div></span><span class="accordion-tabbed__tab-mobile  accordion__closed"><a href="/action/doSearch?ContribAuthorRaw=Kim%2C+Kyounghyun" class="author-name accordion-tabbed__control" data-id="am5" data-db-target-for="am5" aria-controls="am5" aria-haspopup="true" id="am5_Ctrl" role="button"><span>Kyounghyun Kim</span><i aria-hidden="true" class="icon-section_arrow_d"></i></a><span class="comma-separator">, </span><div class="author-info accordion-tabbed__content" data-db-target-of="am5" aria-labelledby="am5_Ctrl" role="region" id="am5">
               <p class="author-name">Kyounghyun Kim</p>
               <p>Institute for Biosciences and Technology, Texas A&M Health Science Center, Houston, TX</p><a class="moreInfoLink" href="/action/doSearch?ContribAuthorRaw=Kim%2C+Kyounghyun">Search for more papers by this author</a></div></span><span class="accordion-tabbed__tab-mobile  accordion__closed"><a href="/action/doSearch?ContribAuthorRaw=Chen%2C+Candy" class="author-name accordion-tabbed__control" data-id="am6" data-db-target-for="am6" aria-controls="am6" aria-haspopup="true" id="am6_Ctrl" role="button"><span>Candy Chen</span><i aria-hidden="true" class="icon-section_arrow_d"></i></a><span class="comma-separator">, </span><div class="author-info accordion-tabbed__content" data-db-target-of="am6" aria-labelledby="am6_Ctrl" role="region" id="am6">
               <p class="author-name">Candy Chen</p>
               <p>Department of Pediatrics, Duke University Medical Center, Durham, NC</p><a class="moreInfoLink" href="/action/doSearch?ContribAuthorRaw=Chen%2C+Candy">Search for more papers by this author</a></div></span><span class="accordion-tabbed__tab-mobile  accordion__closed"><a href="/action/doSearch?ContribAuthorRaw=Crose%2C+Lisa" class="author-name accordion-tabbed__control" data-id="am7" data-db-target-for="am7" aria-controls="am7" aria-haspopup="true" id="am7_Ctrl" role="button"><span>Lisa Crose</span><i aria-hidden="true" class="icon-section_arrow_d"></i></a><span class="comma-separator">, </span><div class="author-info accordion-tabbed__content" data-db-target-of="am7" aria-labelledby="am7_Ctrl" role="region" id="am7">
               <p class="author-name">Lisa Crose</p>
               <p>Department of Pediatrics, Duke University Medical Center, Durham, NC</p><a class="moreInfoLink" href="/action/doSearch?ContribAuthorRaw=Crose%2C+Lisa">Search for more papers by this author</a></div></span><span class="accordion-tabbed__tab-mobile  accordion__closed"><a href="/action/doSearch?ContribAuthorRaw=Linardic%2C+Corinne" class="author-name accordion-tabbed__control" data-id="am8" data-db-target-for="am8" aria-controls="am8" aria-haspopup="true" id="am8_Ctrl" role="button"><span>Corinne Linardic</span><i aria-hidden="true" class="icon-section_arrow_d"></i></a><span class="comma-separator">, </span><div class="author-info accordion-tabbed__content" data-db-target-of="am8" aria-labelledby="am8_Ctrl" role="region" id="am8">
               <p class="author-name">Corinne Linardic</p>
               <p>Department of Pediatrics, Duke University Medical Center, Durham, NC</p>
               <p>Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC</p><a class="moreInfoLink" href="/action/doSearch?ContribAuthorRaw=Linardic%2C+Corinne">Search for more papers by this author</a></div></span><span class="accordion-tabbed__tab-mobile  accordion__closed"><a href="/action/doSearch?ContribAuthorRaw=Safe%2C+Stephen" class="author-name accordion-tabbed__control" data-id="am9" data-db-target-for="am9" aria-controls="am9" aria-haspopup="true" id="am9_Ctrl" role="button"><span>Stephen Safe<i aria-hidden="true" class="icon-mail_outline"></i></span><i aria-hidden="true" class="icon-section_arrow_d"></i></a><span class="comma-separator">, </span><div class="author-info accordion-tabbed__content" data-db-target-of="am9" aria-labelledby="am9_Ctrl" role="region" id="am9">
               <p class="author-type mb-1">Corresponding Author</p>
               <p class="author-name">Stephen Safe</p>
               <ul class="rlist sm-account">
                  <li class="sm-account__item"><a class="sm-account__link" title="Link to email address" href="mailto:ssafe@cvm.tamu.edu"><i aria-hidden="true" class="icon-ic_mail_solid"></i><span>ssafe@cvm.tamu.edu</span></a></li>
               </ul>
               <p>Department of Veterinary Physiology and Pharmacology, Texas A&M University, College Station, TX</p>
               <p>Institute for Biosciences and Technology, Texas A&M Health Science Center, Houston, TX</p>
               <p>Tel.: 979-845-5988, Fax: 979-862-4929</p>Distinguished Professor of Toxicology, Department of Veterinary Physiology and Pharmacology, Texas A&M University, 4466 TAMU, Vet. Res. Bldg. 410, College Station, Texas 77843-4466<a class="moreInfoLink" href="/action/doSearch?ContribAuthorRaw=Safe%2C+Stephen">Search for more papers by this author</a></div></span></div>
   </div>
   <div class="loa-wrapper loa-authors hidden-xs desktop-authors">
      <div id="sb-1" class="accordion">
         <div class="comma__list">
            <div class="accordion-tabbed"><span class="accordion-tabbed__tab-mobile  accordion__closed"><a href="/action/doSearch?ContribAuthorRaw=Chadalapaka%2C+Gayathri" class="author-name accordion-tabbed__control" data-id="a1" data-db-target-for="a1" aria-controls="a1" aria-haspopup="true" id="a1_Ctrl" role="button"><span>Gayathri Chadalapaka</span><i aria-hidden="true" class="icon-section_arrow_d"></i></a><span class="comma-separator">, </span><div class="author-info accordion-tabbed__content" data-db-target-of="a1" aria-labelledby="a1_Ctrl" role="region" id="a1">
                     <p class="author-name">Gayathri Chadalapaka</p>
                     <p>Department of Veterinary Physiology and Pharmacology, Texas A&M University, College Station, TX</p>
                     <p>G.C. and I.J. contributed equally to this work.</p><a class="moreInfoLink" href="/action/doSearch?ContribAuthorRaw=Chadalapaka%2C+Gayathri">Search for more papers by this author</a></div></span><span class="accordion-tabbed__tab-mobile  accordion__closed"><a href="/action/doSearch?ContribAuthorRaw=Jutooru%2C+Indira" class="author-name accordion-tabbed__control" data-id="a2" data-db-target-for="a2" aria-controls="a2" aria-haspopup="true" id="a2_Ctrl" role="button"><span>Indira Jutooru</span><i aria-hidden="true" class="icon-section_arrow_d"></i></a><span class="comma-separator">, </span><div class="author-info accordion-tabbed__content" data-db-target-of="a2" aria-labelledby="a2_Ctrl" role="region" id="a2">
                     <p class="author-name">Indira Jutooru</p>
                     <p>Department of Veterinary Physiology and Pharmacology, Texas A&M University, College Station, TX</p>
                     <p>G.C. and I.J. contributed equally to this work.</p><a class="moreInfoLink" href="/action/doSearch?ContribAuthorRaw=Jutooru%2C+Indira">Search for more papers by this author</a></div></span><span class="accordion-tabbed__tab-mobile  accordion__closed"><a href="/action/doSearch?ContribAuthorRaw=Sreevalsan%2C+Sandeep" class="author-name accordion-tabbed__control" data-id="a3" data-db-target-for="a3" aria-controls="a3" aria-haspopup="true" id="a3_Ctrl" role="button"><span>Sandeep Sreevalsan</span><i aria-hidden="true" class="icon-section_arrow_d"></i></a><span class="comma-separator">, </span><div class="author-info accordion-tabbed__content" data-db-target-of="a3" aria-labelledby="a3_Ctrl" role="region" id="a3">
                     <p class="author-name">Sandeep Sreevalsan</p>
                     <p>Department of Veterinary Physiology and Pharmacology, Texas A&M University, College Station, TX</p><a class="moreInfoLink" href="/action/doSearch?ContribAuthorRaw=Sreevalsan%2C+Sandeep">Search for more papers by this author</a></div></span><span class="accordion-tabbed__tab-mobile  accordion__closed"><a href="/action/doSearch?ContribAuthorRaw=Pathi%2C+Satya" class="author-name accordion-tabbed__control" data-id="a4" data-db-target-for="a4" aria-controls="a4" aria-haspopup="true" id="a4_Ctrl" role="button"><span>Satya Pathi</span><i aria-hidden="true" class="icon-section_arrow_d"></i></a><span class="comma-separator">, </span><div class="author-info accordion-tabbed__content" data-db-target-of="a4" aria-labelledby="a4_Ctrl" role="region" id="a4">
                     <p class="author-name">Satya Pathi</p>
                     <p>Department of Veterinary Physiology and Pharmacology, Texas A&M University, College Station, TX</p><a class="moreInfoLink" href="/action/doSearch?ContribAuthorRaw=Pathi%2C+Satya">Search for more papers by this author</a></div></span><span class="accordion-tabbed__tab-mobile  accordion__closed"><a href="/action/doSearch?ContribAuthorRaw=Kim%2C+Kyounghyun" class="author-name accordion-tabbed__control" data-id="a5" data-db-target-for="a5" aria-controls="a5" aria-haspopup="true" id="a5_Ctrl" role="button"><span>Kyounghyun Kim</span><i aria-hidden="true" class="icon-section_arrow_d"></i></a><span class="comma-separator">, </span><div class="author-info accordion-tabbed__content" data-db-target-of="a5" aria-labelledby="a5_Ctrl" role="region" id="a5">
                     <p class="author-name">Kyounghyun Kim</p>
                     <p>Institute for Biosciences and Technology, Texas A&M Health Science Center, Houston, TX</p><a class="moreInfoLink" href="/action/doSearch?ContribAuthorRaw=Kim%2C+Kyounghyun">Search for more papers by this author</a></div></span><span class="accordion-tabbed__tab-mobile  accordion__closed"><a href="/action/doSearch?ContribAuthorRaw=Chen%2C+Candy" class="author-name accordion-tabbed__control" data-id="a6" data-db-target-for="a6" aria-controls="a6" aria-haspopup="true" id="a6_Ctrl" role="button"><span>Candy Chen</span><i aria-hidden="true" class="icon-section_arrow_d"></i></a><span class="comma-separator">, </span><div class="author-info accordion-tabbed__content" data-db-target-of="a6" aria-labelledby="a6_Ctrl" role="region" id="a6">
                     <p class="author-name">Candy Chen</p>
                     <p>Department of Pediatrics, Duke University Medical Center, Durham, NC</p><a class="moreInfoLink" href="/action/doSearch?ContribAuthorRaw=Chen%2C+Candy">Search for more papers by this author</a></div></span><span class="accordion-tabbed__tab-mobile  accordion__closed"><a href="/action/doSearch?ContribAuthorRaw=Crose%2C+Lisa" class="author-name accordion-tabbed__control" data-id="a7" data-db-target-for="a7" aria-controls="a7" aria-haspopup="true" id="a7_Ctrl" role="button"><span>Lisa Crose</span><i aria-hidden="true" class="icon-section_arrow_d"></i></a><span class="comma-separator">, </span><div class="author-info accordion-tabbed__content" data-db-target-of="a7" aria-labelledby="a7_Ctrl" role="region" id="a7">
                     <p class="author-name">Lisa Crose</p>
                     <p>Department of Pediatrics, Duke University Medical Center, Durham, NC</p><a class="moreInfoLink" href="/action/doSearch?ContribAuthorRaw=Crose%2C+Lisa">Search for more papers by this author</a></div></span><span class="accordion-tabbed__tab-mobile  accordion__closed"><a href="/action/doSearch?ContribAuthorRaw=Linardic%2C+Corinne" class="author-name accordion-tabbed__control" data-id="a8" data-db-target-for="a8" aria-controls="a8" aria-haspopup="true" id="a8_Ctrl" role="button"><span>Corinne Linardic</span><i aria-hidden="true" class="icon-section_arrow_d"></i></a><span class="comma-separator">, </span><div class="author-info accordion-tabbed__content" data-db-target-of="a8" aria-labelledby="a8_Ctrl" role="region" id="a8">
                     <p class="author-name">Corinne Linardic</p>
                     <p>Department of Pediatrics, Duke University Medical Center, Durham, NC</p>
                     <p>Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC</p><a class="moreInfoLink" href="/action/doSearch?ContribAuthorRaw=Linardic%2C+Corinne">Search for more papers by this author</a></div></span><span class="accordion-tabbed__tab-mobile  accordion__closed"><a href="/action/doSearch?ContribAuthorRaw=Safe%2C+Stephen" class="author-name accordion-tabbed__control" data-id="a9" data-db-target-for="a9" aria-controls="a9" aria-haspopup="true" id="a9_Ctrl" role="button"><span>Stephen Safe<i aria-hidden="true" class="icon-mail_outline"></i></span><i aria-hidden="true" class="icon-section_arrow_d"></i></a><span class="comma-separator">, </span><div class="author-info accordion-tabbed__content" data-db-target-of="a9" aria-labelledby="a9_Ctrl" role="region" id="a9">
                     <p class="author-type mb-1">Corresponding Author</p>
                     <p class="author-name">Stephen Safe</p>
                     <ul class="rlist sm-account">
                        <li class="sm-account__item"><a class="sm-account__link" title="Link to email address" href="mailto:ssafe@cvm.tamu.edu"><i aria-hidden="true" class="icon-ic_mail_solid"></i><span>ssafe@cvm.tamu.edu</span></a></li>
                     </ul>
                     <p>Department of Veterinary Physiology and Pharmacology, Texas A&M University, College Station, TX</p>
                     <p>Institute for Biosciences and Technology, Texas A&M Health Science Center, Houston, TX</p>
                     <p>Tel.: 979-845-5988, Fax: 979-862-4929</p>Distinguished Professor of Toxicology, Department of Veterinary Physiology and Pharmacology, Texas A&M University, 4466 TAMU, Vet. Res. Bldg. 410, College Station, Texas 77843-4466<a class="moreInfoLink" href="/action/doSearch?ContribAuthorRaw=Safe%2C+Stephen">Search for more papers by this author</a></div></span></div>
         </div>
      </div>
   </div>
   <div class="epub-sections"><div class="epub-section"><span class="epub-state">First published: </span><span class="epub-date">19 July 2012</span></div>
      <div class="epub-section"><a class="epub-doi" aria-label="Digital Object Identifier" href="https://doi.org/10.1002/ijc.27730">https://doi.org/10.1002/ijc.27730</a></div><div class="epub-section cited-by-count"><span>Citations: <a href="#citedby-section">31</a></span></div></div>
   <div class="epub-sections">
      <div class="article-header__references-container no-truncate" id="fn1" tabindex="0"><sup>†</sup><div class="header-note-content" aria-labelledby="header-note">
            <p>This work is dedicated to Val and Savannah.</p>
         </div>
      </div>
      <div class="article-header__references-container no-truncate" id="fn2" tabindex="0"></div>
      <div class="article-header__references-container no-truncate" id="fn3" tabindex="0"></div>
   </div>
</div></div><div class="fixedCoolBar"><nav aria-label="Article navigation and tools" class="coolBar stickybar"><div class="stickybar__wrapper coolBar__wrapper clearfix"><div class="rlist coolBar__zone"><div class="coolBar__section"><a href="javascript:void(0)" data-db-target-for="article" data-db-switch="icon-close_thin" aria-haspopup="true" aria-controls="article_Pop" role="button" id="article_Ctrl" class="coolBar__ctrl hidden-lg"><i class="icon-abstract"></i><span>About</span></a><div data-db-target-of="article" aria-labelledby="article_Ctrl" role="menu" id="article_Pop" class="coolBar__drop fixed rlist dropBlock__holder"><div data-target=".article-row-right .tab__nav, .coolBar--download" data-remove="false" data-targetClass="hidden-xs hidden-sm" data-toggle="transplant" data-direction="from" data-transplant="self" class="transplant showit"></div></div></div><div class="coolBar__section coolBar--sections"><a id="sections_Ctrl" href="javascript:void(0)" data-db-target-for="sections" data-db-switch="icon-close_thin" aria-haspopup="true" aria-controls="sections_Pop" role="button" class="coolBar__ctrl"><i class="icon-list-unordered"></i><span>Sections</span></a><div data-db-target-of="sections" aria-labelledby="sections_Ctrl" role="menu" id="sections_Pop" class="coolBar__drop dropBlock__holder rlist fixed"></div></div></div><div class="coolBar__second rlist"><div class="coolBar__section coolBar--download PdfLink"><a href="/doi/epdf/10.1002/ijc.27730" title="ePDF" class="coolBar__ctrl pdf-download"><img src="/products/pericles/releasedAssets/images/pdf-icon.png" alt="PDF"/>PDF</a></div>



        
        <div class="relative"><a href="#" data-db-target-for="0e406ce9-5c43-4e2d-b741-e0b43d1f1865" data-db-switch="icon-close_thin" aria-haspopup="true" aria-controls="0e406ce9-5c43-4e2d-b741-e0b43d1f1865_Pop" role="button" id="0e406ce9-5c43-4e2d-b741-e0b43d1f1865_Ctrl" class="article-tools__ctrl"><i aria-hidden="true" class="icon-Icon_Tools"></i><span>Tools</span></a><div data-db-target-of="0e406ce9-5c43-4e2d-b741-e0b43d1f1865" aria-labelledby="0e406ce9-5c43-4e2d-b741-e0b43d1f1865_Ctrl" role="menu" id="0e406ce9-5c43-4e2d-b741-e0b43d1f1865_Pop" class="article-tools__block fixed dropBlock__holder"><ul class="rlist w-slide--list"><li role="presentation" class="article-tool"><a href="https://onlinelibrary.wiley.com/action/rightsLink?doi=10.1002%2Fijc.27730&amp;mode=" role="menuitem" target="_blank"><i aria-hidden="true" class="icon-permissions-key"></i><span>Request permission</span></a></li><li role="presentation" class="article-tool"><a href="/action/showCitFormats?doi=10.1002%2Fijc.27730" role="menuitem" target="_self"><i aria-hidden="true" class="icon-export-icon"></i><span>Export citation</span></a></li><li role="presentation" class="article-tool"><a href="/personalize/addFavoritePublication?doi=10.1002%2Fijc.27730" role="menuitem" target="_self"><i aria-hidden="true" class="icon-favorites"></i><span>Add to favorites</span></a></li><li role="presentation" class="article-tool"><a href="/action/addCitationAlert?doi=10.1002%2Fijc.27730" role="menuitem" target="_self"><i aria-hidden="true" class="icon-Icon_Track-citations"></i><span>Track citation</span></a></li></ul></div></div>




        
        <!-- Go to www.addthis.com/dashboard to customize your tools --><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=ra-51225be51b56b4c4"></script><div class="relative"><a id="share-access__ctrl" href="#" data-db-target-for="dff42abe-4b17-4fe9-a9c5-625405cd1007" data-db-switch="icon-close_thin" aria-haspopup="true" aria-controls="share_Pop" role="button" class="share-access__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i><span>Share</span></a><a id="share__ctrl" href="#" data-db-target-for="dff42abe-4b17-4fe9-a9c5-625405cd1007" data-db-switch="icon-close_thin" aria-haspopup="true" aria-controls="share_Pop" role="button" class="share__ctrl hidden"><i aria-hidden="true" class="icon-Icon_Share"></i><span>Share</span></a><div data-db-target-of="dff42abe-4b17-4fe9-a9c5-625405cd1007" aria-labelledby="share-access__ctrl" role="menu" id="share_Pop" class="share__block dropBlock__holder fixed">



        
        <div data-share-access="/action/authorizeSharing?doi=10.1002/ijc.27730&amp;shareType=P2P" class="share-access hidden"><p>Give access</p><a href="#" data-toggle="modal" data-target="#shareAccess" class="share-access__link"><i class="icon-users"></i>Share full text access</a></div><div class="ux-modal-container share-access__modal"><div id="shareAccess" class="modal"><div class="modal__dialog"><div class="modal__header"><button type="button" data-dismiss="modal" class="close"><i aria-hidden="true" class="icon-close_thin"></i></button><p>Share full-text access</p></div><div class="modal__body"><form method="post"><fieldset><legend>Please review our <a href="https://onlinelibrary.wiley.com/termsAndConditions" target="_blank">Terms and Conditions of Use</a> and check box below to share full-text version of article.</legend><div class="input-group"><label for="terms-and-conditions" class="checkbox--primary"><input id="terms-and-conditions" type="checkbox" value="yes" required="" name="terms-and-conditions" data-ajax-link="/action/generateShareUrl?doi=10.1002/ijc.27730&amp;shareType=P2P&amp;format=FULL-TEXT" data-shareable-link=""/><span class="label-txt">I have read and accept the Wiley Online Library Terms and Conditions of Use</span></label></div></fieldset><hr class="separator"/><div class="shareable"><label>Shareable Link</label><p>Use the link below to share a full-text version of this article with your friends and colleagues. <a href="https://onlinelibrary.wiley.com/researchers/tools-resources/sharing" target="_blank" class="emphasis">Learn more.</a></p><div class="shareable__box"><div class="shareable__text"><div class="shareable__field"><span id="shareable__text"></span><textarea tabindex="-1" class="shareable__text-area"></textarea></div></div><button type="submit" disabled="" class="btn shareable__btn">Copy URL</button></div><div class="error shareable__error hidden"></div></div></form></div></div></div></div>
<p>Share a link</p><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter-t"></i>Twitter</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit-alien"></i>Reddit</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li></ul></div></div>
</div></div></nav></div><div id="accessDenialslot" class="accessDenialslot"></div><div class="article__body "><article>
   
   
   <div class="abstract-group">
      <section class="article-section article-section__abstract" lang="en" data-lang="en" id="section-1-en">
         <h2 id="d14201085" class="article-section__header section__title main abstractlang_en main">Abstract</h2>
         <div class="article-section__content en main">
            
            <p>Specificity protein (Sp) transcription factors Sp1, Sp3 and Sp4 are highly expressed in rhabdomyosarcoma (RMS) cells. In tissue arrays of RMS tumor cores from 71 patients, 80% of RMS patients expressed high levels of Sp1 protein, whereas low expression of Sp1 was detected in normal muscle tissue. The non-steroidal anti-inflammatory drug (NSAID) tolfenamic acid (TA) inhibited growth and migration of RD and RH30 RMS cell lines and also inhibited tumor growth <i>in vivo</i> using a mouse xenograft (RH30 cells) model. The effects of TA were accompanied by downregulation of Sp1, Sp3, Sp4 and Sp-regulated genes in RMS cells and tumors, and the role of Sp protein downregulation in mediating inhibition of RD and RH30 cell growth and migration was confirmed by individual and combined knockdown of Sp1, Sp3 and Sp4 proteins by RNA interference. TA treatment and Sp knockdown in RD and RH30 cells also showed that four genes that are emerging as individual drug targets for treating RMS, namely c-MET, insulin-like growth factor receptor (IGFR), PDGFRα and CXCR4, are also Sp-regulated genes. These results suggest that NSAIDs such as TA may have potential clinical efficacy in drug combinations for treating RMS patients.</p>
            </div>
      </section>
      <section class="article-section article-section__abstract" lang="en" data-lang="en" id="section-1-en">
         <h2 id="d14201087" class="article-section__header short abstractlang_en short">Abstract</h2>
         <div class="article-section__content en short">
            <p><b>What's new?</b></p>
            <p>Rhabdomyosarcoma (RMS) is a soft tissue cancer that primarily affects children and adolescents. RMS cells overproduce specificity protein transcription factors Sp1, Sp3, and Sp4. The NSAID tolfenamic acid (TA) downregulates Sp in other cancers. The authors tested TA on RMS cells, both in cell culture and in mice, and showed that it effects a drop in Sp gene expression and slows the growth of the cancer cells. TA, which is less toxic than the treatments currently used for RMS, could thus provide a better treatment for the disease.</p>
            </div>
      </section>
   </div>
   <div class="pb-dropzone" data-pb-dropzone="below-abstract-group"><!-- Empty dropzone --></div>
   
   <section class="article-section article-section__full">
      <section class="article-section__content" id="sec1-bdy-1">
         
         <p>Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma that is primarily observed in children and adolescents<span><a href="#bib1" class="bibLink tab-link" id="bib1R" data-tab="pane-pcw-references" aria-label="Reference 1 - Curr Probl Cancer">1</a></span> and accounts for approximately 5% of all pediatric cancers and 50% of soft-tissue sarcomas in children.<span><a href="#bib2" class="bibLink tab-link" id="bib2R" data-tab="pane-pcw-references" aria-label="Reference 2">2</a></span> The etiology of this sporadic tumor is unclear; however, a few studies suggest that parental occupations/exposure and the use of marijuana and cocaine may increase the risk for RMS in offspring.<span><a href="#bib3" class="bibLink tab-link" id="bib3R" data-tab="pane-pcw-references" aria-label="Reference 3 - Cancer Causes Control">3</a></span>, <span><a href="#bib4" class="bibLink tab-link" id="bib4R" data-tab="pane-pcw-references" aria-label="Reference 4 - Cancer">4</a></span> Embryonal RMS (ERMS) and alveolar RMS (ARMS) are the two major histologic classes of RMS in children and adolescents. Chromosomal analysis of these tumors has identified two predominant translocations, namely t(2;13)(q35;q14) and t(1:13)(p36;q14), and these encode for the PAX3-FKHR and PAX7-FKHR fusion proteins, respectively.<span><a href="#bib5" class="bibLink tab-link" id="bib5R" data-tab="pane-pcw-references" aria-label="Reference 5 - Nat Genet">5</a></span>, <span><a href="#bib6" class="bibLink tab-link" id="bib6R" data-tab="pane-pcw-references" aria-label="Reference 6 - Cancer Res">6</a></span> The fusion of PAX3 and PAX7 with the FOXO1 (Forkhead, FKHR) gene results in expression of oncogenic chimeric gene products which in turn regulate expression of multiple genes contributing to the aggressive behavior of ARMS and the poor prognosis of ARMS patients.<span><a href="#bib7" class="bibLink tab-link" id="bib7R" data-tab="pane-pcw-references" aria-label="Reference 7 - Genomics">7</a></span>, <span><a href="#bib8" class="bibLink tab-link" id="bib8R" data-tab="pane-pcw-references" aria-label="Reference 8 - Proc Natl Acad Sci U S A">8</a></span> The Children's Oncology Group has reported that among a cohort of metastatic ARMS patients, 55% expressed PAX3-FOXO1 and their overall 4-year survival rate was 8%; 22% of the patients expressed PAX7-FOXO1 and their 4-year survival rate was 75%.<span><a href="#bib9" class="bibLink tab-link" id="bib9R" data-tab="pane-pcw-references" aria-label="Reference 9 - J Clin Oncol">9</a></span></p>
         
         <p>Several protocols for treatment of RMS have been developed and, in North America, these are dependent on criteria established by the Intergroup Rhabdomyosarcoma Study Group which has developed clinical groupings for RMS patients.<span><a href="#bib10" class="bibLink tab-link" id="bib10R" data-tab="pane-pcw-references" aria-label="Reference 10 - J Pediatr Surg">10</a></span>, <span><a href="#bib11" class="bibLink tab-link" id="bib11R" data-tab="pane-pcw-references" aria-label="Reference 11 - Cancer">11</a></span> Treatments include radiotherapy, surgery and chemotherapy with cytotoxic drugs and/or drug combinations. Survival rates vary with the type (ARMS and ERMS) of RMS, and high risk patients with metastasis or recurrence have a poor prognosis.<span><a href="#bib12" class="bibLink tab-link" id="bib12R" data-tab="pane-pcw-references" aria-label="Reference 12 - J Clin Oncol">12</a></span> Improved survival for RMS patients will depend on multiple factors including the development and application of new mechanism-based drugs that target specific pro-oncogenic pathways but exhibit tumor cell-specificity and decreased toxic side effects.</p>
         
         <p>Specificity protein (Sp) transcription factors Sp1, Sp3 and Sp4 are overexpressed in many cancer cell lines and tumors (orthotopic and xenografts),<span><a href="#bib13" class="bibLink tab-link" id="bib13R" data-tab="pane-pcw-references" aria-label="Reference 13 - J Natl Cancer Inst">13</a>-<a href="#bib18" class="bibLink tab-link" id="bib18R" data-tab="pane-pcw-references" aria-label="Reference 18 - Cancer Res">18</a></span> and RNA interference studies show that several Sp-regulated gene products are associated with cancer cell growth [cyclin D1, hepatocyte growth factor receptor (c-MET) and epidermal growth factor receptor (EGFR)], survival (survivin and bcl-2) and angiogenesis [vascular endothelial growth factor (VEGF) and its receptors (VEGFR1/VEGFR2)].<span><a href="#bib16" class="bibLink tab-link" id="bib16R" data-tab="pane-pcw-references" aria-label="Reference 16 - Cancer Res">16</a></span>, <span><a href="#bib19" class="bibLink tab-link" id="bib19R" data-tab="pane-pcw-references" aria-label="Reference 19 - Exp Cell Res">19</a>-<a href="#bib24" class="bibLink tab-link" id="bib24R" data-tab="pane-pcw-references" aria-label="Reference 24 - J Biol Chem">24</a></span> Several drugs downregulate Sp proteins and Sp-regulated gene products in cancer cells and tumors and these include the non-steroidal anti-inflammatory drug (NSAID) tolfenamic acid (TA). Since some Sp-regulated genes such as c-MET and fibroblast growth factor receptor 4 (FGFR4) play a functional role in RMS and are potential therapeutic targets,<span><a href="#bib25" class="bibLink tab-link" id="bib25R" data-tab="pane-pcw-references" aria-label="Reference 25 - Cancer Res">25</a></span>, <span><a href="#bib26" class="bibLink tab-link" id="bib26R" data-tab="pane-pcw-references" aria-label="Reference 26 - Clin Cancer Res">26</a></span> we investigated the expression of Sp1 in tumors from RMS patients and Sp1, Sp3 and Sp4 and Sp-regulated gene products in RMS cells. Sp1, Sp3, Sp4 and several Sp-regulated genes are highly expressed in RMS cells, and Sp1 is overexpressed in tumors from 80% of RMS patients. TA inhibited RMS cell and tumor growth in a xenograft model and this was accompanied by decreased expression of Sp1, Sp3, Sp4 and Sp-regulated genes, suggesting potential clinical efficacy for this NSAID for treating RMS patients.</p>
         
         
         <h2 class="article-section__title section__title section1" id="block1-title"> Abbreviations</h2>
         <p>ARMS: alveolar rhabdomyosarcoma; BA: betulinic acid; CDODA-Me: methyl 2-cyano-3,11-dioxo-18β-olean-1,12-dien-30-oate; c-MET: hepatocyte growth factor receptor; EGFR: epidermal growth factor receptor; ERMS: embryonal rhabdomyosarcoma; FBS: fetal bovine serum; FGFR4: fibroblast growth factor receptor 4; HSMM: human skeletal muscle myoblast; IGFR: insulin-like growth factor receptor; NAC: <i>N</i>-acetylcysteine; NSAID: non-steroidal anti-inflammatory drug; PI: propidium iodide; RMS: rhabdomyosarcoma; ROS: reactive oxygen species; Sp: specificity protein; TA: tolfenamic acid; VEGF: vascular endothelial growth factor</p>
         
         </section>
      <section class="article-section__content" id="sec1-1">
         
         <h2 class="article-section__title section__title section1" id="sec1-1-title"> Material and Methods</h2>
         
         <section class="article-section__sub-content" id="sec2-1">
            
            <h3 class="article-section__sub-title section2" id="sec2-1-title"> Cell lines, human tissues, antibodies, chemicals and other materials</h3>
            
            <p>RH30 and RD human RMS cells were obtained from the American Type Culture Collection (Manassas, VA); genetically modified RMS cell extracts were obtained as described.<span><a href="#bib25" class="bibLink tab-link" id="bib25R" data-tab="pane-pcw-references" aria-label="Reference 25 - Cancer Res">25</a></span>, <span><a href="#bib27" class="bibLink tab-link" id="bib27R" data-tab="pane-pcw-references" aria-label="Reference 27 - Cancer Res">27</a></span> TA was purchased from LKT Laboratories (St. Paul, MN). <i>N</i>-acetylcysteine (NAC) and catalase were purchased from Sigma-Aldrich (St. Louis, MA). Lipofectamine and lipofectamine 2000 were purchased from Invitrogen. Survivin antibody was purchased from R&D Systems (Minneapolis, MN), and monoclonal β-actin and c-MET antibodies were purchased from Sigma-Aldrich and the FOX01 antibody from Cell Signaling (Danvers, MA). Horseradish peroxidase substrate for Western blot analysis, Sp1 and CXCR4 antibody were obtained from Millipore (Bellirica, MA), and all remaining antibodies were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Luciferase reagent was from Promega (Madison, WI), and β-galactosidase reagent was obtained from Tropix (Carlsbad, CA). The Cooperative Human Tissue Network provided the tissue arrays for Sp1 staining. The constructs containing promoter inserts from the Sp1 (−751 to −20), Sp3 (−417 to −38), c-MET (−703 to +60), survivin (−264 to+49) and VEGF (−2018 to +50) genes have previously been reported.<span><a href="#bib16" class="bibLink tab-link" id="bib16R" data-tab="pane-pcw-references" aria-label="Reference 16 - Cancer Res">16</a></span>, <span><a href="#bib19" class="bibLink tab-link" id="bib19R" data-tab="pane-pcw-references" aria-label="Reference 19 - Exp Cell Res">19</a>-<a href="#bib24" class="bibLink tab-link" id="bib24R" data-tab="pane-pcw-references" aria-label="Reference 24 - J Biol Chem">24</a></span></p>
            </section>
         
         <section class="article-section__sub-content" id="sec2-2">
            
            <h3 class="article-section__sub-title section2" id="sec2-2-title"> Cell proliferation assays</h3>
            
            <p>RH30 and RD RMS cells (3 × 10<sup>4</sup> per well) were plated using DMEM:Ham's F-12 medium containing 2.5% charcoal-stripped fetal bovine serum (FBS) in 12-well plates and left to attach for 24 hr. Cells were then treated with either vehicle (DMSO) or TA at given concentrations ± IGF (100 ng/ml) and then counted at the indicated times using a Coulter Z1 particle counter. Each experiment was done in triplicate, and results are expressed as means ± SE for each determination.</p>
            </section>
         
         <section class="article-section__sub-content" id="sec2-3">
            
            <h3 class="article-section__sub-title section2" id="sec2-3-title"> Western blot assays and Annexin V staining</h3>
            
            <p>RH30 and RD cells were seeded in DMEM:Ham's F-12 medium containing 2.5% charcoal-stripped FBS. After 12 hr, cells were treated with either vehicle (DMSO) or the indicated compounds for 24 hr and Western blot analysis was performed essentially as described.<span><a href="#bib22" class="bibLink tab-link" id="bib22R" data-tab="pane-pcw-references" aria-label="Reference 22 - Cancer Res">22</a>-<a href="#bib24" class="bibLink tab-link" id="bib24R" data-tab="pane-pcw-references" aria-label="Reference 24 - J Biol Chem">24</a></span> Annexin V staining was determined using the Vybrant apoptosis assay kit (Molecular Probes, Eugene, OR) as described.<span><a href="#bib22" class="bibLink tab-link" id="bib22R" data-tab="pane-pcw-references" aria-label="Reference 22 - Cancer Res">22</a>-<a href="#bib24" class="bibLink tab-link" id="bib24R" data-tab="pane-pcw-references" aria-label="Reference 24 - J Biol Chem">24</a></span></p>
            </section>
         
         <section class="article-section__sub-content" id="sec2-4">
            
            <h3 class="article-section__sub-title section2" id="sec2-4-title"> Fluorescence-activated cell sorting and transfection assays</h3>
            
            <p>Both RH30 and RD cancer cells were treated with either the vehicle (DMSO) and TA for indicated time periods. Cells were analyzed on an Accuri C6 FACS calibur flow cytometer using CellQuest acquisition software (Accuri, Ann Arbor, MI). Propidium iodide (PI) fluorescence was collected through a 585/42 nm band pass filter, and list mode data were acquired on a minimum of 20,000 single cells defined by a dot plot of PI width <i>versus</i> PI area. Data analysis was performed using Cflow software (Accuri). siRNAs, antisense-miRs and expression plasmids were transfected into RD and RH30 cells using LipofectAMINE essentially as described.<span><a href="#bib18" class="bibLink tab-link" id="bib18R" data-tab="pane-pcw-references" aria-label="Reference 18 - Cancer Res">18</a></span>, <span><a href="#bib19" class="bibLink tab-link" id="bib19R" data-tab="pane-pcw-references" aria-label="Reference 19 - Exp Cell Res">19</a></span>, <span><a href="#bib22" class="bibLink tab-link" id="bib22R" data-tab="pane-pcw-references" aria-label="Reference 22 - Cancer Res">22</a>-<a href="#bib24" class="bibLink tab-link" id="bib24R" data-tab="pane-pcw-references" aria-label="Reference 24 - J Biol Chem">24</a></span> DAP1 and PI staining were used and the results showed minimal (&lt;5%) PI positive cells.</p>
            </section>
         
         <section class="article-section__sub-content" id="sec2-5">
            
            <h3 class="article-section__sub-title section2" id="sec2-5-title"> Transwell migration and scratch assays</h3>
            
            <p>RH30 and RD cells were added to the upper chamber of a transwell chamber in duplicate and allowed to migrate into the lower chamber containing Hams F12 media with 20% FBS by incubating for 12 hr at 5% CO<sub>2</sub> at 37°C. The cells were then treated with control or TA for the indicated time periods, and the cells migrating to the outer side of the upper chamber were fixed, stained and counted. The effects of TA on IGF-induced responses used 100 ng/ml of the growth factor. The scratch assay was carried out as described.<span><a href="#bib20" class="bibLink tab-link" id="bib20R" data-tab="pane-pcw-references" aria-label="Reference 20 - Cancer Res">20</a></span></p>
            </section>
         
         <section class="article-section__sub-content" id="sec2-6">
            
            <h3 class="article-section__sub-title section2" id="sec2-6-title"> Xenograft and immunohistochemistry experiments</h3>
            
            <p>Female athymic nude mice, age 4–6 weeks, were purchased from Harlan-Sprague Dawley. RH30 cells (2 × 10<sup>6</sup>) in 1:1 ratio of Matrigel (BD Biosciences, San Jose, CA) were injected into the either side of the flank area of nude mice. Six days after the tumor cell inoculation, mice were divided into two groups of eight animals each. The first group received 100 μl vehicle (corn oil) by oral gavage, and the second group of animals received 50 mg/kg/dose oral gavage of TA in 2.5% DMSO and 97.5% corn oil every second day for 20 d. The mice were weighed, and tumor areas were measured throughout the study. After 20 d, the animals were sacrificed; final body and tumor weights were determined and plotted. Tissues were processed for immunohistochemistry and Western blotting as described above.<span><a href="#bib19" class="bibLink tab-link" id="bib19R" data-tab="pane-pcw-references" aria-label="Reference 19 - Exp Cell Res">19</a></span>, <span><a href="#bib23" class="bibLink tab-link" id="bib23R" data-tab="pane-pcw-references" aria-label="Reference 23 - Mol Pharmacol">23</a></span>, <span><a href="#bib24" class="bibLink tab-link" id="bib24R" data-tab="pane-pcw-references" aria-label="Reference 24 - J Biol Chem">24</a></span> A pilot xenograft study using RD cells (three animals/group) was also carried out.</p>
            </section>
         
         <section class="article-section__sub-content" id="sec2-7">
            
            <h3 class="article-section__sub-title section2" id="sec2-7-title"> Human tissue microarray and grading</h3>
            
            <p>Slides were deparaffinized by heating at 60°C for 30 min and immediately transferred to xylene (Safeclear, Fisher, Pittsburgh, PA). Sections were rehydrated by treating with graded ethanol (100%, 95%, 70% and 35%) and then with PBS. Sections were incubated with sodium citrate for antigen retrieval as per manufacturer's protocol (Vector Labs, Burlingame, CA) and endogenous peroxides were quenched using 0.3% H<sub>2</sub>O<sub>2</sub> in methanol for 6 min. Tissue sections were processed, mounted using permount (Fisher) and visualized using a Carl Zeiss Axiovert microscope (Carl Zeiss, Thornwood, NY) as described.<span><a href="#bib23" class="bibLink tab-link" id="bib23R" data-tab="pane-pcw-references" aria-label="Reference 23 - Mol Pharmacol">23</a></span>, <span><a href="#bib24" class="bibLink tab-link" id="bib24R" data-tab="pane-pcw-references" aria-label="Reference 24 - J Biol Chem">24</a></span> A total of 77 tissue array samples were analyzed for positive Sp1 staining (brown) in the nucleus by four independent investigators on three consecutive days. The array core consisted of normal and RMS tissues interspersed randomly. A standard semiquantitative grading system (1–4) of Sp1 nuclear staining intensity was applied and graded as follows: 1, presence of &lt;5% of Sp1 nuclear staining; 2, presence of 15–50% of positive staining; 3, presence of 50–75% of positive cells; and 4, presence of &gt;75% positive staining nuclei. This immunohistological grading method has been established as a semiquantitative means for antigen detection and quantitation.<span><a href="#bib28" class="bibLink tab-link" id="bib28R" data-tab="pane-pcw-references" aria-label="Reference 28 - Cancer J">28</a></span> Percent staining and number of patient samples were plotted on the Y- and X-axes, respectively.</p>
            </section>
         
         <section class="article-section__sub-content" id="sec2-8">
            
            <h3 class="article-section__sub-title section2" id="sec2-8-title"> Statistical analysis</h3>
            
            <p>Statistical significance of differences was determined by ANOVA and Student's <i>t</i> test, and the levels of probability were noted. All statistical tests were two sided.</p>
            </section>
         </section>
      <section class="article-section__content" id="sec1-2">
         
         <h2 class="article-section__title section__title section1" id="sec1-2-title"> Results</h2>
         
         <section class="article-section__sub-content" id="sec2-9">
            
            <h3 class="article-section__sub-title section2" id="sec2-9-title"> Expression of Sp1, Sp3 and Sp4 in RMS cells and effects of TA</h3>
            
            <p>Sp1, Sp3 and Sp4 are overexpressed in multiple cancer cell lines and tumors,<span><a href="#bib13" class="bibLink tab-link" id="bib13R" data-tab="pane-pcw-references" aria-label="Reference 13 - J Natl Cancer Inst">13</a>-<a href="#bib18" class="bibLink tab-link" id="bib18R" data-tab="pane-pcw-references" aria-label="Reference 18 - Cancer Res">18</a></span> and results in Figure <a href="#fig1">1</a><i>a</i> show that these transcription factors are also highly expressed in RH30 (ARMS) and RD (ERMS) cells. TA decreased expression of Sp1, Sp3 and Sp4 in RH30 and RD cells (Fig. <a href="#fig1">1</a><i>a</i>) and similar results were observed after treatment with the triterpenoids betulinic acid (BA) or methyl 2-cyano-3,11-dioxo-18-olean-1,12-dien-30-oate (CDODA-Me) (Supporting Information Fig. <a href="#fig1">1</a>). Moreover, we surveyed expression of Sp1, Sp3 and Sp4 in several other RMS cell lines and high levels were also observed in these cells (Supporting Information Fig. <a href="#fig2">2</a>). Stable transduction of primary human skeletal muscle myoblasts (HSMMs) with viral vectors expressing <i>PAX-3-FOXO1</i> (HSMM<sup>PF</sup>), <i>PAX3-FOXO1</i> plus the catalytic subunit of telomerase (<i>hTERT</i>) (HSMM<sup>PF+H</sup>), and <i>PAX3-FOXO1</i> plus <i>hTERT</i> plus <i>NMyc</i> (HSMM<sup>PF+H+M</sup>) yielded cell lines in which only the HSMM<sup>PF+H+M</sup> cells were tumorigenic in SCID/beige mice.<span><a href="#bib27" class="bibLink tab-link" id="bib27R" data-tab="pane-pcw-references" aria-label="Reference 27 - Cancer Res">27</a></span>, <span><a href="#bib29" class="bibLink tab-link" id="bib29R" data-tab="pane-pcw-references" aria-label="Reference 29 - Cancer Res">29</a></span>, <span><a href="#bib30" class="bibLink tab-link" id="bib30R" data-tab="pane-pcw-references" aria-label="Reference 30 - Cancer Res">30</a></span> Figure <a href="#fig1">1</a><i>b</i> shows that Sp4 protein was expressed in HSMM cells and the genetically transfected cell lines, whereas Sp1 and Sp3 levels were relatively low in muscle myoblasts transfected with <i>PAX3-FOXO1</i> and <i>PAX3-FOXO1</i> plus <i>hTERT</i> and were dramatically increased in cells transfected with all three genes. The genetic model for ERMS was developed in HSMMs transduced with SV40 large-T and small-t oncoproteins (T/t), telomerase and activated H-Ras<sup>G12V</sup> and expressed comparable levels of Sp1, Sp3 and Sp4 were observed in all the genetic models (Fig. <a href="#fig1">1</a><i>b</i>), and this was due to expression of SV40 which induces Sp1.<span><a href="#bib31" class="bibLink tab-link" id="bib31R" data-tab="pane-pcw-references" aria-label="Reference 31 - Genes Dev">31</a></span> Figure <a href="#fig1">1</a><i>b</i> also compares expression of Sp1, Sp3 and Sp4 and c-MET and survivin expression in HSMM and HSMM<sup>PF+H+M</sup> and shows that Sp-regulated c-MET and survivin are more highly expressed in the transformed cell line compared to HSMM cells. Previous studies in this laboratory show two separable forms of Sp3 (110–115 and 70–80 kDa) in cancer cell lines<span><a href="#bib13" class="bibLink tab-link" id="bib13R" data-tab="pane-pcw-references" aria-label="Reference 13 - J Natl Cancer Inst">13</a>-<a href="#bib23" class="bibLink tab-link" id="bib23R" data-tab="pane-pcw-references" aria-label="Reference 23 - Mol Pharmacol">23</a></span>; the low molecular weight band contains two forms and these results are consistent with previous studies on characterization of Sp3 isoforms.<span><a href="#bib32" class="bibLink tab-link" id="bib32R" data-tab="pane-pcw-references" aria-label="Reference 32 - Nucleic Acids Res">32</a></span>, <span><a href="#bib33" class="bibLink tab-link" id="bib33R" data-tab="pane-pcw-references" aria-label="Reference 33 - J Biol Chem">33</a></span>
               </p>
            
            <section class="article-section__inline-figure">
               <figure class="figure" id="fig1"><a target="_blank" href="/cms/asset/b818ae37-e5af-4a67-9121-a4f90fcd5bdf/mfig001.jpg"><picture>
                        <source srcset="/cms/asset/b818ae37-e5af-4a67-9121-a4f90fcd5bdf/mfig001.jpg" media="(min-width: 1650px)"></source><img class="figure__image" src="/cms/asset/7f39516f-d2a8-4914-a36b-696f980f049a/mfig001.jpg" data-lg-src="/cms/asset/b818ae37-e5af-4a67-9121-a4f90fcd5bdf/mfig001.jpg" alt="Details are in the caption following the image" loading="lazy"></picture></a><figcaption class="figure__caption">
                     <div class="figure__caption__header"><strong class="figure__title">Figure 1</strong><div class="figure-extra"><a href="#" class="open-figure-link">Open in figure viewer</a><a href="/action/downloadFigures?id=fig1&amp;doi=10.1002%2Fijc.27730" class="ppt-figure-link"><i aria-hidden="true" class="icon-Icon_Download"></i><span>PowerPoint</span></a></div>
                     </div>
                     <div class="figure__caption figure__caption-text">
                        <p>Sp protein expression in RMS cells and tumors and effects of TA. (<i>a</i>) RH30 and RD cells. Cells were treated with DMSO or TA, and whole cell lysates were examined for expression of Sp1, Sp3 and Sp4 proteins by Western blots as described in the “Material and Methods” section. (<i>b</i>) Genetic models of RMS. Whole cell lysates from HSMM and stably transfected RMS cells were analyzed for protein expression as described in (<i>a</i>). Relative intensity of Sp1 staining in RMS patient tumors and muscle tissue (<i>c</i>) and in specific samples (<i>d</i>). Samples provided by the Cooperative Human Tissue Network were stained for Sp1 and relative staining intensities were assigned as described in the “Material and Methods” section. β-Actin was used as a loading control for all Western blots.</p>
                        </div>
                  </figcaption>
               </figure>
            </section>
            </section>
         
         <section class="article-section__sub-content" id="sec2-10">
            
            <h3 class="article-section__sub-title section2" id="sec2-10-title"> Sp1 expression in RMS patients</h3>
            
            <p>The Cooperative Human Tissue Network provided us with tissue arrays of RMS tumor cores from 71 patients and six normal muscle tissues, and these were stained for Sp1 protein and initially sub-divided into four groups (1–4; increasing Sp1 staining) based on their Sp1 staining intensity. Muscle cell staining for Sp1 was ≤2 (low) for all six normal samples; in contrast, 80% of the RMS samples exhibited high (≥3) staining for Sp1, whereas 20% exhibited low staining (≤2) (Fig. <a href="#fig1">1</a><i>c</i>). Figure <a href="#fig1">1</a><i>d</i> illustrates the typical high Sp1 staining in ARMS and ERMS tumors compared to muscle tissue, and magnification of these images indicates that Sp1 is primarily nuclear in the tumor samples.</p>
            </section>
         
         <section class="article-section__sub-content" id="sec2-11">
            
            <h3 class="article-section__sub-title section2" id="sec2-11-title"> TA inhibits RMS cell growth and migration and induces apoptosis</h3>
            
            <p>Figure <a href="#fig2">2</a><i>a</i> shows that TA decreased proliferation of both RH30 and RD cells, and the former cell line was more responsive to the growth inhibitory effects of TA. IGF (100 ng/ml) increased proliferation of RH30 (1.3-fold) and RD (1.15-fold) cells; cotreatment with TA also decreased IGF-induced cell proliferation (Fig. <a href="#fig2">2</a><i>a</i>). FACS analysis of RH30 and RD cells after treatment with TA for 24 or 48 hr showed that in RH30 cells the percent of cells in S and G<sub>2</sub>/M phases increased and decreased, respectively, whereas no changes were observed in RD cells (Fig. <a href="#fig2">2</a><i>b</i>). TA induced Annexin V staining (apoptosis) in both cell lines (Fig. <a href="#fig2">2</a><i>c</i>) and, in a scratch assay, treatment of RH30 cells with the solvent control (DMSO) resulted in extensive cell migration (Fig. <a href="#fig2">2</a><i>d</i>) after 48 hr, whereas in cells treated with 75 μM TA, cell migration was markedly inhibited. IGF also enhanced cell migration and this response was inhibited by TA. Similar results were observed for RD cells; TA (100 μM) inhibited migration of RD cells (± IGF) and there was also evidence for growth inhibition of these cells by TA (Fig. <a href="#fig2">2</a><i>d</i>).</p>
            
            <section class="article-section__inline-figure">
               <figure class="figure" id="fig2"><a target="_blank" href="/cms/asset/74657eb1-71d4-457c-a8d6-aec6be8e2444/mfig002.jpg"><picture>
                        <source srcset="/cms/asset/74657eb1-71d4-457c-a8d6-aec6be8e2444/mfig002.jpg" media="(min-width: 1650px)"></source><img class="figure__image" src="/cms/asset/d567d0bf-dae7-4c76-a575-f2782c9fb77d/mfig002.jpg" data-lg-src="/cms/asset/74657eb1-71d4-457c-a8d6-aec6be8e2444/mfig002.jpg" alt="Details are in the caption following the image" loading="lazy"></picture></a><figcaption class="figure__caption">
                     <div class="figure__caption__header"><strong class="figure__title">Figure 2</strong><div class="figure-extra"><a href="#" class="open-figure-link">Open in figure viewer</a><a href="/action/downloadFigures?id=fig2&amp;doi=10.1002%2Fijc.27730" class="ppt-figure-link"><i aria-hidden="true" class="icon-Icon_Download"></i><span>PowerPoint</span></a></div>
                     </div>
                     <div class="figure__caption figure__caption-text">
                        <p>TA inhibits RMS cell growth, induces apoptosis and inhibits migration. Effects of TA on cell proliferation (<i>a</i>) and cell cycle progression (<i>b</i>). RH30 and RD cells were treated with DMSO, TA or TA+IGF (100 ng/ml) (cell proliferation only), and effects on cell proliferation or percent distribution of cells in G<sub>0</sub>/G<sub>1</sub>, S and G<sub>2</sub>/M phases were determined as described in the “Material and Methods” section. Induction of apoptosis (<i>c</i>) and inhibition of RMS cell migration by TA (<i>d</i>). RMS cells were treated with DMSO, TA or TA+IGF (100 ng/ml), and effects on Annexin V staining and cell migration (scratch assay) were determined as outlined in the “Material and Methods” section. Results are expressed as means ± SE for at least three separate determinations, and significant (<i>p</i> &lt; 0.05) induction (*) or inhibition (**) by TA is indicated.</p>
                        </div>
                  </figcaption>
               </figure>
            </section>
            </section>
         
         <section class="article-section__sub-content" id="sec2-12">
            
            <h3 class="article-section__sub-title section2" id="sec2-12-title"> TA treatment and Sp knockdown in RMS cells induce comparable effects</h3>
            
            <p>The linkage between the effects of TA and downregulation of Sp proteins was investigated by comparing RNA interference and knockdown of Sp1, Sp3 and Sp4 proteins alone and in combination to the effects of TA on selected Sp-regulated genes. Results in Figure <a href="#fig3">3</a><i>a</i> show that each individual oligonucleotide (iSp1, iSp3 and iSp4) deceased expression of its own target gene product with minimal effects on expression of the other Sp proteins; the cocktail of the combined oligonucleotides (iSp1/3/4) decreased expression of all three Sp proteins, and the specificity of these oligonucleotides has previously been reported.<span><a href="#bib21" class="bibLink tab-link" id="bib21R" data-tab="pane-pcw-references" aria-label="Reference 21 - Mol Cancer Res">21</a></span>, <span><a href="#bib23" class="bibLink tab-link" id="bib23R" data-tab="pane-pcw-references" aria-label="Reference 23 - Mol Pharmacol">23</a></span>, <span><a href="#bib24" class="bibLink tab-link" id="bib24R" data-tab="pane-pcw-references" aria-label="Reference 24 - J Biol Chem">24</a></span> A comparison of the effects of TA <i>versus</i> iSp1/3/4 on putative Sp-regulated gene products is summarized in Figures <a href="#fig3">3</a><i>b</i> and <a href="#fig3">3</a><i>c</i>. TA decreased expression of cyclin D1, survivin and VEGF in both cell lines as described in previous studies<span><a href="#bib13" class="bibLink tab-link" id="bib13R" data-tab="pane-pcw-references" aria-label="Reference 13 - J Natl Cancer Inst">13</a></span>, <span><a href="#bib15" class="bibLink tab-link" id="bib15R" data-tab="pane-pcw-references" aria-label="Reference 15 - Carcinogenesis">15</a></span>; however, TA also decreased PDGFRα, c-MET, IGFR and CXCR4 protein levels (Fig. <a href="#fig3">3</a><i>c</i>), and all three of these proteins are individually potential targets for treating RMS.<span><a href="#bib25" class="bibLink tab-link" id="bib25R" data-tab="pane-pcw-references" aria-label="Reference 25 - Cancer Res">25</a></span>, <span><a href="#bib34" class="bibLink tab-link" id="bib34R" data-tab="pane-pcw-references" aria-label="Reference 34 - Oncogene">34</a>-<a href="#bib36" class="bibLink tab-link" id="bib36R" data-tab="pane-pcw-references" aria-label="Reference 36 - Clin Exp Metastasis">36</a></span> Knockdown of Sp proteins by RNA interference also decreased expression of the same gene products that were decreased by TA (Fig. <a href="#fig3">3</a><i>d</i>); however, it was evident that these proteins were differentially regulated by individual Sp proteins and there were cell context-dependent differences. For example, cyclin D1 was primarily regulated by Sp1 in RH30 cells but by Sp1, Sp3 and Sp4 in RD cells. c-MET, IGFR, CXCR4 and PDGFRα were also decreased in RD and RH30 cells transfected with iSp1/3/4 (combination), and the effects of individual Sp protein knockdown were variable and the most effective knockdown was observed with iSp1/3/4. In a separate RNA interference study, we also showed that knockdown of Sp1 or combined knockdown of Sp1/3/4 (Supporting Information Fig. <a href="#fig3">3</a>A) decreased expression of a high molecular weight FOXO1 band (using a FOXO1 antibody) that has previously been identified as the chimeric PAX3-FOXO1 protein.<span><a href="#bib27" class="bibLink tab-link" id="bib27R" data-tab="pane-pcw-references" aria-label="Reference 27 - Cancer Res">27</a></span> Moreover, TA also decreased expression of this chimeric protein and it is possible that PAX3-FOXO1 downregulation may play a role in the decreased expression of some of the other Sp-regulated genes (Figs. <a href="#fig3">3</a><i>c</i> and <a href="#fig3">3</a><i>d</i>). The effects of TA on luciferase activity in RH30 and RD cells transfected with constructs containing GC-rich promoter inserts from the Sp1 (−751 to -20), Sp3 (−417 to −38), c-MET (−703 to +60), survivin (−264 to +49) and VEGF (−2018 to +50) genes was also determined. TA significantly decreased activity in cells transfected with all five constructs in both cell lines (Supporting Information Fig. <a href="#fig3">3</a>B), indicating that loss of Sp proteins is also correlated with decreased Sp-dependent transactivation.</p>
            
            <section class="article-section__inline-figure">
               <figure class="figure" id="fig3"><a target="_blank" href="/cms/asset/f8750311-e7f1-4346-953c-eefa819e4316/mfig003.jpg"><picture>
                        <source srcset="/cms/asset/f8750311-e7f1-4346-953c-eefa819e4316/mfig003.jpg" media="(min-width: 1650px)"></source><img class="figure__image" src="/cms/asset/da65e870-5c49-4fcf-8532-7c988bf402cb/mfig003.jpg" data-lg-src="/cms/asset/f8750311-e7f1-4346-953c-eefa819e4316/mfig003.jpg" alt="Details are in the caption following the image" loading="lazy"></picture></a><figcaption class="figure__caption">
                     <div class="figure__caption__header"><strong class="figure__title">Figure 3</strong><div class="figure-extra"><a href="#" class="open-figure-link">Open in figure viewer</a><a href="/action/downloadFigures?id=fig3&amp;doi=10.1002%2Fijc.27730" class="ppt-figure-link"><i aria-hidden="true" class="icon-Icon_Download"></i><span>PowerPoint</span></a></div>
                     </div>
                     <div class="figure__caption figure__caption-text">
                        <p>Effects of RNAi and TA on Sp1, Sp3, Sp4 and Sp-regulated genes in RMS cells. (<i>a</i>) Downregulation of Sp proteins by RNAi. Cells were transfected with specific oligonucleotides or a combination, and whole cell lysates were analyzed by Western blots as described in the “Material and Methods” section. TA decreases CD1, survivin, VEGF (<i>b</i>) and other critical gene products (<i>c</i>) in RMS cells. Cells were treated with DMSO or TA, and whole cell lysates were analyzed by Western blots as described in the “Material and Methods” section. (<i>d</i>) Effects of RNAi on Sp-regulated genes. RMS cells were transfected with oligonucleotides as outlined in (<i>a</i>), and whole cell lysates were analyzed by Western blots as described in the “Material and Methods” section.</p>
                        </div>
                  </figcaption>
               </figure>
            </section>
            
            <p>The similarities between the effects of Sp knockdown and TA on cell migration was also investigated. TA significantly decreased migration of RH30 (Fig. <a href="#fig4">4</a><i>a</i>) and RD (Fig. <a href="#fig4">4</a><i>b</i>) cells in a Boyden Chamber assay and TA also inhibited IGF (100 ng/ml)-induced migration. Knockdown of Sp1 alone (iSp1) also decreased migration in both cell lines (Fig. <a href="#fig4">4</a><i>c</i>). iSp1, iSp4 and iSp1/3/4 significantly decreased proliferation of both cell lines, whereas iSp3 significantly decreased growth of RH30 but not RD cells (Fig. <a href="#fig4">4</a><i>d</i>). These results also support the role of TA-induced downregulation of Sp1, Sp3 and Sp4 (Fig. <a href="#fig2">2</a><i>a</i>) in the growth inhibitory and antimigratory activities of TA (Figs. <a href="#fig2">2</a><i>a</i>, <a href="#fig2">2</a><i>d</i> and <a href="#fig4">4</a><i>a</i>, <a href="#fig4">4</a><i>b</i>). The effects of TA on growth inhibition may also be due, in part, to increased apoptosis.</p>
            
            <section class="article-section__inline-figure">
               <figure class="figure" id="fig4"><a target="_blank" href="/cms/asset/ffc3617b-a391-4ec2-8df1-be6e1468db13/mfig004.jpg"><picture>
                        <source srcset="/cms/asset/ffc3617b-a391-4ec2-8df1-be6e1468db13/mfig004.jpg" media="(min-width: 1650px)"></source><img class="figure__image" src="/cms/asset/30ae2df9-3ef3-46e2-bd3a-46c56ecfdbb5/mfig004.jpg" data-lg-src="/cms/asset/ffc3617b-a391-4ec2-8df1-be6e1468db13/mfig004.jpg" alt="Details are in the caption following the image" loading="lazy"></picture></a><figcaption class="figure__caption">
                     <div class="figure__caption__header"><strong class="figure__title">Figure 4</strong><div class="figure-extra"><a href="#" class="open-figure-link">Open in figure viewer</a><a href="/action/downloadFigures?id=fig4&amp;doi=10.1002%2Fijc.27730" class="ppt-figure-link"><i aria-hidden="true" class="icon-Icon_Download"></i><span>PowerPoint</span></a></div>
                     </div>
                     <div class="figure__caption figure__caption-text">
                        <p>TA and RNAi inhibit RMS cell migration (Boyden chamber) and proliferation. Inhibition of RH30 (<i>a</i>) and RD (<i>b</i>) cell migration by TA. RMS cells were treated with DMSO or TA, and inhibition of cell migration in the Boyden chamber assay was determined as outlined in the Materials and Methods. Knockdown of Sp and effects on RMS cell migration (<i>c</i>) and proliferation (<i>d</i>). Cells were transfected with iSp1 and effects on cell migration (Boyden chamber) and effects of iSp1, iSp3, iSp4 and iSp1/3/4 on proliferation were determined as described in the “Material and Methods” section. Results in (<i>a</i>)–(<i>d</i>) are means ± SE for at least three separate experiments, and significant (<i>p</i> &lt; 0.05) inhibition by TA or Sp knockdown are indicated (*). The DMSO and iLamin treatment controls were set at 100%, and the absolute values for these controls in RH30 and RD cells were not significantly different.</p>
                        </div>
                  </figcaption>
               </figure>
            </section>
            </section>
         
         <section class="article-section__sub-content" id="sec2-13">
            
            <h3 class="article-section__sub-title section2" id="sec2-13-title"> Effects of TA on proteasome-independent and dependent Sp downregulation</h3>
            
            <p>TA induces proteasome-dependent degradation of Sp1, Sp3 and Sp4<span><a href="#bib13" class="bibLink tab-link" id="bib13R" data-tab="pane-pcw-references" aria-label="Reference 13 - J Natl Cancer Inst">13</a></span>, <span><a href="#bib20" class="bibLink tab-link" id="bib20R" data-tab="pane-pcw-references" aria-label="Reference 20 - Cancer Res">20</a></span>; however, in RH30 cells, the proteasome inhibitors MG132 and lactacystin did not block TA-dependent downregulation of Sp1, Sp3 and Sp4 (Fig. <a href="#fig5">5</a><i>a</i>). In RD cells, lactacystin only inhibited TA-induced degradation of Sp3 but not Sp1 or Sp4 (Fig. <a href="#fig5">5</a><i>b</i>), and MG132 enhanced the effects of TA in this cell line. Another mechanism of drug-induced Sp downregulation has been linked to induction of reactive oxygen species (ROS)<span><a href="#bib19" class="bibLink tab-link" id="bib19R" data-tab="pane-pcw-references" aria-label="Reference 19 - Exp Cell Res">19</a></span>, <span><a href="#bib23" class="bibLink tab-link" id="bib23R" data-tab="pane-pcw-references" aria-label="Reference 23 - Mol Pharmacol">23</a></span>, <span><a href="#bib24" class="bibLink tab-link" id="bib24R" data-tab="pane-pcw-references" aria-label="Reference 24 - J Biol Chem">24</a></span>, <span><a href="#bib37" class="bibLink tab-link" id="bib37R" data-tab="pane-pcw-references" aria-label="Reference 37 - Mol Cancer Res">37</a></span>; however, the effects of ROS inhibitors such as NAC and catalase did not affect TA-mediated downregulation of Sp1, Sp3 and Sp4 proteins in RH30 or RD cells (Supporting Information Fig. <a href="#fig4">4</a>). ZBTB10 is an Sp repressor that binds GC-rich sites and ZBTB10 expression in cancer cells is blocked by miR-27a and this interaction facilitates the high expression of Sp proteins in cancer cells.<span><a href="#bib17" class="bibLink tab-link" id="bib17R" data-tab="pane-pcw-references" aria-label="Reference 17 - Int J Cancer">17</a></span>, <span><a href="#bib18" class="bibLink tab-link" id="bib18R" data-tab="pane-pcw-references" aria-label="Reference 18 - Cancer Res">18</a></span>, <span><a href="#bib23" class="bibLink tab-link" id="bib23R" data-tab="pane-pcw-references" aria-label="Reference 23 - Mol Pharmacol">23</a></span> TA decreased miR-27a and induced expression of the Sp repressor ZBTB10 in RH30 cells, whereas in RD cells, TA induced ZBTB10 but this was not accompanied by decreased miR-27a expression (Fig. <a href="#fig5">5</a><i>c</i>). Previous studies have demonstrated the relationship between miR-27a and ZBTB10 in cancer cell lines<span><a href="#bib17" class="bibLink tab-link" id="bib17R" data-tab="pane-pcw-references" aria-label="Reference 17 - Int J Cancer">17</a></span>, <span><a href="#bib18" class="bibLink tab-link" id="bib18R" data-tab="pane-pcw-references" aria-label="Reference 18 - Cancer Res">18</a></span>, <span><a href="#bib23" class="bibLink tab-link" id="bib23R" data-tab="pane-pcw-references" aria-label="Reference 23 - Mol Pharmacol">23</a></span>, <span><a href="#bib37" class="bibLink tab-link" id="bib37R" data-tab="pane-pcw-references" aria-label="Reference 37 - Mol Cancer Res">37</a></span> and the role of drug-induced ROS in mediating downregulation of miR-27a and induction of ZBTB10.<span><a href="#bib23" class="bibLink tab-link" id="bib23R" data-tab="pane-pcw-references" aria-label="Reference 23 - Mol Pharmacol">23</a></span>, <span><a href="#bib24" class="bibLink tab-link" id="bib24R" data-tab="pane-pcw-references" aria-label="Reference 24 - J Biol Chem">24</a></span>, <span><a href="#bib37" class="bibLink tab-link" id="bib37R" data-tab="pane-pcw-references" aria-label="Reference 37 - Mol Cancer Res">37</a></span> However, this process was ROS-independent in RH30 cells (Supporting Information Fig. <a href="#fig3">3</a>) and miR-27a was not linked to regulation of ZBTB10 in RD cells. Nevertheless, overexpression of ZBTB10 decreased Sp1, Sp3 and Sp4 expression in RH30 and RD cells (Fig. <a href="#fig5">5</a><i>d</i>) and the effects were more pronounced in the latter cell line. Identification of miRs or other pathways that regulate expression of ZBTB10 is currently being investigated.</p>
            
            <section class="article-section__inline-figure">
               <figure class="figure" id="fig5"><a target="_blank" href="/cms/asset/9d2fdc2c-81c8-4eb2-8b40-0ad15f836903/mfig005.jpg"><picture>
                        <source srcset="/cms/asset/9d2fdc2c-81c8-4eb2-8b40-0ad15f836903/mfig005.jpg" media="(min-width: 1650px)"></source><img class="figure__image" src="/cms/asset/0922bb3a-689c-42d0-8c43-84fe11ee2db4/mfig005.jpg" data-lg-src="/cms/asset/9d2fdc2c-81c8-4eb2-8b40-0ad15f836903/mfig005.jpg" alt="Details are in the caption following the image" loading="lazy"></picture></a><figcaption class="figure__caption">
                     <div class="figure__caption__header"><strong class="figure__title">Figure 5</strong><div class="figure-extra"><a href="#" class="open-figure-link">Open in figure viewer</a><a href="/action/downloadFigures?id=fig5&amp;doi=10.1002%2Fijc.27730" class="ppt-figure-link"><i aria-hidden="true" class="icon-Icon_Download"></i><span>PowerPoint</span></a></div>
                     </div>
                     <div class="figure__caption figure__caption-text">
                        <p>Activation of proteasome-dependent or -independent pathways by TA. Effects of proteasome inhibitors on TA-induced Sp downregulation in RH30 (<i>a</i>) and RD (<i>b</i>) cells. Cells were treated with DMSO or TA in the presence or absence of proteasome inhibitors, and expression of Sp proteins in whole cell lysates was analyzed by Western blots. (<i>c</i>) Modulation of ZBTB10 and miR-27a expression by TA. Cells were treated with DMSO or TA for 24 hr and analyzed for expression of ZBTB10 and miR-27a by real-time PCR as outlined in the “Material and Methods” section. Results are expressed as means ± SE for three separate experiments, and significant (<i>p</i> &lt; 0.05) induction (*) or inhibition (**) compared to DMSO control are indicated. (<i>d</i>) ZBTB10 overexpression. Cells were transfected with ZBTB10 expression plasmid, and whole cell lysates were analyzed by Western blots as described in the “Material and Methods” section.</p>
                        </div>
                  </figcaption>
               </figure>
            </section>
            </section>
         
         <section class="article-section__sub-content" id="sec2-14">
            
            <h3 class="article-section__sub-title section2" id="sec2-14-title"> <i>In vivo</i> effects of TA on RMS tumors</h3>
            
            <p>The <i>in vivo</i> effects of TA were investigated in athymic nude mice bearing RH30 cells as xenografts. Mice treated with TA at a dose of 50 mg/kg/dose exhibited decreased tumor size and weights compared to the corn oil control and this was not accompanied by any changes in organ or body weights (Fig. <a href="#fig6">6</a><i>a</i>) as previously reported for this dose of TA.<span><a href="#bib13" class="bibLink tab-link" id="bib13R" data-tab="pane-pcw-references" aria-label="Reference 13 - J Natl Cancer Inst">13</a></span>, <span><a href="#bib20" class="bibLink tab-link" id="bib20R" data-tab="pane-pcw-references" aria-label="Reference 20 - Cancer Res">20</a></span> In a pilot study with RD cells (three animals per treatment group), TA also decreased tumor growth (Fig. <a href="#fig6">6</a><i>a</i>). Western blot analyses of tumor lysates showed that treatment with TA decreased levels of Sp1, Sp3, Sp4, cyclin D1 and c-MET proteins in tumors (Fig. <a href="#fig6">6</a><i>b</i>) as previously observed in RH30 cells (Figs. <a href="#fig1">1</a><i>a</i> and <a href="#fig3">3</a><i>b</i>). H&E staining of slides of tumor sections from control and TA-treated mice were analyzed using a Zeiss imaging workstation and a color range tool, and there was approximately a 4.5-fold increase in apoptosis in tumors from treated mice compared to controls (data not shown). Immunostaining showed that TA decreased Sp1 and c-MET in TA-treated tumors compared to controls (untreated) (Fig. <a href="#fig6">6</a><i>c</i>), and similar results were observed for VEGF (Fig. <a href="#fig6">6</a><i>d</i>). This demonstrates that TA decreases expression of Sp1, Sp3 and Sp4 and critical Sp-regulated genes in RMS cells and tumors, suggesting that drugs such as TA may have clinical potential for treatment of RMS.</p>
            
            <section class="article-section__inline-figure">
               <figure class="figure" id="fig6"><a target="_blank" href="/cms/asset/64303b7e-13b1-4b6f-99d4-b064d32d800a/mfig006.jpg"><picture>
                        <source srcset="/cms/asset/64303b7e-13b1-4b6f-99d4-b064d32d800a/mfig006.jpg" media="(min-width: 1650px)"></source><img class="figure__image" src="/cms/asset/ec5fdc01-6a3a-4bcc-b06b-b42cec2b042e/mfig006.jpg" data-lg-src="/cms/asset/64303b7e-13b1-4b6f-99d4-b064d32d800a/mfig006.jpg" alt="Details are in the caption following the image" loading="lazy"></picture></a><figcaption class="figure__caption">
                     <div class="figure__caption__header"><strong class="figure__title">Figure 6</strong><div class="figure-extra"><a href="#" class="open-figure-link">Open in figure viewer</a><a href="/action/downloadFigures?id=fig6&amp;doi=10.1002%2Fijc.27730" class="ppt-figure-link"><i aria-hidden="true" class="icon-Icon_Download"></i><span>PowerPoint</span></a></div>
                     </div>
                     <div class="figure__caption figure__caption-text">
                        <p>TA inhibits tumor growth and downregulates Sp and Sp-regulated proteins in tumors. TA-mediated inhibition of tumor volume and weight (<i>a</i>) and downregulation of Sp proteins (<i>b</i>). Athymic nude mice bearing RH30 cells as xenografts were treated with corn oil (control) or TA (50 mg/kg/dose) (eight mice per treatment group) every second day, and tumor areas and weights were determined. Similar results were observed in a pilot study using RD cells as xenografts (three animals per treatment group) (<i>a</i>). Expression of Sp-proteins and Sp-regulated genes were determined in tumor lysates from control and treated mice by Western blots as outlined in the “Material and Methods” section. Immunostaining for Sp1 and c-MET (<i>c</i>) and VEGF (<i>d</i>). Fixed tumor samples from control and treated mice were immunostained for Sp1, c-MET and VEGF as described in the “Material and Methods” section. Significant (<i>p</i> &lt; 0.05) inhibition of tumor growth and weights are indicated (*).</p>
                        </div>
                  </figcaption>
               </figure>
            </section>
            </section>
         </section>
      <section class="article-section__content" id="sec1-3">
         
         <h2 class="article-section__title section__title section1" id="sec1-3-title"> Discussion</h2>
         
         <p>Specificity protein (Sp) transcription factor are members of the Sp1/Krüppel-like family (KLF) of zinc finger proteins that modulate transcription of multiple genes through interactions with GC-rich sequences in target gene promoters.<span><a href="#bib38" class="bibLink tab-link" id="bib38R" data-tab="pane-pcw-references" aria-label="Reference 38 - Mol Cell Endocrinol">38</a></span>, <span><a href="#bib39" class="bibLink tab-link" id="bib39R" data-tab="pane-pcw-references" aria-label="Reference 39 - J Cell Physiol">39</a></span> Sp1 and other Sp-regulated genes are critical during early embryonal and postnatal development; however, there is evidence that in adult tissues from rodent models and humans that expression of Sp1 and other Sp proteins is low.<span><a href="#bib40" class="bibLink tab-link" id="bib40R" data-tab="pane-pcw-references" aria-label="Reference 40 - J Biol Chem">40</a>-<a href="#bib42" class="bibLink tab-link" id="bib42R" data-tab="pane-pcw-references" aria-label="Reference 42 - Biochem Biophys Res Commun">42</a></span> In contrast, Sp1, Sp3 and Sp4 protein levels are highly expressed in many different human cancer cell lines and their derived tumors in xenograft/orthotopic athymic nude mouse models,<span><a href="#bib13" class="bibLink tab-link" id="bib13R" data-tab="pane-pcw-references" aria-label="Reference 13 - J Natl Cancer Inst">13</a>-<a href="#bib18" class="bibLink tab-link" id="bib18R" data-tab="pane-pcw-references" aria-label="Reference 18 - Cancer Res">18</a></span> and epidemiology studies show that pancreatic and gastric cancer patients with tumors expressing high levels of Sp1 protein had significantly poorer prognosis than patients with tumors that express low levels of Sp1.<span><a href="#bib43" class="bibLink tab-link" id="bib43R" data-tab="pane-pcw-references" aria-label="Reference 43 - Cancer Epidemiol Biomarkers Prev">43</a></span>, <span><a href="#bib44" class="bibLink tab-link" id="bib44R" data-tab="pane-pcw-references" aria-label="Reference 44 - Clin Cancer Res">44</a></span> Lou <i>et al</i>.<span><a href="#bib45" class="bibLink tab-link" id="bib45R" data-tab="pane-pcw-references" aria-label="Reference 45 - Cancer Res">45</a></span> examined the role of Sp1 in carcinogen-induced transformation of normal skin fibroblast that express low levels of Sp1; an 8- to 18-fold increase in Sp1 expression was observed after transformation. Moreover, knockdown of Sp1 in the transformed cells abrogated their ability to form tumors.</p>
         
         <p>Previous studies have reported high expression of Sp-regulated genes such as <i>FGFR4</i>,<span><a href="#bib26" class="bibLink tab-link" id="bib26R" data-tab="pane-pcw-references" aria-label="Reference 26 - Clin Cancer Res">26</a></span>
            <i>c-MET</i>,<span><a href="#bib25" class="bibLink tab-link" id="bib25R" data-tab="pane-pcw-references" aria-label="Reference 25 - Cancer Res">25</a></span>
            <i>IGFR</i><span><a href="#bib46" class="bibLink tab-link" id="bib46R" data-tab="pane-pcw-references" aria-label="Reference 46 - Oncogene">46</a></span> and <i>VEGF</i><span><a href="#bib47" class="bibLink tab-link" id="bib47R" data-tab="pane-pcw-references" aria-label="Reference 47 - Neoplasia">47</a></span> in RMS cells, and overexpression of <i>PDGFRα</i> in human ARMS cells plays a functional role in tumor cell growth.<span><a href="#bib34" class="bibLink tab-link" id="bib34R" data-tab="pane-pcw-references" aria-label="Reference 34 - Oncogene">34</a></span> Western blot analysis of RMS cell lines clearly demonstrated that Sp1, Sp3 and Sp4 were highly expressed in RH30 and RD cell lines derived from ARMS and ERMS patients, respectively. Moreover, in the genetically modified HSMM<sup>PF+H+M</sup> cell line that resembles ARMS cells, there was also high expression of Sp1, Sp3 and Sp4 and the increase in Sp1 and Sp3 was only observed after viral infection of HSMM<sup>PF+H</sup> cells with NMyc (Fig. <a href="#fig1">1</a><i>b</i>). Sp4, but not Sp1 or Sp3, was highly expressed in HSMMs and enhanced expression of Sp1 and Sp3 was only observed after three genetic modifications (PF+H+M) which were also necessary for transformation of this cell line.<span><a href="#bib27" class="bibLink tab-link" id="bib27R" data-tab="pane-pcw-references" aria-label="Reference 27 - Cancer Res">27</a></span>, <span><a href="#bib29" class="bibLink tab-link" id="bib29R" data-tab="pane-pcw-references" aria-label="Reference 29 - Cancer Res">29</a></span>, <span><a href="#bib30" class="bibLink tab-link" id="bib30R" data-tab="pane-pcw-references" aria-label="Reference 30 - Cancer Res">30</a></span> Currently, we are further investigating this ARMS-like cell model to determine the role of Sp1 and Sp3 in the transformation process. Transformation of HSMM cells with SV40 T/t antigen, hTERT and Ras to give HSMM<sup>T/t+H+R</sup> (ERMS-like) was less informative with respect to the role of Sp transcription factors since Sp1 and Sp3 were highly expressed in HSMM<sup>T/t</sup> cells and this was consistent with a previous report showing that SV40 alone stimulates Sp1 expression.<span><a href="#bib31" class="bibLink tab-link" id="bib31R" data-tab="pane-pcw-references" aria-label="Reference 31 - Genes Dev">31</a></span> Nevertheless, the high expression of Sp1 and Sp3 in HSMM<sup>T/t</sup> cells which do not form tumors in mice indicates that in this model Sp1, Sp3 and Sp4 expression are not sufficient for transformation, and we are currently investigating other factors required for transformation.</p>
         
         <p>The Cooperative Human Tissue Network provided us with several RMS patient samples and normal muscle tissue for immunostaining for Sp1. Staining intensities were graded as non-detectable (1), low (2), medium (3) and high (4). Over 80% of the RMS tumors were highly stained for Sp1 (≥3), whereas in the small number of normal muscle tissue samples, only low staining for Sp1 (≤2) was observed (Figs. <a href="#fig1">1</a><i>c</i> and <a href="#fig1">1</a><i>d</i>). The percent distribution of patients with high Sp1 staining was similar to that observed in gastric cancer patients,<span><a href="#bib44" class="bibLink tab-link" id="bib44R" data-tab="pane-pcw-references" aria-label="Reference 44 - Clin Cancer Res">44</a></span> whereas in pancreatic cancer patients, only 22% and 54% of female and male patients, respectively, were classified as Sp1-positive.<span><a href="#bib43" class="bibLink tab-link" id="bib43R" data-tab="pane-pcw-references" aria-label="Reference 43 - Cancer Epidemiol Biomarkers Prev">43</a></span> In RMS patients and RMS cells, Sp1 is primarily nuclear and this may account for the high expression of pro-oncogenic Sp-regulated genes.</p>
         
         <p>Anticancer agents that decrease expression of Sp1, Sp3, Sp4 and Sp-regulated genes include arsenic trioxide, TA, curcumin, BA and synthetic triterpenoids such as CDODA-Me.<span><a href="#bib13" class="bibLink tab-link" id="bib13R" data-tab="pane-pcw-references" aria-label="Reference 13 - J Natl Cancer Inst">13</a>-<a href="#bib17" class="bibLink tab-link" id="bib17R" data-tab="pane-pcw-references" aria-label="Reference 17 - Int J Cancer">17</a></span>, <span><a href="#bib20" class="bibLink tab-link" id="bib20R" data-tab="pane-pcw-references" aria-label="Reference 20 - Cancer Res">20</a></span>, <span><a href="#bib21" class="bibLink tab-link" id="bib21R" data-tab="pane-pcw-references" aria-label="Reference 21 - Mol Cancer Res">21</a></span> TA is used in human and veterinary medicine and is well tolerated in febrile children.<span><a href="#bib48" class="bibLink tab-link" id="bib48R" data-tab="pane-pcw-references" aria-label="Reference 48 - Int J Clin Pharmacol Ther">48</a></span>, <span><a href="#bib49" class="bibLink tab-link" id="bib49R" data-tab="pane-pcw-references" aria-label="Reference 49 - Vet Anaesth Analg">49</a></span> TA inhibited RMS cell growth and downregulated Sp1, Sp3 and Sp4 (Figs. <a href="#fig1">1</a> and <a href="#fig2">2</a>) in RH30 and RD cells, and similar results were also observed for BA and CDODA-Me (Supporting Information Fig. <a href="#fig1">1</a>). TA also inhibited tumor growth in athymic nude mice bearing RH30 cells as xenografts and this was accompanied by decreased expression of Sp1, Sp3, Sp4 and c-MET in tumors from TA-treated mice (Fig. <a href="#fig6">6</a>). Although relatively high concentrations of TA were required to inhibit RH30 and RD cell proliferation within 24–48 hr after treatment, lower concentrations are growth inhibitory after prolonged treatment (up to 6 days) and this is consistent with the 50 mg/kg dose every second day which significantly inhibited tumor growth (Fig. <a href="#fig6">6</a>). These observations were similar to those previously observed for TA in other cancer cells and tumors.<span><a href="#bib13" class="bibLink tab-link" id="bib13R" data-tab="pane-pcw-references" aria-label="Reference 13 - J Natl Cancer Inst">13</a></span>, <span><a href="#bib15" class="bibLink tab-link" id="bib15R" data-tab="pane-pcw-references" aria-label="Reference 15 - Carcinogenesis">15</a></span>, <span><a href="#bib20" class="bibLink tab-link" id="bib20R" data-tab="pane-pcw-references" aria-label="Reference 20 - Cancer Res">20</a></span> Other NSAIDs including sulindac and its derivatives also require higher (≥ 100 μM) concentrations <i>in vitro</i> than <i>in vivo</i> for their inhibition of cancer cell and tumor growth and effects on other pathways.<span><a href="#bib50" class="bibLink tab-link" id="bib50R" data-tab="pane-pcw-references" aria-label="Reference 50 - Neoplasia">50</a></span></p>
         
         <p>Since expression of many Sp-regulated genes may also be dependent on other transcription factors such as NFκB in some cell lines,<span><a href="#bib24" class="bibLink tab-link" id="bib24R" data-tab="pane-pcw-references" aria-label="Reference 24 - J Biol Chem">24</a></span> we used RNA interference to confirm that the effects of TA on putative Sp-regulated genes were due to downregulation of these transcription factors. However, these results do not exclude coregulation of these genes by other factors and the effects of TA may be due to both Sp downregulation and other Sp-independent pathways. Results summarized in Figures <a href="#fig3">3</a> and <a href="#fig4">4</a> clearly link the growth inhibitory and pro-apoptotic effects of TA on repression of Sp1, Sp3 and Sp4 proteins. Simultaneous knockdown of Sp1, Sp3 and Sp4 or treatment of RH30 and RD cells with TA decreased cell migration and expression of CD1, survivin, VEGF, c-MET, IGFR, PDGFRα and CXCR4 gene products. The relative contributions of Sp1, Sp3 and Sp4 to expression of these gene products was both gene- and cell context-dependent and this was consistent with comparable RNA interference studies in other cancer cell lines.<span><a href="#bib20" class="bibLink tab-link" id="bib20R" data-tab="pane-pcw-references" aria-label="Reference 20 - Cancer Res">20</a></span>, <span><a href="#bib21" class="bibLink tab-link" id="bib21R" data-tab="pane-pcw-references" aria-label="Reference 21 - Mol Cancer Res">21</a></span>, <span><a href="#bib23" class="bibLink tab-link" id="bib23R" data-tab="pane-pcw-references" aria-label="Reference 23 - Mol Pharmacol">23</a></span>, <span><a href="#bib24" class="bibLink tab-link" id="bib24R" data-tab="pane-pcw-references" aria-label="Reference 24 - J Biol Chem">24</a></span> For example, cyclin D1 expression in RH30 cells was primarily Sp1-dependent, whereas in RD cells, knockdown of Sp1, Sp3 or Sp4 protein decreased levels of CD1 protein (Fig. <a href="#fig3">3</a><i>c</i>). Thus, the effects of TA on VEGF, survivin, CD1, c-MET, PDGFRα, IGFR and CXCR4 expression on RMS cells (Fig. <a href="#fig3">3</a>) and tumors (Fig. <a href="#fig6">6</a>) are associated with downregulation of Sp1, Sp3 and Sp4 proteins, and ongoing array studies have identified other Sp-regulated genes that contribute to the effectiveness of agents that target Sp proteins. Sp-regulated gene products such as PDGFRα, IGFR, CXCR4 and c-MET are individual targets for treatment of RMS and have been directly linked to growth survival and angiogenesis of RMS cells and/or tumors.<span><a href="#bib25" class="bibLink tab-link" id="bib25R" data-tab="pane-pcw-references" aria-label="Reference 25 - Cancer Res">25</a></span>, <span><a href="#bib34" class="bibLink tab-link" id="bib34R" data-tab="pane-pcw-references" aria-label="Reference 34 - Oncogene">34</a>-<a href="#bib36" class="bibLink tab-link" id="bib36R" data-tab="pane-pcw-references" aria-label="Reference 36 - Clin Exp Metastasis">36</a></span> Since TA or knockdown of Sp1 also decreased expression of PAX3-FOXO1 in RH30 cells (Supporting Information Fig. <a href="#fig3">3</a>A), this response may also be important for regulating other pro-oncogenic factors. At least one advantage of TA over inhibitors of PDGFRα, CXCR4, IGFR and c-MET is that TA inhibits expression of all four gene products and other Sp-regulated genes and Sp-independent responses induced by TA may also be important.</p>
         
         <p>The mechanism of action of drug-induced downregulation of Sp1, Sp3 and Sp4 is dependent on the specific agent and cell context. For example, TA induced proteasome-dependent downregulation of Sp1, Sp3 and Sp4 in pancreatic cancer cells<span><a href="#bib13" class="bibLink tab-link" id="bib13R" data-tab="pane-pcw-references" aria-label="Reference 13 - J Natl Cancer Inst">13</a></span> but in esophageal cancer cells, this same TA-induced response was proteasome-independent.<span><a href="#bib15" class="bibLink tab-link" id="bib15R" data-tab="pane-pcw-references" aria-label="Reference 15 - Carcinogenesis">15</a></span> We have previously identified other pathways for drug-induced Sp downregulation; arsenic trioxide induces caspase- and ROS-dependent cleavage of Sp1, Sp3 and Sp4 in bladder cancer cells<span><a href="#bib19" class="bibLink tab-link" id="bib19R" data-tab="pane-pcw-references" aria-label="Reference 19 - Exp Cell Res">19</a></span>; CDDO-Me and a nitro-NSAID also induce ROS-dependent downregulation of miR-27a and induction of ZBTB10, an Sp repressor.<span><a href="#bib23" class="bibLink tab-link" id="bib23R" data-tab="pane-pcw-references" aria-label="Reference 23 - Mol Pharmacol">23</a></span>, <span><a href="#bib37" class="bibLink tab-link" id="bib37R" data-tab="pane-pcw-references" aria-label="Reference 37 - Mol Cancer Res">37</a></span> Results in Figure <a href="#fig5">5</a> show that TA-induced downregulation of Sp1, Sp3 and Sp4 in RH30 cells and Sp1 and Sp4 in RD cells is proteasome-independent and Sp3 degradation in RD cells is proteasome-dependent. TA induced ZBTB10 and downregulated miR-27a in RH30 cells, whereas in RD cells, TA induced ZBTB10 but did not affect expression of miR-27a. However, since ROS and caspase inhibitors did not block downregulation of Sp1, Sp3 or Sp4 in RH30 or RD cells treated with TA (Supporting Information Fig. <a href="#fig3">3</a>), the mechanisms associated with induction of the transcriptional repressor ZBTB10 and downregulation of miRs (and their identity) by TA is unknown and is currently being investigated.</p>
         
         <p>In summary, results of this study show that Sp1 is overexpressed in approximately 80% of RMS patients, and Sp1, Sp3, Sp4 and Sp-regulated gene products are also highly expressed in RMS cells. The effects of TA on Sp1, Sp3, Sp4 and Sp-regulated genes and responses were similar in the representative ARMS (RH30) and ERMS (RD) cell lines, and future studies will investigate TA-induced effects in the HSMM-derived cells. The mechanisms associated with Sp downregulation are cell context-dependent and this has previously been observed in other cancer cell lines treated with TA and drugs that downregulate Sp proteins.<span><a href="#bib13" class="bibLink tab-link" id="bib13R" data-tab="pane-pcw-references" aria-label="Reference 13 - J Natl Cancer Inst">13</a>-<a href="#bib17" class="bibLink tab-link" id="bib17R" data-tab="pane-pcw-references" aria-label="Reference 17 - Int J Cancer">17</a></span>, <span><a href="#bib19" class="bibLink tab-link" id="bib19R" data-tab="pane-pcw-references" aria-label="Reference 19 - Exp Cell Res">19</a>-<a href="#bib24" class="bibLink tab-link" id="bib24R" data-tab="pane-pcw-references" aria-label="Reference 24 - J Biol Chem">24</a></span> The NSAID TA decreased RMS cell and tumor growth, and results of RNA interference studies (Sp knockdown) suggest that the anticancer activity of TA is due, in part, to targeting downregulation of Sp transcription factors and Sp-regulated genes such as c-MET, IGFR, PDGFRα and CXCR4 (<i>e.g</i>., Figs. <a href="#fig3">3</a> and <a href="#fig6">6</a>). This data suggest that drugs, such as TA, are another option for clinical treatment of RMS patients with these compounds alone or in combination with the currently used drug combinations.</p>
         </section>
      <section class="article-section article-section__supporting" data-suppl="/doi/suppl/10.1002/ijc.27730?onlyLog=true">
         <div class="accordion article-accordion">
            <h2><a class="accordion__control" role="button" aria-controls="d14201083e285" aria-expanded="false">
                  <div tabindex="0" class="section__title" id="support-information-section"><span>Supporting Information</span><i aria-hidden="true" class="icon-section_arrow_d"></i></div></a></h2>
            <div class="accordion__content" role="region" aria-labelledby="support-information-section" style="display: none;" id="d14201083e285" aria-hidden="false">
               <div class="support-info__table-wrapper article-table-content-wrapper">
                  <p>
Additional Supporting Information may be found in the online version of this article.

</p>
                  
                  
                  <table class="support-info__table table article-section__table">
                     <thead>
                        <th id="article-filename" scope="col">Filename</th>
                        <th id="article-description" scope="col">Description</th>
                     </thead>
                     <tbody>
                        <tr id="">
                           <td headers="article-filename"><a href="/action/downloadSupplement?doi=10.1002%2Fijc.27730&amp;file=IJC_27730_sm_SuppInfo.pdf">IJC_27730_sm_SuppInfo.pdf</a>637 KB</td>
                           <td headers="article-description">Supporting Information</td>
                        </tr>
                     </tbody>
                  </table>
                  <p class="disclaimer_text">Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.</p>
               </div>
            </div>
         </div>
      </section>
      <section class="article-section article-section__references" id="references-section">
         <div class="accordion article-accordion">
            <h2>
               <div tabindex="0" role="button" class="accordion__control" aria-expanded="false" data-references="/action/ajaxShowEnhancedAbstract?widgetId=5cf4c79f-0ae9-4dc5-96ce-77f62de7ada9&ajax=true&doi=10.1002%2Fijc.27730&pbContext=%3Bissue%3Aissue%3Adoi%5C%3A10.1002%2Fijc.v132.4%3Bpage%3Astring%3AArticle%2FChapter+View%3Barticle%3Aarticle%3Adoi%5C%3A10.1002%2Fijc.27730%3Bctype%3Astring%3AJournal+Content%3Bwebsite%3Awebsite%3Apericles%3Bjournal%3Ajournal%3A10970215%3Bwgroup%3Astring%3APublication+Websites%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3BrequestedJournal%3Ajournal%3A10970215&accordionHeadingWrapper=h2&onlyLog=true"><span class="section__title" id="references-section-1">References</span><i aria-hidden="true" class="icon-section_arrow_d"></i></div>
            </h2>
            <div class="accordion__content" style="display: none;" role="region" aria-labelledby="references-section-1">
               <ul class="rlist separator">
                  
                  
                  <li data-bib-id="bib1"><span class="bullet">1</span>
                     <span class="author">Paulino AC</span>,
<span class="author">Okcu MF</span>.
<span class="articleTitle">Rhabdomyosarcoma</span>.
<i>Curr Probl Cancer</i>
                     <span class="pubYear">2008</span>;
 <span class="vol">32</span>:
 <span class="pageFirst">7</span>– <span class="pageLast">34</span>.
                     <div class="extra-links" id="e_1_2_5_2_2"><span><a href="/servlet/linkout?suffix=null&amp;dbid=16&amp;doi=10.1002%2Fijc.27730&amp;key=10.1016%2Fj.currproblcancer.2007.11.001" onclick="newWindow(this.href);return false" class="visitable">Crossref</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27730&amp;key=18206520" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27730&amp;key=000252950900002" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2008&pages=7-34&journal=Curr+Probl+Cancer&author=AC+Paulino&author=MF+Okcu&title=Rhabdomyosarcoma"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="bib2"><span class="bullet">2</span>
                     <span class="author">Ries LAG</span>,
<span class="author">Smith MA</span>,
<span class="author">Gurney JG</span>, et al.
 <span class="otherTitle">Cancer Incidence and Survival Among Children and Adolescents: United States SEER Program 1975–1995</span>. NIH Publication No. 99–4649 National Institutes of Health,
<span class="pubYear">1999</span>.
                     <div class="extra-links" id="e_1_2_5_3_2"><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar?hl=en&q=%0ARies+LAG%2C%0ASmith+MA%2C%0AGurney+JG%2C+et+al.%0A+Cancer+Incidence+and+Survival+Among+Children+and+Adolescents%3A+United+States+SEER+Program+1975%E2%80%931995.+NIH+Publication+No.+99%E2%80%934649+National+Institutes+of+Health%2C%0A1999."target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="bib3"><span class="bullet">3</span>
                     <span class="author">Grufferman S</span>,
<span class="author">Schwartz AG</span>,
<span class="author">Ruymann FB</span>, et al.
<span class="articleTitle">Parents' use of cocaine and marijuana and increased risk of rhabdomyosarcoma in their children</span>.
<i>Cancer Causes Control</i>
                     <span class="pubYear">1993</span>;
 <span class="vol">4</span>:
 <span class="pageFirst">217</span>– <span class="pageLast">24</span>.
                     <div class="extra-links" id="e_1_2_5_4_2"><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27730&amp;key=1%3ASTN%3A280%3ADyaK3szgsFyltA%253D%253D" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27730&amp;key=8318638" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27730&amp;key=A1993LC88500006" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1993&pages=217-24&journal=Cancer+Causes+Control&author=S+Grufferman&author=AG+Schwartz&author=FB+Ruymann&title=Parents%27+use+of+cocaine+and+marijuana+and+increased+risk+of+rhabdomyosarcoma+in+their+children"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="bib4"><span class="bullet">4</span>
                     <span class="author">Hicks N</span>,
<span class="author">Zack M</span>,
<span class="author">Caldwell GG</span>, et al.
<span class="articleTitle">Childhood cancer and occupational radiation exposure in parents</span>.
<i>Cancer</i>
                     <span class="pubYear">1984</span>;
 <span class="vol">53</span>:
 <span class="pageFirst">1637</span>– <span class="pageLast">43</span>.
                     <div class="extra-links" id="e_1_2_5_5_2"><span><a href="/doi/10.1002/1097-0142%2819840415%2953%3A8%3C1637%3A%3AAID-CNCR2820530802%3E3.0.CO%3B2-Y" onclick="newWindow(this.href);return false" class="visitable">Wiley Online Library</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27730&amp;key=1%3ASTN%3A280%3ADyaL2c7ivF2jsw%253D%253D" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27730&amp;key=6321012" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27730&amp;key=A1984SL28700001" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1984&pages=1637-43&journal=Cancer&author=N+Hicks&author=M+Zack&author=GG+Caldwell&title=Childhood+cancer+and+occupational+radiation+exposure+in+parents"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="bib5"><span class="bullet">5</span>
                     <span class="author">Barr FG</span>,
<span class="author">Galili N</span>,
<span class="author">Holick J</span>, et al.
<span class="articleTitle">Rearrangement of the PAX3 paired box gene in the paediatric solid tumour alveolar rhabdomyosarcoma</span>.
<i>Nat Genet</i>
                     <span class="pubYear">1993</span>;
 <span class="vol">3</span>:
 <span class="pageFirst">113</span>– <span class="pageLast">7</span>.
                     <div class="extra-links" id="e_1_2_5_6_2"><span><a href="/servlet/linkout?suffix=null&amp;dbid=16&amp;doi=10.1002%2Fijc.27730&amp;key=10.1038%2Fng0293-113" onclick="newWindow(this.href);return false" class="visitable">Crossref</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27730&amp;key=1%3ACAS%3A528%3ADyaK3sXhsVCksL4%253D" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27730&amp;key=8098985" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27730&amp;key=A1993KL01000006" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1993&pages=113-7&journal=Nat+Genet&author=FG+Barr&author=N+Galili&author=J+Holick&title=Rearrangement+of+the+PAX3+paired+box+gene+in+the+paediatric+solid+tumour+alveolar+rhabdomyosarcoma"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="bib6"><span class="bullet">6</span>
                     <span class="author">Davis RJ</span>,
<span class="author">D'Cruz CM</span>,
<span class="author">Lovell MA</span>, et al.
<span class="articleTitle">Fusion of PAX7 to FKHR by the variant t(1;13)(p36;q14) translocation in alveolar rhabdomyosarcoma</span>.
<i>Cancer Res</i>
                     <span class="pubYear">1994</span>;
 <span class="vol">54</span>:
 <span class="pageFirst">2869</span>– <span class="pageLast">72</span>.
                     <div class="extra-links" id="e_1_2_5_7_2"><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27730&amp;key=1%3ACAS%3A528%3ADyaK2cXktlahsrs%253D" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27730&amp;key=8187070" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27730&amp;key=A1994NN72400014" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1994&pages=2869-72&journal=Cancer+Res&author=RJ+Davis&author=CM+D%27Cruz&author=MA+Lovell&title=Fusion+of+PAX7+to+FKHR+by+the+variant+t%281%3B13%29%28p36%3Bq14%29+translocation+in+alveolar+rhabdomyosarcoma"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="bib7"><span class="bullet">7</span>
                     <span class="author">Barber TD</span>,
<span class="author">Barber MC</span>,
<span class="author">Tomescu O</span>, et al.
<span class="articleTitle">Identification of target genes regulated by PAX3 and PAX3-FKHR in embryogenesis and alveolar rhabdomyosarcoma</span>.
<i>Genomics</i>
                     <span class="pubYear">2002</span>;
 <span class="vol">79</span>:
 <span class="pageFirst">278</span>– <span class="pageLast">84</span>.
                     <div class="extra-links" id="e_1_2_5_8_2"><span><a href="/servlet/linkout?suffix=null&amp;dbid=16&amp;doi=10.1002%2Fijc.27730&amp;key=10.1006%2Fgeno.2002.6703" onclick="newWindow(this.href);return false" class="visitable">Crossref</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27730&amp;key=1%3ACAS%3A528%3ADC%252BD38XhsVGgsL8%253D" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27730&amp;key=11863357" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27730&amp;key=000174224200003" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2002&pages=278-84&journal=Genomics&author=TD+Barber&author=MC+Barber&author=O+Tomescu&title=Identification+of+target+genes+regulated+by+PAX3+and+PAX3%E2%80%90FKHR+in+embryogenesis+and+alveolar+rhabdomyosarcoma"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="bib8"><span class="bullet">8</span>
                     <span class="author">Khan J</span>,
<span class="author">Bittner ML</span>,
<span class="author">Saal LH</span>, et al.
<span class="articleTitle">cDNA microarrays detect activation of a myogenic transcription program by the PAX3-FKHR fusion oncogene</span>.
<i>Proc Natl Acad Sci U S A</i>
                     <span class="pubYear">1999</span>;
 <span class="vol">96</span>:
 <span class="pageFirst">13264</span>– <span class="pageLast">9</span>.
                     <div class="extra-links" id="e_1_2_5_9_2"><span><a href="/servlet/linkout?suffix=null&amp;dbid=16&amp;doi=10.1002%2Fijc.27730&amp;key=10.1073%2Fpnas.96.23.13264" onclick="newWindow(this.href);return false" class="visitable">Crossref</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27730&amp;key=1%3ACAS%3A528%3ADyaK1MXns1GmtrY%253D" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27730&amp;key=10557309" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27730&amp;key=000083649400054" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1999&pages=13264-9&journal=Proc+Natl+Acad+Sci+U+S+A&author=J+Khan&author=ML+Bittner&author=LH+Saal&title=cDNA+microarrays+detect+activation+of+a+myogenic+transcription+program+by+the+PAX3%E2%80%90FKHR+fusion+oncogene"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="bib9"><span class="bullet">9</span>
                     <span class="author">Sorensen PH</span>,
<span class="author">Lynch JC</span>,
<span class="author">Qualman SJ</span>, et al.
<span class="articleTitle">PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the children's oncology group</span>.
<i>J Clin Oncol</i>
                     <span class="pubYear">2002</span>;
 <span class="vol">20</span>:
 <span class="pageFirst">2672</span>– <span class="pageLast">9</span>.
                     <div class="extra-links" id="e_1_2_5_10_2"><span><a href="/servlet/linkout?suffix=null&amp;dbid=16&amp;doi=10.1002%2Fijc.27730&amp;key=10.1200%2FJCO.2002.03.137" onclick="newWindow(this.href);return false" class="visitable">Crossref</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27730&amp;key=1%3ACAS%3A528%3ADC%252BD38XkvF2mtr0%253D" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27730&amp;key=12039929" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27730&amp;key=000175890000010" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2002&pages=2672-9&journal=J+Clin+Oncol&author=PH+Sorensen&author=JC+Lynch&author=SJ+Qualman&title=PAX3%E2%80%90FKHR+and+PAX7%E2%80%90FKHR+gene+fusions+are+prognostic+indicators+in+alveolar+rhabdomyosarcoma%3A+a+report+from+the+children%27s+oncology+group"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="bib10"><span class="bullet">10</span>
                     <span class="author">Maurer HM</span>.
<span class="articleTitle">The Intergroup Rhabdomyosarcoma Study (NIH): objectives and clinical staging classification</span>.
<i>J Pediatr Surg</i>
                     <span class="pubYear">1975</span>;
 <span class="vol">10</span>:
 <span class="pageFirst">977</span>– <span class="pageLast">78</span>.
                     <div class="extra-links" id="e_1_2_5_11_2"><span><a href="/servlet/linkout?suffix=null&amp;dbid=16&amp;doi=10.1002%2Fijc.27730&amp;key=10.1016%2FS0022-3468%2875%2980109-6" onclick="newWindow(this.href);return false" class="visitable">Crossref</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27730&amp;key=A1975BB69800022" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1975&pages=977-78&journal=J+Pediatr+Surg&author=HM+Maurer&title=The+Intergroup+Rhabdomyosarcoma+Study+%28NIH%29%3A+objectives+and+clinical+staging+classification"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="bib11"><span class="bullet">11</span>
                     <span class="author">Maurer HM</span>,
<span class="author">Moon T</span>,
<span class="author">Donaldson M</span>, et al.
<span class="articleTitle">The intergroup rhabdomyosarcoma study: a preliminary report</span>.
<i>Cancer</i>
                     <span class="pubYear">1977</span>;
 <span class="vol">40</span>:
 <span class="pageFirst">2015</span>– <span class="pageLast">26</span>.
                     <div class="extra-links" id="e_1_2_5_12_2"><span><a href="/doi/10.1002/1097-0142%28197711%2940%3A5%3C2015%3A%3AAID-CNCR2820400505%3E3.0.CO%3B2-K" onclick="newWindow(this.href);return false" class="visitable">Wiley Online Library</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27730&amp;key=1%3ASTN%3A280%3ADyaE1c%252FktFGmsw%253D%253D" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27730&amp;key=336175" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27730&amp;key=A1977EC72600004" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1977&pages=2015-26&journal=Cancer&author=HM+Maurer&author=T+Moon&author=M+Donaldson&title=The+intergroup+rhabdomyosarcoma+study%3A+a+preliminary+report"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="bib12"><span class="bullet">12</span>
                     <span class="author">Breneman JC</span>,
<span class="author">Lyden E</span>,
<span class="author">Pappo AS</span>, et al.
<span class="articleTitle">Prognostic factors and clinical outcomes in children and adolescents with metastatic rhabdomyosarcoma—a report from the Intergroup Rhabdomyosarcoma Study IV</span>.
<i>J Clin Oncol</i>
                     <span class="pubYear">2003</span>;
 <span class="vol">21</span>:
 <span class="pageFirst">78</span>– <span class="pageLast">84</span>.
                     <div class="extra-links" id="e_1_2_5_13_2"><span><a href="/servlet/linkout?suffix=null&amp;dbid=16&amp;doi=10.1002%2Fijc.27730&amp;key=10.1200%2FJCO.2003.06.129" onclick="newWindow(this.href);return false" class="visitable">Crossref</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27730&amp;key=12506174" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27730&amp;key=000183281100014" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2003&pages=78-84&journal=J+Clin+Oncol&author=JC+Breneman&author=E+Lyden&author=AS+Pappo&title=Prognostic+factors+and+clinical+outcomes+in+children+and+adolescents+with+metastatic+rhabdomyosarcoma%E2%80%94a+report+from+the+Intergroup+Rhabdomyosarcoma+Study+IV"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="bib13"><span class="bullet">13</span>
                     <span class="author">Abdelrahim M</span>,
<span class="author">Baker CH</span>,
<span class="author">Abbruzzese JL</span>, et al.
<span class="articleTitle">Tolfenamic acid and pancreatic cancer growth, angiogenesis, and Sp protein degradation</span>.
<i>J Natl Cancer Inst</i>
                     <span class="pubYear">2006</span>;
 <span class="vol">98</span>:
 <span class="pageFirst">855</span>– <span class="pageLast">68</span>.
                     <div class="extra-links" id="e_1_2_5_14_2"><span><a href="/servlet/linkout?suffix=null&amp;dbid=16&amp;doi=10.1002%2Fijc.27730&amp;key=10.1093%2Fjnci%2Fdjj232" onclick="newWindow(this.href);return false" class="visitable">Crossref</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27730&amp;key=1%3ACAS%3A528%3ADC%252BD28Xmt1Wktr8%253D" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27730&amp;key=16788159" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27730&amp;key=000238817700011" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2006&pages=855-68&journal=J+Natl+Cancer+Inst&author=M+Abdelrahim&author=CH+Baker&author=JL+Abbruzzese&title=Tolfenamic+acid+and+pancreatic+cancer+growth%2C+angiogenesis%2C+and+Sp+protein+degradation"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="bib14"><span class="bullet">14</span>
                     <span class="author">Chintharlapalli S</span>,
<span class="author">Papineni S</span>,
<span class="author">Ramaiah SK</span>, et al.
<span class="articleTitle">Betulinic acid inhibits prostate cancer growth through inhibition of specificity protein transcription factors</span>.
<i>Cancer Res</i>
                     <span class="pubYear">2007</span>;
 <span class="vol">67</span>:
 <span class="pageFirst">2816</span>– <span class="pageLast">23</span>.
                     <div class="extra-links" id="e_1_2_5_15_2"><span><a href="/servlet/linkout?suffix=null&amp;dbid=16&amp;doi=10.1002%2Fijc.27730&amp;key=10.1158%2F0008-5472.CAN-06-3735" onclick="newWindow(this.href);return false" class="visitable">Crossref</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27730&amp;key=1%3ACAS%3A528%3ADC%252BD2sXivV2nsbw%253D" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27730&amp;key=17363604" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27730&amp;key=000245019100053" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=2816-23&journal=Cancer+Res&author=S+Chintharlapalli&author=S+Papineni&author=SK+Ramaiah&title=Betulinic+acid+inhibits+prostate+cancer+growth+through+inhibition+of+specificity+protein+transcription+factors"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="bib15"><span class="bullet">15</span>
                     <span class="author">Papineni S</span>,
<span class="author">Chintharlapalli S</span>,
<span class="author">Abdelrahim M</span>, et al.
<span class="articleTitle">Tolfenamic acid inhibits esophageal cancer through repression of specificity proteins and c-Met</span>.
<i>Carcinogenesis</i>
                     <span class="pubYear">2009</span>;
 <span class="vol">30</span>:
 <span class="pageFirst">1193</span>– <span class="pageLast">201</span>.
                     <div class="extra-links" id="e_1_2_5_16_2"><span><a href="/servlet/linkout?suffix=null&amp;dbid=16&amp;doi=10.1002%2Fijc.27730&amp;key=10.1093%2Fcarcin%2Fbgp092" onclick="newWindow(this.href);return false" class="visitable">Crossref</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27730&amp;key=1%3ACAS%3A528%3ADC%252BD1MXot1Cis78%253D" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27730&amp;key=19406933" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27730&amp;key=000267666100016" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2009&pages=1193-201&journal=Carcinogenesis&author=S+Papineni&author=S+Chintharlapalli&author=M+Abdelrahim&title=Tolfenamic+acid+inhibits+esophageal+cancer+through+repression+of+specificity+proteins+and+c%E2%80%90Met"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="bib16"><span class="bullet">16</span>
                     <span class="author">Chadalapaka G</span>,
<span class="author">Jutooru I</span>,
<span class="author">Chintharlapalli S</span>, et al.
<span class="articleTitle">Curcumin decreases specificity protein expression in bladder cancer cells</span>.
<i>Cancer Res</i>
                     <span class="pubYear">2008</span>;
 <span class="vol">68</span>:
 <span class="pageFirst">5345</span>– <span class="pageLast">54</span>.
                     <div class="extra-links" id="e_1_2_5_17_2"><span><a href="/servlet/linkout?suffix=null&amp;dbid=16&amp;doi=10.1002%2Fijc.27730&amp;key=10.1158%2F0008-5472.CAN-07-6805" onclick="newWindow(this.href);return false" class="visitable">Crossref</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27730&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnvFyjt70%253D" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27730&amp;key=18593936" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27730&amp;key=000257415300048" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2008&pages=5345-54&journal=Cancer+Res&author=G+Chadalapaka&author=I+Jutooru&author=S+Chintharlapalli&title=Curcumin+decreases+specificity+protein+expression+in+bladder+cancer+cells"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="bib17"><span class="bullet">17</span>
                     <span class="author">Chintharlapalli S</span>,
<span class="author">Papineni S</span>,
<span class="author">Abdelrahim M</span>, et al.
<span class="articleTitle">Oncogenic microRNA-27a is a target for anticancer agent methyl 2-cyano-3,11-dioxo-18beta-olean-1,12-dien-30-oate in colon cancer cells</span>.
<i>Int J Cancer</i>
                     <span class="pubYear">2009</span>;
 <span class="vol">125</span>:
 <span class="pageFirst">1965</span>– <span class="pageLast">74</span>.
                     <div class="extra-links" id="e_1_2_5_18_2"><span><a href="/doi/10.1002/ijc.24530" onclick="newWindow(this.href);return false" class="visitable">Wiley Online Library</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27730&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVGisr7N" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27730&amp;key=19582879" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27730&amp;key=000270011000028" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2009&pages=1965-74&journal=Int+J+Cancer&author=S+Chintharlapalli&author=S+Papineni&author=M+Abdelrahim&title=Oncogenic+microRNA%E2%80%9027a+is+a+target+for+anticancer+agent+methyl+2%E2%80%90cyano%E2%80%903%2C11%E2%80%90dioxo%E2%80%9018beta%E2%80%90olean%E2%80%901%2C12%E2%80%90dien%E2%80%9030%E2%80%90oate+in+colon+cancer+cells"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="bib18"><span class="bullet">18</span>
                     <span class="author">Mertens-Talcott SU</span>,
<span class="author">Chintharlapalli S</span>,
<span class="author">Li X</span>, et al.
<span class="articleTitle">The oncogenic microRNA-27a targets genes that regulate specificity protein transcription factors and the G2-M checkpoint in MDA-MB-231 breast cancer cells</span>.
<i>Cancer Res</i>
                     <span class="pubYear">2007</span>;
 <span class="vol">67</span>:
 <span class="pageFirst">11001</span>– <span class="pageLast">11</span>.
                     <div class="extra-links" id="e_1_2_5_19_2"><span><a href="/servlet/linkout?suffix=null&amp;dbid=16&amp;doi=10.1002%2Fijc.27730&amp;key=10.1158%2F0008-5472.CAN-07-2416" onclick="newWindow(this.href);return false" class="visitable">Crossref</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27730&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlSlsLrL" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27730&amp;key=18006846" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27730&amp;key=000251044000046" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=11001-11&journal=Cancer+Res&author=SU+Mertens%E2%80%90Talcott&author=S+Chintharlapalli&author=X+Li&title=The+oncogenic+microRNA%E2%80%9027a+targets+genes+that+regulate+specificity+protein+transcription+factors+and+the+G2%E2%80%90M+checkpoint+in+MDA%E2%80%90MB%E2%80%90231+breast+cancer+cells"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="bib19"><span class="bullet">19</span>
                     <span class="author">Jutooru I</span>,
<span class="author">Chadalapaka G</span>,
<span class="author">Sreevalsan S</span>, et al.
<span class="articleTitle">Arsenic trioxide downregulates specificity protein (Sp) transcription factors and inhibits bladder cancer cell and tumor growth</span>.
<i>Exp Cell Res</i>
                     <span class="pubYear">2010</span>;
 <span class="vol">316</span>:
 <span class="pageFirst">2174</span>– <span class="pageLast">88</span>.
                     <div class="extra-links" id="e_1_2_5_20_2"><span><a href="/servlet/linkout?suffix=null&amp;dbid=16&amp;doi=10.1002%2Fijc.27730&amp;key=10.1016%2Fj.yexcr.2010.04.027" onclick="newWindow(this.href);return false" class="visitable">Crossref</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27730&amp;key=1%3ACAS%3A528%3ADC%252BC3cXnvVOmt70%253D" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27730&amp;key=20435036" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27730&amp;key=000279288100012" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=316&publication_year=2010&pages=2174-88&journal=Exp+Cell+Res&author=I+Jutooru&author=G+Chadalapaka&author=S+Sreevalsan&title=Arsenic+trioxide+downregulates+specificity+protein+%28Sp%29+transcription+factors+and+inhibits+bladder+cancer+cell+and+tumor+growth"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="bib20"><span class="bullet">20</span>
                     <span class="author">Abdelrahim M</span>,
<span class="author">Baker CH</span>,
<span class="author">Abbruzzese JL</span>, et al.
<span class="articleTitle">Regulation of vascular endothelial growth factor receptor-1 expression by specificity proteins 1, 3, and 4 in pancreatic cancer cells</span>.
<i>Cancer Res</i>
                     <span class="pubYear">2007</span>;
 <span class="vol">67</span>:
 <span class="pageFirst">3286</span>– <span class="pageLast">94</span>.
                     <div class="extra-links" id="e_1_2_5_21_2"><span><a href="/servlet/linkout?suffix=null&amp;dbid=16&amp;doi=10.1002%2Fijc.27730&amp;key=10.1158%2F0008-5472.CAN-06-3831" onclick="newWindow(this.href);return false" class="visitable">Crossref</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27730&amp;key=1%3ACAS%3A528%3ADC%252BD2sXksVGks70%253D" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27730&amp;key=17409437" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27730&amp;key=000245622900047" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=3286-94&journal=Cancer+Res&author=M+Abdelrahim&author=CH+Baker&author=JL+Abbruzzese&title=Regulation+of+vascular+endothelial+growth+factor+receptor%E2%80%901+expression+by+specificity+proteins+1%2C+3%2C+and+4+in+pancreatic+cancer+cells"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="bib21"><span class="bullet">21</span>
                     <span class="author">Chadalapaka G</span>,
<span class="author">Jutooru I</span>,
<span class="author">Burghardt R</span>, et al.
<span class="articleTitle">Drugs that target specificity proteins downregulate epidermal growth factor receptor in bladder cancer cells</span>.
<i>Mol Cancer Res</i>
                     <span class="pubYear">2010</span>;
 <span class="vol">8</span>:
 <span class="pageFirst">739</span>– <span class="pageLast">50</span>.
                     <div class="extra-links" id="e_1_2_5_22_2"><span><a href="/servlet/linkout?suffix=null&amp;dbid=16&amp;doi=10.1002%2Fijc.27730&amp;key=10.1158%2F1541-7786.MCR-09-0493" onclick="newWindow(this.href);return false" class="visitable">Crossref</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27730&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmtFams7g%253D" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27730&amp;key=20407012" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27730&amp;key=000278487100010" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2010&pages=739-50&journal=Mol+Cancer+Res&author=G+Chadalapaka&author=I+Jutooru&author=R+Burghardt&title=Drugs+that+target+specificity+proteins+downregulate+epidermal+growth+factor+receptor+in+bladder+cancer+cells"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="bib22"><span class="bullet">22</span>
                     <span class="author">Abdelrahim M</span>,
<span class="author">Smith R</span>, 3rd,
<span class="author">Burghardt R</span>, et al.
<span class="articleTitle">Role of Sp proteins in regulation of vascular endothelial growth factor expression and proliferation of pancreatic cancer cells</span>.
<i>Cancer Res</i>
                     <span class="pubYear">2004</span>;
 <span class="vol">64</span>:
 <span class="pageFirst">6740</span>– <span class="pageLast">9</span>.
                     <div class="extra-links" id="e_1_2_5_23_2"><span><a href="/servlet/linkout?suffix=null&amp;dbid=16&amp;doi=10.1002%2Fijc.27730&amp;key=10.1158%2F0008-5472.CAN-04-0713" onclick="newWindow(this.href);return false" class="visitable">Crossref</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27730&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnsFOks7o%253D" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27730&amp;key=15374992" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27730&amp;key=000224089700055" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=6740-9&journal=Cancer+Res&author=M+Abdelrahim&author=R+Smith&author=R+Burghardt&title=Role+of+Sp+proteins+in+regulation+of+vascular+endothelial+growth+factor+expression+and+proliferation+of+pancreatic+cancer+cells"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="bib23"><span class="bullet">23</span>
                     <span class="author">Jutooru I</span>,
<span class="author">Chadalapaka G</span>,
<span class="author">Abdelrahim M</span>, et al.
<span class="articleTitle">Methyl 2-cyano-3,12-dioxooleana-1,9-dien-28-oate decreases specificity protein transcription factors and inhibits pancreatic tumor growth: role of microRNA-27a</span>.
<i>Mol Pharmacol</i>
                     <span class="pubYear">2010</span>;
 <span class="vol">78</span>:
 <span class="pageFirst">226</span>– <span class="pageLast">36</span>.
                     <div class="extra-links" id="e_1_2_5_24_2"><span><a href="/servlet/linkout?suffix=null&amp;dbid=16&amp;doi=10.1002%2Fijc.27730&amp;key=10.1124%2Fmol.110.064451" onclick="newWindow(this.href);return false" class="visitable">Crossref</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27730&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpsl2jtLY%253D" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27730&amp;key=20488920" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27730&amp;key=000279888000008" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2010&pages=226-36&journal=Mol+Pharmacol&author=I+Jutooru&author=G+Chadalapaka&author=M+Abdelrahim&title=Methyl+2%E2%80%90cyano%E2%80%903%2C12%E2%80%90dioxooleana%E2%80%901%2C9%E2%80%90dien%E2%80%9028%E2%80%90oate+decreases+specificity+protein+transcription+factors+and+inhibits+pancreatic+tumor+growth%3A+role+of+microRNA%E2%80%9027a"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="bib24"><span class="bullet">24</span>
                     <span class="author">Jutooru I</span>,
<span class="author">Chadalapaka G</span>,
<span class="author">Lei P</span>, et al.
<span class="articleTitle">Inhibition of NFkappaB and pancreatic cancer cell and tumor growth by curcumin is dependent on specificity protein down-regulation</span>.
<i>J Biol Chem</i>
                     <span class="pubYear">2010</span>;
 <span class="vol">285</span>:
 <span class="pageFirst">25332</span>– <span class="pageLast">44</span>.
                     <div class="extra-links" id="e_1_2_5_25_2"><span><a href="/servlet/linkout?suffix=null&amp;dbid=16&amp;doi=10.1002%2Fijc.27730&amp;key=10.1074%2Fjbc.M109.095240" onclick="newWindow(this.href);return false" class="visitable">Crossref</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27730&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpslKjtrk%253D" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27730&amp;key=20538607" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27730&amp;key=000280682400026" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=25332-44&journal=J+Biol+Chem&author=I+Jutooru&author=G+Chadalapaka&author=P+Lei&title=Inhibition+of+NFkappaB+and+pancreatic+cancer+cell+and+tumor+growth+by+curcumin+is+dependent+on+specificity+protein+down%E2%80%90regulation"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="bib25"><span class="bullet">25</span>
                     <span class="author">Taulli R</span>,
<span class="author">Scuoppo C</span>,
<span class="author">Bersani F</span>, et al.
<span class="articleTitle">Validation of met as a therapeutic target in alveolar and embryonal rhabdomyosarcoma</span>.
<i>Cancer Res</i>
                     <span class="pubYear">2006</span>;
 <span class="vol">66</span>:
 <span class="pageFirst">4742</span>– <span class="pageLast">9</span>.
                     <div class="extra-links" id="e_1_2_5_26_2"><span><a href="/servlet/linkout?suffix=null&amp;dbid=16&amp;doi=10.1002%2Fijc.27730&amp;key=10.1158%2F0008-5472.CAN-05-4292" onclick="newWindow(this.href);return false" class="visitable">Crossref</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27730&amp;key=1%3ACAS%3A528%3ADC%252BD28XjvF2ktr0%253D" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27730&amp;key=16651427" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27730&amp;key=000237496900026" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=4742-9&journal=Cancer+Res&author=R+Taulli&author=C+Scuoppo&author=F+Bersani&title=Validation+of+met+as+a+therapeutic+target+in+alveolar+and+embryonal+rhabdomyosarcoma"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="bib26"><span class="bullet">26</span>
                     <span class="author">Yu SJ</span>,
<span class="author">Zheng L</span>,
<span class="author">Ladanyi M</span>, et al.
<span class="articleTitle">Sp1-mediated transcriptional control of fibroblast growth factor receptor 4 in sarcomas of skeletal muscle lineage</span>.
<i>Clin Cancer Res</i>
                     <span class="pubYear">2004</span>;
 <span class="vol">10</span>:
 <span class="pageFirst">6750</span>– <span class="pageLast">8</span>.
                     <div class="extra-links" id="e_1_2_5_27_2"><span><a href="/servlet/linkout?suffix=null&amp;dbid=16&amp;doi=10.1002%2Fijc.27730&amp;key=10.1158%2F1078-0432.CCR-04-0223" onclick="newWindow(this.href);return false" class="visitable">Crossref</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27730&amp;key=1%3ACAS%3A528%3ADC%252BD2cXot1OhsrY%253D" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27730&amp;key=15475466" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27730&amp;key=000224521300041" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=6750-8&journal=Clin+Cancer+Res&author=SJ+Yu&author=L+Zheng&author=M+Ladanyi&title=Sp1%E2%80%90mediated+transcriptional+control+of+fibroblast+growth+factor+receptor+4+in+sarcomas+of+skeletal+muscle+lineage"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="bib27"><span class="bullet">27</span>
                     <span class="author">Linardic CM</span>,
<span class="author">Naini S</span>,
<span class="author">Herndon JE</span>, 2nd, et al.
<span class="articleTitle">The PAX3-FKHR fusion gene of rhabdomyosarcoma cooperates with loss of p16INK4A to promote bypass of cellular senescence</span>.
<i>Cancer Res</i>
                     <span class="pubYear">2007</span>;
 <span class="vol">67</span>:
 <span class="pageFirst">6691</span>– <span class="pageLast">9</span>.
                     <div class="extra-links" id="e_1_2_5_28_2"><span><a href="/servlet/linkout?suffix=null&amp;dbid=16&amp;doi=10.1002%2Fijc.27730&amp;key=10.1158%2F0008-5472.CAN-06-3210" onclick="newWindow(this.href);return false" class="visitable">Crossref</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27730&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnslOjur4%253D" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27730&amp;key=17638879" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27730&amp;key=000248319000022" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=6691-9&journal=Cancer+Res&author=CM+Linardic&author=S+Naini&author=JE+Herndon&title=The+PAX3%E2%80%90FKHR+fusion+gene+of+rhabdomyosarcoma+cooperates+with+loss+of+p16INK4A+to+promote+bypass+of+cellular+senescence"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="bib28"><span class="bullet">28</span>
                     <span class="author">Rimm DL</span>,
<span class="author">Camp RL</span>,
<span class="author">Charette LA</span>, et al.
<span class="articleTitle">Tissue microarray: a new technology for amplification of tissue resources</span>.
<i>Cancer J</i>
                     <span class="pubYear">2001</span>;
 <span class="vol">7</span>:
 <span class="pageFirst">24</span>– <span class="pageLast">31</span>.
                     <div class="extra-links" id="e_1_2_5_29_2"><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27730&amp;key=1%3ASTN%3A280%3ADC%252BD3M7mslKjsA%253D%253D" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27730&amp;key=11269645" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27730&amp;key=000167218400004" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2001&pages=24-31&journal=Cancer+J&author=DL+Rimm&author=RL+Camp&author=LA+Charette&title=Tissue+microarray%3A+a+new+technology+for+amplification+of+tissue+resources"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="bib29"><span class="bullet">29</span>
                     <span class="author">Kendall SD</span>,
<span class="author">Linardic CM</span>,
<span class="author">Adam SJ</span>, et al.
<span class="articleTitle">A network of genetic events sufficient to convert normal human cells to a tumorigenic state</span>.
<i>Cancer Res</i>
                     <span class="pubYear">2005</span>;
 <span class="vol">65</span>:
 <span class="pageFirst">9824</span>– <span class="pageLast">8</span>.
                     <div class="extra-links" id="e_1_2_5_30_2"><span><a href="/servlet/linkout?suffix=null&amp;dbid=16&amp;doi=10.1002%2Fijc.27730&amp;key=10.1158%2F0008-5472.CAN-05-1543" onclick="newWindow(this.href);return false" class="visitable">Crossref</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27730&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFKktLzL" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27730&amp;key=16267004" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27730&amp;key=000232967000030" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2005&pages=9824-8&journal=Cancer+Res&author=SD+Kendall&author=CM+Linardic&author=SJ+Adam&title=A+network+of+genetic+events+sufficient+to+convert+normal+human+cells+to+a+tumorigenic+state"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="bib30"><span class="bullet">30</span>
                     <span class="author">Naini S</span>,
<span class="author">Etheridge KT</span>,
<span class="author">Adam SJ</span>, et al.
<span class="articleTitle">Defining the cooperative genetic changes that temporally drive alveolar rhabdomyosarcoma</span>.
<i>Cancer Res</i>
                     <span class="pubYear">2008</span>;
 <span class="vol">68</span>:
 <span class="pageFirst">9583</span>– <span class="pageLast">8</span>.
                     <div class="extra-links" id="e_1_2_5_31_2"><span><a href="/servlet/linkout?suffix=null&amp;dbid=16&amp;doi=10.1002%2Fijc.27730&amp;key=10.1158%2F0008-5472.CAN-07-6178" onclick="newWindow(this.href);return false" class="visitable">Crossref</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27730&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVegtb3F" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27730&amp;key=19047133" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27730&amp;key=000261488900005" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2008&pages=9583-8&journal=Cancer+Res&author=S+Naini&author=KT+Etheridge&author=SJ+Adam&title=Defining+the+cooperative+genetic+changes+that+temporally+drive+alveolar+rhabdomyosarcoma"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="bib31"><span class="bullet">31</span>
                     <span class="author">Saffer JD</span>,
<span class="author">Jackson SP</span>,
<span class="author">Thurston SJ</span>.
<span class="articleTitle">SV40 stimulates expression of the transacting factor Sp1 at the mRNA level</span>.
<i>Genes Dev</i>
                     <span class="pubYear">1990</span>;
 <span class="vol">4</span>:
 <span class="pageFirst">659</span>– <span class="pageLast">66</span>.
                     <div class="extra-links" id="e_1_2_5_32_2"><span><a href="/servlet/linkout?suffix=null&amp;dbid=16&amp;doi=10.1002%2Fijc.27730&amp;key=10.1101%2Fgad.4.4.659" onclick="newWindow(this.href);return false" class="visitable">Crossref</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27730&amp;key=1%3ACAS%3A528%3ADyaK3cXktVWmsb0%253D" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27730&amp;key=2163346" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27730&amp;key=A1990DD09700016" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1990&pages=659-66&journal=Genes+Dev&author=JD+Saffer&author=SP+Jackson&author=SJ+Thurston&title=SV40+stimulates+expression+of+the+transacting+factor+Sp1+at+the+mRNA+level"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="bib32"><span class="bullet">32</span>
                     <span class="author">Kennett SB</span>,
<span class="author">Udvadia AJ</span>,
<span class="author">Horowitz JM</span>.
<span class="articleTitle">Sp3 encodes multiple proteins that differ in their capacity to stimulate or repress transcription</span>.
<i>Nucleic Acids Res</i>
                     <span class="pubYear">1997</span>;
 <span class="vol">25</span>:
 <span class="pageFirst">3110</span>– <span class="pageLast">7</span>.
                     <div class="extra-links" id="e_1_2_5_33_2"><span><a href="/servlet/linkout?suffix=null&amp;dbid=16&amp;doi=10.1002%2Fijc.27730&amp;key=10.1093%2Fnar%2F25.15.3110" onclick="newWindow(this.href);return false" class="visitable">Crossref</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27730&amp;key=1%3ACAS%3A528%3ADyaK2sXltlCrs70%253D" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27730&amp;key=9224612" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27730&amp;key=A1997XP99500022" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1997&pages=3110-7&journal=Nucleic+Acids+Res&author=SB+Kennett&author=AJ+Udvadia&author=JM+Horowitz&title=Sp3+encodes+multiple+proteins+that+differ+in+their+capacity+to+stimulate+or+repress+transcription"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="bib33"><span class="bullet">33</span>
                     <span class="author">Kennett SB</span>,
<span class="author">Moorefield KS</span>,
<span class="author">Horowitz JM</span>.
<span class="articleTitle">Sp3 represses gene expression via the titration of promoter-specific transcription factors</span>.
<i>J Biol Chem</i>
                     <span class="pubYear">2002</span>;
 <span class="vol">277</span>:
 <span class="pageFirst">9780</span>– <span class="pageLast">9</span>.
                     <div class="extra-links" id="e_1_2_5_34_2"><span><a href="/servlet/linkout?suffix=null&amp;dbid=16&amp;doi=10.1002%2Fijc.27730&amp;key=10.1074%2Fjbc.M108661200" onclick="newWindow(this.href);return false" class="visitable">Crossref</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27730&amp;key=1%3ACAS%3A528%3ADC%252BD38XisVyls7g%253D" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27730&amp;key=11773047" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27730&amp;key=000174549200026" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=9780-9&journal=J+Biol+Chem&author=SB+Kennett&author=KS+Moorefield&author=JM+Horowitz&title=Sp3+represses+gene+expression+via+the+titration+of+promoter%E2%80%90specific+transcription+factors"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="bib34"><span class="bullet">34</span>
                     <span class="author">Taniguchi E</span>,
<span class="author">Nishijo K</span>,
<span class="author">McCleish AT</span>, et al.
<span class="articleTitle">PDGFR-A is a therapeutic target in alveolar rhabdomyosarcoma</span>.
<i>Oncogene</i>
                     <span class="pubYear">2008</span>;
 <span class="vol">27</span>:
 <span class="pageFirst">6550</span>– <span class="pageLast">60</span>.
                     <div class="extra-links" id="e_1_2_5_35_2"><span><a href="/servlet/linkout?suffix=null&amp;dbid=16&amp;doi=10.1002%2Fijc.27730&amp;key=10.1038%2Fonc.2008.255" onclick="newWindow(this.href);return false" class="visitable">Crossref</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27730&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlSktLbL" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27730&amp;key=18679424" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27730&amp;key=000260501700002" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2008&pages=6550-60&journal=Oncogene&author=E+Taniguchi&author=K+Nishijo&author=AT+McCleish&title=PDGFR%E2%80%90A+is+a+therapeutic+target+in+alveolar+rhabdomyosarcoma"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="bib35"><span class="bullet">35</span>
                     <span class="author">Libura J</span>,
<span class="author">Drukala J</span>,
<span class="author">Majka M</span>, et al.
<span class="articleTitle">CXCR4-SDF-1 signaling is active in rhabdomyosarcoma cells and regulates locomotion, chemotaxis, and adhesion</span>.
<i>Blood</i>
                     <span class="pubYear">2002</span>;
 <span class="vol">100</span>:
 <span class="pageFirst">2597</span>– <span class="pageLast">606</span>.
                     <div class="extra-links" id="e_1_2_5_36_2"><span><a href="/servlet/linkout?suffix=null&amp;dbid=16&amp;doi=10.1002%2Fijc.27730&amp;key=10.1182%2Fblood-2002-01-0031" onclick="newWindow(this.href);return false" class="visitable">Crossref</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27730&amp;key=1%3ACAS%3A528%3ADC%252BD38XnvVGitrg%253D" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27730&amp;key=12239174" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27730&amp;key=000178266000041" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2002&pages=2597-606&journal=Blood&author=J+Libura&author=J+Drukala&author=M+Majka&title=CXCR4%E2%80%90SDF%E2%80%901+signaling+is+active+in+rhabdomyosarcoma+cells+and+regulates+locomotion%2C+chemotaxis%2C+and+adhesion"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="bib36"><span class="bullet">36</span>
                     <span class="author">Strahm B</span>,
<span class="author">Durbin AD</span>,
<span class="author">Sexsmith E</span>, et al.
<span class="articleTitle">The CXCR4-SDF1alpha axis is a critical mediator of rhabdomyosarcoma metastatic signaling induced by bone marrow stroma</span>.
<i>Clin Exp Metastasis</i>
                     <span class="pubYear">2008</span>;
 <span class="vol">25</span>:
 <span class="pageFirst">1</span>– <span class="pageLast">10</span>.
                     <div class="extra-links" id="e_1_2_5_37_2"><span><a href="/servlet/linkout?suffix=null&amp;dbid=16&amp;doi=10.1002%2Fijc.27730&amp;key=10.1007%2Fs10585-007-9094-6" onclick="newWindow(this.href);return false" class="visitable">Crossref</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27730&amp;key=1%3ACAS%3A528%3ADC%252BD1cXkslaltrs%253D" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27730&amp;key=17768666" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27730&amp;key=000252806300001" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2008&pages=1-10&journal=Clin+Exp+Metastasis&author=B+Strahm&author=AD+Durbin&author=E+Sexsmith&title=The+CXCR4%E2%80%90SDF1alpha+axis+is+a+critical+mediator+of+rhabdomyosarcoma+metastatic+signaling+induced+by+bone+marrow+stroma"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="bib37"><span class="bullet">37</span>
                     <span class="author">Pathi SS</span>,
<span class="author">Jutooru I</span>,
<span class="author">Chadalapaka G</span>, et al.
<span class="articleTitle">GT-094, a NO-NSAID, inhibits colon cancer cell growth by activation of a reactive oxygen species-microRNA-27a: ZBTB10-specificity protein pathway</span>.
<i>Mol Cancer Res</i>
                     <span class="pubYear">2011</span>;
 <span class="vol">9</span>:
 <span class="pageFirst">195</span>– <span class="pageLast">202</span>.
                     <div class="extra-links" id="e_1_2_5_38_2"><span><a href="/servlet/linkout?suffix=null&amp;dbid=16&amp;doi=10.1002%2Fijc.27730&amp;key=10.1158%2F1541-7786.MCR-10-0363" onclick="newWindow(this.href);return false" class="visitable">Crossref</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27730&amp;key=1%3ACAS%3A528%3ADC%252BC3MXitVWls7w%253D" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27730&amp;key=21156786" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27730&amp;key=000288607700006" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2011&pages=195-202&journal=Mol+Cancer+Res&author=SS+Pathi&author=I+Jutooru&author=G+Chadalapaka&title=GT%E2%80%90094%2C+a+NO%E2%80%90NSAID%2C+inhibits+colon+cancer+cell+growth+by+activation+of+a+reactive+oxygen+species%E2%80%90microRNA%E2%80%9027a%3A+ZBTB10%E2%80%90specificity+protein+pathway"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="bib38"><span class="bullet">38</span>
                     <span class="author">Bouwman P</span>,
<span class="author">Philipsen S</span>.
<span class="articleTitle">Regulation of the activity of Sp1-related transcription factors</span>.
<i>Mol Cell Endocrinol</i>
                     <span class="pubYear">2002</span>;
 <span class="vol">195</span>:
 <span class="pageFirst">27</span>– <span class="pageLast">38</span>.
                     <div class="extra-links" id="e_1_2_5_39_2"><span><a href="/servlet/linkout?suffix=null&amp;dbid=16&amp;doi=10.1002%2Fijc.27730&amp;key=10.1016%2FS0303-7207%2802%2900221-6" onclick="newWindow(this.href);return false" class="visitable">Crossref</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27730&amp;key=000178843400002" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=195&publication_year=2002&pages=27-38&journal=Mol+Cell+Endocrinol&author=P+Bouwman&author=S+Philipsen&title=Regulation+of+the+activity+of+Sp1%E2%80%90related+transcription+factors"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="bib39"><span class="bullet">39</span>
                     <span class="author">Black AR</span>,
<span class="author">Black JD</span>,
<span class="author">Azizkhan-Clifford J</span>.
<span class="articleTitle">Sp1 and kruppel-like factor family of transcription factors in cell growth regulation and cancer</span>.
<i>J Cell Physiol</i>
                     <span class="pubYear">2001</span>;
 <span class="vol">188</span>:
 <span class="pageFirst">143</span>– <span class="pageLast">60</span>.
                     <div class="extra-links" id="e_1_2_5_40_2"><span><a href="/doi/10.1002/jcp.1111" onclick="newWindow(this.href);return false" class="visitable">Wiley Online Library</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27730&amp;key=1%3ACAS%3A528%3ADC%252BD3MXltVKmsbc%253D" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27730&amp;key=11424081" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27730&amp;key=000169767600001" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=188&publication_year=2001&pages=143-60&journal=J+Cell+Physiol&author=AR+Black&author=JD+Black&author=J+Azizkhan%E2%80%90Clifford&title=Sp1+and+kruppel%E2%80%90like+factor+family+of+transcription+factors+in+cell+growth+regulation+and+cancer"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="bib40"><span class="bullet">40</span>
                     <span class="author">Ammendola R</span>,
<span class="author">Mesuraca M</span>,
<span class="author">Russo T</span>, et al.
<span class="articleTitle">Sp1 DNA binding efficiency is highly reduced in nuclear extracts from aged rat tissues</span>.
<i>J Biol Chem</i>
                     <span class="pubYear">1992</span>;
 <span class="vol">267</span>:
 <span class="pageFirst">17944</span>– <span class="pageLast">8</span>.
                     <div class="extra-links" id="e_1_2_5_41_2"><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27730&amp;key=1%3ACAS%3A528%3ADyaK38XkvVCmtL8%253D" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27730&amp;key=1381357" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27730&amp;key=A1992JM22300071" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=1992&pages=17944-8&journal=J+Biol+Chem&author=R+Ammendola&author=M+Mesuraca&author=T+Russo&title=Sp1+DNA+binding+efficiency+is+highly+reduced+in+nuclear+extracts+from+aged+rat+tissues"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="bib41"><span class="bullet">41</span>
                     <span class="author">Adrian GS</span>,
<span class="author">Seto E</span>,
<span class="author">Fischbach KS</span>, et al.
<span class="articleTitle">YY1 and Sp1 transcription factors bind the human transferrin gene in an age-related manner</span>.
<i>J Gerontol A Biol Sci Med Sci</i>
                     <span class="pubYear">1996</span>;
 <span class="vol">51</span>:
 <span class="pageFirst">B66</span>– <span class="pageLast">75</span>.
                     <div class="extra-links" id="e_1_2_5_42_2"><span><a href="/servlet/linkout?suffix=null&amp;dbid=16&amp;doi=10.1002%2Fijc.27730&amp;key=10.1093%2Fgerona%2F51A.1.B66" onclick="newWindow(this.href);return false" class="visitable">Crossref</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27730&amp;key=1%3ASTN%3A280%3ADyaK287kt1artw%253D%253D" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27730&amp;key=8548503" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27730&amp;key=A1996TP04300011" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=1996&pages=B66-75&journal=J+Gerontol+A+Biol+Sci+Med+Sci&author=GS+Adrian&author=E+Seto&author=KS+Fischbach&title=YY1+and+Sp1+transcription+factors+bind+the+human+transferrin+gene+in+an+age%E2%80%90related+manner"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="bib42"><span class="bullet">42</span>
                     <span class="author">Oh JE</span>,
<span class="author">Han JA</span>,
<span class="author">Hwang ES</span>.
<span class="articleTitle">Downregulation of transcription factor, Sp1, during cellular senescence</span>.
<i>Biochem Biophys Res Commun</i>
                     <span class="pubYear">2007</span>;
 <span class="vol">353</span>:
 <span class="pageFirst">86</span>– <span class="pageLast">91</span>.
                     <div class="extra-links" id="e_1_2_5_43_2"><span><a href="/servlet/linkout?suffix=null&amp;dbid=16&amp;doi=10.1002%2Fijc.27730&amp;key=10.1016%2Fj.bbrc.2006.11.118" onclick="newWindow(this.href);return false" class="visitable">Crossref</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27730&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1Sntg%253D%253D" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27730&amp;key=17161377" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27730&amp;key=000243336900014" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=353&publication_year=2007&pages=86-91&journal=Biochem+Biophys+Res+Commun&author=JE+Oh&author=JA+Han&author=ES+Hwang&title=Downregulation+of+transcription+factor%2C+Sp1%2C+during+cellular+senescence"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="bib43"><span class="bullet">43</span>
                     <span class="author">Jiang NY</span>,
<span class="author">Woda BA</span>,
<span class="author">Banner BF</span>, et al.
<span class="articleTitle">Sp1, a new biomarker that identifies a subset of aggressive pancreatic ductal adenocarcinoma</span>.
<i>Cancer Epidemiol Biomarkers Prev</i>
                     <span class="pubYear">2008</span>;
 <span class="vol">17</span>:
 <span class="pageFirst">1648</span>– <span class="pageLast">52</span>.
                     <div class="extra-links" id="e_1_2_5_44_2"><span><a href="/servlet/linkout?suffix=null&amp;dbid=16&amp;doi=10.1002%2Fijc.27730&amp;key=10.1158%2F1055-9965.EPI-07-2791" onclick="newWindow(this.href);return false" class="visitable">Crossref</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27730&amp;key=1%3ACAS%3A528%3ADC%252BD1cXosFGhsLY%253D" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27730&amp;key=18628415" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27730&amp;key=000257735500010" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2008&pages=1648-52&journal=Cancer+Epidemiol+Biomarkers+Prev&author=NY+Jiang&author=BA+Woda&author=BF+Banner&title=Sp1%2C+a+new+biomarker+that+identifies+a+subset+of+aggressive+pancreatic+ductal+adenocarcinoma"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="bib44"><span class="bullet">44</span>
                     <span class="author">Wang L</span>,
<span class="author">Wei D</span>,
<span class="author">Huang S</span>, et al.
<span class="articleTitle">Transcription factor Sp1 expression is a significant predictor of survival in human gastric cancer</span>.
<i>Clin Cancer Res</i>
                     <span class="pubYear">2003</span>;
 <span class="vol">9</span>:
 <span class="pageFirst">6371</span>– <span class="pageLast">80</span>.
                     <div class="extra-links" id="e_1_2_5_45_2"><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27730&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhtVSqurzK" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27730&amp;key=14695137" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27730&amp;key=000187661300010" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2003&pages=6371-80&journal=Clin+Cancer+Res&author=L+Wang&author=D+Wei&author=S+Huang&title=Transcription+factor+Sp1+expression+is+a+significant+predictor+of+survival+in+human+gastric+cancer"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="bib45"><span class="bullet">45</span>
                     <span class="author">Lou Z</span>,
<span class="author">O'Reilly S</span>,
<span class="author">Liang H</span>, et al.
<span class="articleTitle">Down-regulation of overexpressed sp1 protein in human fibrosarcoma cell lines inhibits tumor formation</span>.
<i>Cancer Res</i>
                     <span class="pubYear">2005</span>;
 <span class="vol">65</span>:
 <span class="pageFirst">1007</span>– <span class="pageLast">17</span>.
                     <div class="extra-links" id="e_1_2_5_46_2"><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27730&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVWntbk%253D" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27730&amp;key=15705902" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27730&amp;key=000226739600045" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2005&pages=1007-17&journal=Cancer+Res&author=Z+Lou&author=S+O%27Reilly&author=H+Liang&title=Down%E2%80%90regulation+of+overexpressed+sp1+protein+in+human+fibrosarcoma+cell+lines+inhibits+tumor+formation"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="bib46"><span class="bullet">46</span>
                     <span class="author">Mayeenuddin LH</span>,
<span class="author">Yu Y</span>,
<span class="author">Kang Z</span>, et al.
<span class="articleTitle">Insulin-like growth factor 1 receptor antibody induces rhabdomyosarcoma cell death via a process involving AKT and Bcl-x(L)</span>.
<i>Oncogene</i>
                     <span class="pubYear">2010</span>;
 <span class="vol">29</span>:
 <span class="pageFirst">6367</span>– <span class="pageLast">77</span>.
                     <div class="extra-links" id="e_1_2_5_47_2"><span><a href="/servlet/linkout?suffix=null&amp;dbid=16&amp;doi=10.1002%2Fijc.27730&amp;key=10.1038%2Fonc.2010.364" onclick="newWindow(this.href);return false" class="visitable">Crossref</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27730&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFWksrnM" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27730&amp;key=20818434" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27730&amp;key=000284874700007" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2010&pages=6367-77&journal=Oncogene&author=LH+Mayeenuddin&author=Y+Yu&author=Z+Kang&title=Insulin%E2%80%90like+growth+factor+1+receptor+antibody+induces+rhabdomyosarcoma+cell+death+via+a+process+involving+AKT+and+Bcl%E2%80%90x%28L%29"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="bib47"><span class="bullet">47</span>
                     <span class="author">Wan X</span>,
<span class="author">Shen N</span>,
<span class="author">Mendoza A</span>, et al.
<span class="articleTitle">CCI-779 inhibits rhabdomyosarcoma xenograft growth by an antiangiogenic mechanism linked to the targeting of mTOR/Hif-1alpha/VEGF signaling</span>.
<i>Neoplasia</i>
                     <span class="pubYear">2006</span>;
 <span class="vol">8</span>:
 <span class="pageFirst">394</span>– <span class="pageLast">401</span>.
                     <div class="extra-links" id="e_1_2_5_48_2"><span><a href="/servlet/linkout?suffix=null&amp;dbid=16&amp;doi=10.1002%2Fijc.27730&amp;key=10.1593%2Fneo.05820" onclick="newWindow(this.href);return false" class="visitable">Crossref</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27730&amp;key=1%3ACAS%3A528%3ADC%252BD28XovVKks7o%253D" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27730&amp;key=16790088" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27730&amp;key=000239283000007" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2006&pages=394-401&journal=Neoplasia&author=X+Wan&author=N+Shen&author=A+Mendoza&title=CCI%E2%80%90779+inhibits+rhabdomyosarcoma+xenograft+growth+by+an+antiangiogenic+mechanism+linked+to+the+targeting+of+mTOR%2FHif%E2%80%901alpha%2FVEGF+signaling"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="bib48"><span class="bullet">48</span>
                     <span class="author">Haliotis FA</span>,
<span class="author">Tzortzinis AA</span>,
<span class="author">Papanastasiou DA</span>.
<span class="articleTitle">Use of tolfenamic acid in febrile children with and without glucose-6-phosphate dehydrogenase deficiency</span>.
<i>Int J Clin Pharmacol Ther</i>
                     <span class="pubYear">1997</span>;
 <span class="vol">35</span>:
 <span class="pageFirst">103</span>– <span class="pageLast">6</span>.
                     <div class="extra-links" id="e_1_2_5_49_2"><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27730&amp;key=1%3ACAS%3A528%3ADyaK2sXitFyisr0%253D" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27730&amp;key=9088998" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27730&amp;key=A1997WM94300004" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1997&pages=103-6&journal=Int+J+Clin+Pharmacol+Ther&author=FA+Haliotis&author=AA+Tzortzinis&author=DA+Papanastasiou&title=Use+of+tolfenamic+acid+in+febrile+children+with+and+without+glucose%E2%80%906%E2%80%90phosphate+dehydrogenase+deficiency"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="bib49"><span class="bullet">49</span>
                     <span class="author">Lascelles BD</span>,
<span class="author">Court MH</span>,
<span class="author">Hardie EM</span>, et al.
<span class="articleTitle">Nonsteroidal anti-inflammatory drugs in cats: a review</span>.
<i>Vet Anaesth Analg</i>
                     <span class="pubYear">2007</span>;
 <span class="vol">34</span>:
 <span class="pageFirst">228</span>– <span class="pageLast">50</span>.
                     <div class="extra-links" id="e_1_2_5_50_2"><span><a href="/doi/10.1111/j.1467-2995.2006.00322.x" onclick="newWindow(this.href);return false" class="visitable">Wiley Online Library</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27730&amp;key=1%3ACAS%3A528%3ADC%252BD2sXoslKjsbs%253D" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27730&amp;key=17451496" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27730&amp;key=000247228000002" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2007&pages=228-50&journal=Vet+Anaesth+Analg&author=BD+Lascelles&author=MH+Court&author=EM+Hardie&title=Nonsteroidal+anti%E2%80%90inflammatory+drugs+in+cats%3A+a+review"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="bib50"><span class="bullet">50</span>
                     <span class="author">Stein U</span>,
<span class="author">Arlt F</span>,
<span class="author">Smith J</span>, et al.
<span class="articleTitle">Intervening in beta-catenin signaling by sulindac inhibits S100A4-dependent colon cancer metastasis</span>.
<i>Neoplasia</i>
                     <span class="pubYear">2011</span>;
 <span class="vol">13</span>:
 <span class="pageFirst">131</span>– <span class="pageLast">44</span>.
                     <div class="extra-links" id="e_1_2_5_51_2"><span><a href="/servlet/linkout?suffix=null&amp;dbid=16&amp;doi=10.1002%2Fijc.27730&amp;key=10.1593%2Fneo.101172" onclick="newWindow(this.href);return false" class="visitable">Crossref</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27730&amp;key=1%3ACAS%3A528%3ADC%252BC3MXivVensro%253D" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27730&amp;key=21403839" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27730&amp;key=000286944300005" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2011&pages=131-44&journal=Neoplasia&author=U+Stein&author=F+Arlt&author=J+Smith&title=Intervening+in+beta%E2%80%90catenin+signaling+by+sulindac+inhibits+S100A4%E2%80%90dependent+colon+cancer+metastasis"target="_blank">Google Scholar</a></span></div>
                  </li>
                  </ul>
            </div>
         </div>
      </section>
   </section>
   <div style="display:none">
      <ul class="custom-style-list noteList"></ul>
   </div>
   <div class="pb-dropzone" data-pb-dropzone="citedBy-dropzone"><section id="cited-by" class="article-section article-section__citedBy cited-by"><div class="accordion article-accordion"><h2><div tabindex="0" role="button" aria-controls="cited-by__content" aria-expanded="false" class="accordion__control"><span id="citedby-section" class="section__title">Citing Literature</span><i aria-hidden="true" class="icon-section_arrow_d"></i></div></h2><div id="cited-by__content" data-source="/pb/widgets/citedBy?page=0&amp;widgetId=f6d59956-1f70-4e88-8811-a42ff3d9d1fa&amp;pbContext=%3Bissue%3Aissue%3Adoi%5C%3A10.1002%2Fijc.v132.4%3Bpage%3Astring%3AArticle%2FChapter+View%3Barticle%3Aarticle%3Adoi%5C%3A10.1002%2Fijc.27730%3Bctype%3Astring%3AJournal+Content%3Bwebsite%3Awebsite%3Apericles%3Bjournal%3Ajournal%3A10970215%3Bwgroup%3Astring%3APublication+Websites%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3BrequestedJournal%3Ajournal%3A10970215" class="accordion__content cited-by__content"><div class="sciteMetricsDropzone"></div></div></div></section></div>
   </article></div></div><div class="col-lg-4 col-md-4 col-sm-4 hidden-xs hidden-sm hidden-md article-row-right"><div class="publication-cover-info clearfix">



        
        <div class="cover-image-wrapper cover-image__image hasDetails"><a href="/toc/10970215/2013/132/4" title="View Volume 132, Issue 4"><img src="/cms/asset/17892127-3ce6-4bcc-9dd3-52f0bb298032/ijc.v132.4.cover.gif" alt=""/></a></div><div class="extra-info-wrapper cover-image__details"><p class="volume-issue"><a href="/toc/10970215/2013/132/4" title="View Volume 132, Issue 4"><span>Volume</span><span class="val">132</span>, <span>Issue</span><span class="val">4</span></a></p><p>15 February 2013</p><p class="page-range"><span>Pages</span><span> 795-806</span></p>



        
        
</div>
</div>



        
        <div>



        
        



        <div class="pb-ad">
            <div id="advert-rail-1" class="advert advert-rail">
			<script>

				googletag.cmd.push 		( function () {
					googletag.display 	( 'advert-rail-1' );
				});

			</script>

			<!-- No JavaScript support is a call to an image -->
			<noscript>
				<a href="/action/clickThrough?id=1011&url=https%3A%2F%2Fpubads.g.doubleclick.net%2Fgampad%2Fjump%3Fiu%3D%24googlePublisherCategory%26amp%3Bsz%3D160x600%7C160x320%7C160x160%7C120x600%26amp%3Btile%3D2%26amp%3Bc%3D%24random&loc=%2Fdoi%2F10.1002%2Fijc.27730&pubId=57787093&placeholderId=1014&productId=101018" target="_blank">
					<img src="https://pubads.g.doubleclick.net/gampad/ad?iu=$googlePublisherCategory&amp;sz=160x600|160x320|160x160|120x600&amp;tile=2&amp;c=$random">
				</a>
			</noscript>
		</div>
        </div>
    





        
        



        <div class="pb-ad">
            <aside>
	<div id="advert-rail-2" class="advert advert-rail">
		<script>

			googletag.cmd.push 		( function () {
				googletag.display 	( 'advert-rail-2' );
			});

		</script>

		<!-- No JavaScript support is a call to an image -->
		<noscript>
			<a href="/action/clickThrough?id=1012&url=https%3A%2F%2Fpubads.g.doubleclick.net%2Fgampad%2Fjump%3Fiu%3D%24googlePublisherCategory%26amp%3Bsz%3D160x600%7C160x320%7C160x160%7C120x600%26amp%3Btile%3D2%26amp%3Bc%3D%24random&loc=%2Fdoi%2F10.1002%2Fijc.27730&pubId=57787093&placeholderId=1013&productId=101018" target="_blank">
				<img src="https://pubads.g.doubleclick.net/gampad/ad?iu=$googlePublisherCategory&amp;sz=160x600|160x320|160x160|120x600&amp;tile=2&amp;c=$random">
			</a>
		</noscript>
	</div>
</aside>
        </div>
    

</div>
<div class="tabs__wrapper"><div data-default-tab="related" class="tab tab--slide tab--flex sticko__md tabs--xs dynamic-sticko article__tab  tab--flex  tabs--xs "><ul data-mobile-toggle="slide" role="tablist" class="rlist tab__nav w-slide--list"><li role="presentation" class="tab__nav__item"><a id="pane-pcw-figurescon" href="#pane-pcw-figures" data-slide-clone="self" aria-controls="#pane-pcw-figures" role="tab" data-toggle="tab" data-slide-target="#pane-pcw-figures" class="tab__nav__item__link article-row-right__tabLinks w-slide__btn figures-tab"><i aria-hidden="true" class="icon-multi-figure"></i><h2>Figures</h2></a></li><li role="presentation" class="tab__nav__item"><a id="pane-pcw-referencescon" href="#pane-pcw-references" data-slide-clone="self" aria-controls="#pane-pcw-references" role="tab" data-toggle="tab" data-slide-target="#pane-pcw-references" class="tab__nav__item__link article-row-right__tabLinks w-slide__btn references-tab"><i aria-hidden="true" class="icon-chain"></i><h2>References</h2></a></li><li role="presentation" class="tab__nav__item"><a id="pane-pcw-relatedcon" href="#pane-pcw-related" data-slide-clone="self" aria-controls="#pane-pcw-related" role="tab" data-toggle="tab" data-slide-target="#pane-pcw-related" class="tab__nav__item__link article-row-right__tabLinks w-slide__btn related-tab"><i aria-hidden="true" class="icon-related-circles-extend-button"></i><h2>Related</h2></a></li><li role="presentation" class="tab__nav__item"><a id="pane-pcw-detailscon" href="#pane-pcw-details" data-slide-clone="self" aria-controls="#pane-pcw-details" role="tab" data-toggle="tab" data-slide-target="#pane-pcw-details" class="tab__nav__item__link article-row-right__tabLinks w-slide__btn details-tab"><i aria-hidden="true" class="icon-Icon_Information"></i><h2>Information</h2></a></li></ul><div role="presentation" class="tab__content"><div id="pane-pcw-figures" aria-labelledby="pane-pcw-figurescon" role="tabpanel" class="tab__pane article-row-right__panes empty"></div><div id="pane-pcw-references" aria-labelledby="pane-pcw-referencescon" role="tabpanel" class="tab__pane article-row-right__panes empty"></div><div id="pane-pcw-related" aria-labelledby="pane-pcw-relatedcon" role="tabpanel" class="tab__pane article-row-right__panes"></div><div id="pane-pcw-details" aria-labelledby="pane-pcw-detailscon" role="tabpanel" class="tab__pane article-row-right__panes empty"><div class="contentTab"></div></div><div class="tab__spinner"><div class="tab__spinner--box"><img src="/ux3/releasedAssets/images/spinner.gif" id="spinner" alt=""/></div></div></div></div></div><div class="articleAdvert fixed-element"></div></div></div></article><script>var articleRef = document.querySelector('.article__body:not(.show-references) .article__references');
if (articleRef) { articleRef.style.display = "none"; }

</script><div id="figure-viewer" data-ux3-wrapper="figure-viewer" data-ux3-transformed-by="figureInit" data-ux3-role="parent" role="dialog" class="figure-viewer"><div class="figure-viewer__reg__top clearfix"><div class="figure-viewer__top__right"><a href="#" data-ux3-role="controller" role="button" class="figure-viewer__ctrl__close"><span class="icon-close_thin"><span class="sr-only">Close Figure Viewer</span></span></a></div><div class="figure-viewer__top__left"><a href="#" role="button" class="figure-viewer__ctrl__return is-hidden"><span class="icon-arrow-left"><span class="sr-only">Return to Figure</span></span></a><button title="zoom out" class="figure-viewer__label__zoom icon-zoom-out zoom-out"></button><span tabindex="1" class="zoomSlider js__zoom-slider ui-slider"><input type="range" class="zoom-range"/></span><button title="zoom in" class="figure-viewer__label__zoom icon-zoom-in zoom-in"></button></div></div><div class="figure-viewer__reg__center"><div class="figure-viewer__cent__left"><div class="figure-viewer__hold__fig"><figure class="holder"></figure></div><a href="#" role="button" class="figure-viewer__ctrl__prev"><span class="icon-arrow_l"><span class="sr-only">Previous Figure</span></span></a><a href="#" role="button" class="figure-viewer__ctrl__next"><span class="icon-arrow_r"><span class="sr-only">Next Figure</span></span></a><div class="figure-viewer__hold__list clearfix container"></div></div><div class="figure-viewer__cent__right"><div class="figure-viewer__title"><a title="Open/Close Caption" href="#" class="figure-viewer__ctrl__caption"><span class="icon-doublearrow"></span><span class="figure-viewer__caption__label">Caption</span></a><span class="figure-viewer__title__text"></span></div><div class="figure-viewer__hold__figcap"></div></div></div></div>




        
        <div style="text-align: right!important;"><a style="font-weight: 300!important; font-size: 90%;" href="/doi/pdf/10.1002/ijc.27730">Download PDF</a></div>
</div>
</div></div></div>

        </section>
    
        </div>
    </div><!--end pagefulltext-->
</main>

        </div>
    










        <div data-widget-def="pageFooter" data-widget-id="053994f3-7d80-4bb1-97a4-c67fbc4768cd" class="pageFooter">
        



        
        <footer class="page-footer">
    <div data-pb-dropzone="main">
    



        
        <div class="main-footer">



        
        <style>
    .footer-links {
        text-align: center;
    }
    .footer-links h3 {
        font-weight: 300;
    }
    .footer-links a {
        font-weight: 600;
    }
    @media (min-width: 992px) {
        .footer-links {
            text-align: left;
        }
    }
</style>










        <div data-widget-def="ux3-layout-widget" data-widget-id="2753bec1-a79d-4403-827b-6c788ddd6db3" class="footer-sections">
        



        
            <h2 class="sr-only">
                Additional links
            </h2>
        
        <div class="container"><div class="row"><div class=" col-md-3">



        
        <div class="footer-links mb-3">
  <h3>About Wiley Online Library</h3>
  <ul class="rlist">
    <li><a href="https://www.wiley.com/privacy">Privacy Policy</a></li>
    <li><a href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms of Use</a></li>
    <li><a href="https://onlinelibrary.wiley.com/cookies">Cookies</a></li>
    <li><a href="https://onlinelibrary.wiley.com/accessibility">Accessibility</a></li>
        <li><a href="https://onlinelibrary.wiley.com/publishing-policies">Publishing Policies</a></li>
  </ul>
</div>
</div><div class=" col-md-3">



        
         <div class="footer-links mb-3">
    <h3>Help & Support</h3>
    <ul class="rlist">
      <li><a href="https://hub.wiley.com/community/support/onlinelibrary">Contact Us</a></li>
      <li><a href="https://www.wiley.com/customer-success/wiley-online-library-training-hub">Training and Support</a></li>
    <li><a href="https://onlinelibrary.wiley.com/dmca-notification-policy">DMCA &amp; Reporting Piracy</a></li>
 
    </ul>
  </div>
</div><div class=" col-md-3">



        
         <div class="footer-links mb-3">
    <h3>Opportunities</h3>
    <ul class="rlist">
      <li><a href="https://onlinelibrary.wiley.com/agents">Subscription Agents</a></li>
      <li><a href="https://onlinelibrary.wiley.com/advertisers">Advertisers & Corporate Partners</a></li>
    </ul>
  </div>
</div><div class=" col-md-3">



        
        <div class="footer-links mb-3">
    <h3>Connect with Wiley</h3>
    <ul class="rlist">
      <li><a href="https://www.wiley.com/network">The Wiley Network</a></li>
      <li><a href="https://newsroom.wiley.com/">Wiley Press Room</a></li>
    </ul>
  </div>
</div></div></div>

        </div>
    










        <div data-widget-def="ux3-layout-widget" data-widget-id="86584e25-e4db-4118-9550-9b4f5341a4ac" class="copyright-container">
        



        
        <div class="container"><div class="row"><div class=" col-md-12">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="bfbf6c5d-a650-4662-828f-5275fada9120" class="copyright">
        



        
        <div class="copyright pull-left">Copyright &copy; 1999-2022 <a href="https://www.wiley.com">John Wiley &amp; Sons, Inc</a>. All rights reserved</div>

        </div>
    




        
        <div class="footer-logo pull-right">
        
<a href="https://www.wiley.com" title="Wiley Home Page" aria-label="Wiley"><img alt="Wiley Home Page" src="/pb-assets/tmp-images/footer-logo-wiley-1510029248417.png"></a>

</div>
</div></div></div>

        </div>
    
</div>
    </div>
</footer>

        </div>
    




        
        <!--  -->  <div id="iucr-failure"> <p><i class="icon-notice"></i>The full text of this article hosted at iucr.org is unavailable due to technical difficulties.<a href="#" class="close-iucr-failure"><i class="icon-x"></i></a> </p> </div> 




        
        


















<div class="popup login-popup hidden" role="dialog" tabindex="-1" aria-labelledby="loginPopupHead">



    <div class="content">
        <a href="#" role="button" aria-label="Cancel Login" class="close">
            <i class="icon-tools_close" aria-hidden="true"></i>
        </a>
        <div class="modal__header">
            

<div class="header_logo">
    <img src="/pb-assets/hub-assets/pericles/logo-header-1526603583437.png" alt="">
</div>
        </div>

        <div class="modal__body">
            <div class="ssoLogin">
                
            </div>

            <h2 id="loginPopupHead">Log in to Wiley Online Library</h2>

            































<div class="login-form">
    

    

    
    <form action="/action/doLogin?societyURLCode=" class="bordered" method="post"><input type="hidden" name="id" value="67065c09-4a88-49cd-934c-ac707951d35c" />
        
            <input type="hidden" name="popup" value="true" />
        
        

        
        <input type="hidden" name="loginUri" value="/doi/10.1002/ijc.27730" />
        
            





        <input type="hidden" name="redirectUri" value="/doi/10.1002/ijc.27730" />
    

<input type="hidden" name="loginUri" value="/doi/10.1002/ijc.27730" />
            
        
        
        
                






















    
    
        
    <div class="input-group">
        <div class="label">

            
                    <label for="username">Email or Customer ID</label>
                
        </div>
        
        
                <input id="username" class="login" type="text" name="login" value="" size="15" placeholder="Enter your email"autocorrect="off"spellcheck="false"autocapitalize="off"required="true" />
            
        
                    
                        <div class="actions">
                            
                        </div>
                    
                
    </div>


                
                



















    
    <div class="input-group">
        <div class="label">
            <label for="password">Password</label>
        </div>
        
        
                <input id="password" class="password" type="password" name="password" value="" autocomplete="off" placeholder="Enter your password"autocorrect="off"spellcheck="false"autocapitalize="off"required="true" />
            
        <span class="password-eye-icon icon-eye hidden"></span>
        
                
    </div>

                
                    
                        <div class="actions">
                            
                            <a href="/action/requestResetPassword" class="link show-request-reset-password">
                                Forgot password?
                            </a>
                        </div>
                    
                
            
        
        <div class="loginExtraBeans-dropZone" data-pb-dropzone="loginExtraBeans">
            
        </div>

        
                <div class="align-end">
                    
                    
                            
                            <span class="submit ">
                                <input class="button btn submit primary no-margin-bottom accessSubmit" type="submit" name="submitButton" value="Log In" />
                            </span>
                        
                </div></form>
    <div class="societySpecificInstructions">
        
    </div>
</div>

            
                <div class="login-container clearfix form-btn">
                    <a href="/action/registration" class="linkBtn float-left">
                        
                        NEW USER <span aria-hidden="true">></span>
                    </a>
                    
                        <a href="/action/ssostart?redirectUri=%2Fdoi%2F10.1002%2Fijc.27730" class="linkBtn float-right instituation-login">
                            
                            INSTITUTIONAL LOGIN <span aria-hidden="true">></span>
                        </a>
                    
                </div>
            

        </div>
    </div>
</div>




        
        






<div class="popup change-password-drawer hidden" role="dialog" tabindex="-1" aria-labelledby="changePasswordPopupHead">
    <div class="content">
        <a href="#" class="close cancel" role="button" aria-label="close dialog"><i class="icon-close_thin"></i></a>
        <div class="modal__header">
            

<div class="header_logo">
    <img src="/pb-assets/hub-assets/pericles/logo-header-1526603583437.png" alt="">
</div>

            <h2 id="changePasswordPopupHead">Change Password</h2>
        </div>
        <div class="modal__body">

            <div class="form">

                <form action="/action/changePassword" method="post"><div class="message error"></div>
                    <input type="hidden" name="submit" value="submit" />
                    <div class="input-group">
                        <div class="label">
                            <label for="a589574e-bb98-4c6e-8fed-67365ff05357-old">Old Password</label>
                        </div>
                        <input id="a589574e-bb98-4c6e-8fed-67365ff05357-old" class="old" type="password" name="old" value="" autocomplete="off" />
                        <span class="password-eye-icon icon-eye hidden"></span>
                    </div>
                    <div class="input-group">
                        <div class="label">
                            <label for="a589574e-bb98-4c6e-8fed-67365ff05357-new">New Password</label>
                        </div>
                        <input id="a589574e-bb98-4c6e-8fed-67365ff05357-new" class="pass-hint new" type="password" name="new" value="" autocomplete="off" />
                        <span class="password-eye-icon icon-eye hidden"></span>
                        
                            







    


    


    


<div class="password-strength-indicator" data-min="10" data-max="32" data-strength="3">
    <span class="text too-short">Too Short</span>
    <span class="text weak">Weak</span>
    <span class="text medium">Medium</span>
    <span class="text strong">Strong</span>
    <span class="text very-strong">Very Strong</span>
    <span class="text too-long">Too Long</span>
</div>
                        
                    </div>
                    <input class="button primary submit" type="submit" value="Submit" disabled="disabled" /></form>
                <a href="#" class="fakeFormLastElement"></a>
            </div>
            <div class="success-template hidden">
                <h2>Password Changed Successfully</h2>
                <p>Your password has been changed</p>
            </div>
        </div>
    </div>
</div>





        
        





<div class="popup registration-popup hidden"  role="dialog" tabindex="-1" aria-labelledby="createAccountPopupHead">



    <div class="content">
        <a href="#" class="close" role="button" aria-label="close dialog"><i class="icon-tools_close"></i></a>
        <div class="modal__header">
            <div class="logoDropZone" data-pb-dropzone="logoDropZone">
                
            </div>

            <h2 id="createAccountPopupHead">Create a new account</h2>
        </div>

        <div class="modal__body">
            <form action="/action/registration" class="registration-form" method="post"><input type="hidden" name="redirectUri" value="/doi/10.1002/ijc.27730" />
                <div class="input-group">
                    <div class="label">
                        <label for="4e647394-f751-4441-baa4-df426bca4b6e.email">Email or Customer ID</label>
                    </div>
                    <input id="4e647394-f751-4441-baa4-df426bca4b6e.email" class="email" type="text" name="email" value="" size="15" />
                </div>
                <div class="submit">
                    <input class="button submit primary" type="submit" value="Register" />
                </div></form>
            <div class="center">
                <a href="/action/showLogin" class="show-login">
                    
                    Returning user
                </a>
            </div>
        </div>
    </div>
</div>




        
        



<div class="popup top-drawer request-reset-password-drawer hidden" role="dialog" tabindex="-1" aria-labelledby="resetPasswordPopupHead">
    <div class="content">
        <div class="modal__header">
            <a href="#" class="cancel close" role="button" aria-label="close dialog"><i class="icon-close_thin"></i></a>

            

<div class="header_logo">
    <img src="/pb-assets/hub-assets/pericles/logo-header-1526603583437.png" alt="">
</div>

            <h2 id="resetPasswordPopupHead">Forgot your password?</h2>
            <p class="sub">Enter your email address below. </p>

        </div>

        <div class="modal__body">

            









<div class="error"></div>


<form action="/action/requestResetPassword" class="request-reset-password-form" method="post"><input type="hidden" name="requestResetPassword" value="true" />
    
            <div class="input-group">
                






















    
    
        
    <div class="input-group">
        <div class="label">

            
                    <label for="email">Email or Customer ID</label>
                
        </div>
        
        
                <input id="email" class="email" type="text" name="email" value="" size="15" placeholder="Enter your email"autocorrect="off"spellcheck="false"autocapitalize="off" />
            
        
    </div>

            </div>
        


    
            <div class="password-recaptcha-ajax"></div>
        

    <div class="message error"></div>

    <div class="form-btn">
        <input class="button btn primary submit" type="submit" name="submit" value="RESET PASSWORD" disabled="disabled" />
    </div></form>
            

            <div class="success-template hidden">

                <p>Please check your email for instructions on resetting your password.
                    If you do not receive an email within 10 minutes, your email address may not be registered,
                    and you may need to create a new Wiley Online Library account.</p>

            </div>
        </div>
    </div>
</div>





        
        <div><div class="pb-dropzone" data-pb-dropzone="col-0" title="col-0"></div></div>




        
        




<div class="popup top-drawer request-username-drawer username-popup hidden"  role="dialog" tabindex="-1" aria-labelledby="requestUsernamePopupHead">
    <a href="#" class="close" role="button" aria-label="close dialog"><i class="icon-close_thin"></i></a>
    <div class="content">
        <h2 id="requestUsernamePopupHead">Request Username</h2>
        <div class="form">
            <p>Can't sign in? Forgot your username?</p>
            <p class="sub">Enter your email address below and we will send you your username</p>
            <div class="message error"></div>
            <form action="/action/requestUsername" method="post"><input type="hidden" name="requestUsername" value="requestUsername" />
                <div class="input-group">
                    <div class="label">
                        <label for="ac834f24-aa07-4ad2-9d13-f77c843f21cb.email">Email or Customer ID</label>
                    </div>
                    <input id="ac834f24-aa07-4ad2-9d13-f77c843f21cb.email" class="email" type="text" name="email" value="" size="15" />
                </div>

                <div class="username-recaptcha-ajax">
                </div>

                <input class="button primary submit" type="submit" name="submit" value="Submit" disabled="disabled" />
                <div class="center">
                    <a href="#" class="cancel">Close</a>
                </div></form>
        </div>
        <div class="success-template hidden note">
            <p>If the address matches an existing account you will receive an email with instructions to retrieve your username</p>
        </div>
    </div>
</div>




        
        <!-- Belongs at the bottom of the page -->

<script type="text/javascript">
if(window._satellite) { 
_satellite.pageBottom(); 
}
</script>
        </div>
    </div>








<script src="/products/acropolis/pericles/releasedAssets/js/build.lazyload.bundle-5a18e39b1102801a673f.js"></script><script src="/products/acropolis/pericles/releasedAssets/js/main.bundle-5d90fdc14b265e545d95.js"></script>
<script type="text/javascript" src="/wro/l0m7~product.js"></script>

<script>var _prum=[['id','59e8fecb3847311aab7b23c6'],['mark','firstbyte',(new Date()).getTime()]];(function(){var s=document.getElementsByTagName('script')[0],p=document.createElement('script');p.async='async';p.src='//rum-static.pingdom.net/prum.min.js';s.parentNode.insertBefore(p,s);})();</script>
















<script>
    $(document).ready(function () {
        var start = new Date();
        var doi = $("meta[name='dc.identifier']").attr('content');
        $(window).unload(function () {
            var end = new Date();
            $.ajax({
                url: '/action/analytics',
                method: 'post',
                data: {
                    'Duration': end - start,
                    'DOI': doi,
                    'EventType': 'FullTextDuration'
                },
                async: false
            });
        });

        window.onafterprint = function () {
            $.ajax({
                url: '/action/analytics',
                method: 'post',
                data: {
                    'DOI': doi,
                    'EventType': 'FullTextPrint'
                }
            });
        };
    });
</script>
<script type="text/javascript">(function(){window['__CF$cv$params']={r:'6e7ad8586de17e4c',m:'wOGV4YWd6jKeXBk6IilERc17ihwIs1h02fy_WO63dIs-1646567126-0-AQJrhRO92vXv1e1o2Es/hSmth10eztTRiV6OccRPX1vR02fwkjaTHDXyUhxbIiJOjoeE+v/j8xU/owOe6HKMPRaXfVFtB7JWBi3Aqwt3jdoIDRpaOaw6jxojRs6pOpTEwcBS/RoP/OYJfdT3f1Q1gRg=',s:[0xf630fca0cb,0x95bf367527],}})();</script><script defer src="https://static.cloudflareinsights.com/beacon.min.js/v652eace1692a40cfa3763df669d7439c1639079717194" integrity="sha512-Gi7xpJR8tSkrpF7aordPZQlW2DLtzUlZcumS8dMQjwDHEnw9I7ZLyiOj/6tZStRBGtGgN6ceN6cMH8z7etPGlw==" data-cf-beacon='{"rayId":"6e7ad8586de17e4c","token":"f3dd54df2ac243bab2129483f57546d1","version":"2021.12.0","si":100}' crossorigin="anonymous"></script>
</body>
</html>
